molecule_chembl_id,canonical_smiles,target_pref_name,standard_type,standard_value,assay_description,bioactivity_class,assay_chembl_id
CHEMBL177468,C(=C1\CCc2ccccc21)\c1c[nH]cn1,Cytochrome P450 11B2,IC50,41,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL178036,C(=C1/CCc2ccccc21)\c1c[nH]cn1,Cytochrome P450 11B2,IC50,11,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL367483,N#Cc1ccc2c(c1)CCC/C2=C/c1c[nH]cn1,Cytochrome P450 11B2,IC50,22.7,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL177921,N#Cc1ccc2c(c1)CC/C2=C\c1c[nH]cn1,Cytochrome P450 11B2,IC50,35.9,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL175091,N#Cc1ccc2c(c1)CC/C2=C/c1ncc[nH]1,Cytochrome P450 11B2,IC50,35.7,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL175144,Clc1ccc2c(c1)/C(=C/c1c[nH]cn1)CCC2,Cytochrome P450 11B2,IC50,47.3,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL359817,Fc1ccc2c(c1)CC/C2=C\c1c[nH]cn1,Cytochrome P450 11B2,IC50,16.7,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL362187,C(=C1\CCCc2ccccc21)\c1c[nH]cn1,Cytochrome P450 11B2,IC50,24.8,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL367719,C(=C1/CCCc2ccccc21)\c1c[nH]cn1,Cytochrome P450 11B2,IC50,9.6,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL179247,Fc1ccc2c(c1)CC/C2=C/c1c[nH]cn1,Cytochrome P450 11B2,IC50,13.9,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL177692,Clc1ccc2c(c1)CC/C2=C\c1c[nH]cn1,Cytochrome P450 11B2,IC50,88.8,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL175688,Clc1ccc2c(c1)CC/C2=C/c1c[nH]cn1,Cytochrome P450 11B2,IC50,3.7,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL177293,Brc1ccc2c(c1)CC/C2=C\c1c[nH]cn1,Cytochrome P450 11B2,IC50,92.8,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL174579,Brc1ccc2c(c1)CC/C2=C/c1c[nH]cn1,Cytochrome P450 11B2,IC50,10.3,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL9298,N#Cc1ccc(C2CCCc3cncn32)cc1,Cytochrome P450 11B2,IC50,1,In vitro inhibition of [14C]deoxycorticosterone binding to human cytochrome P450 11B2 expressed in hamster V79 MZh cells,active,CHEMBL831483
CHEMBL176118,Brc1ccc2c(c1)CC/C2=C/c1cccnc1,Cytochrome P450 11B2,IC50,171,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL176609,COc1ccc2c(c1)CC/C2=C\c1cccnc1,Cytochrome P450 11B2,IC50,34,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL176101,COc1ccc2c(c1)CC/C2=C/c1cccnc1,Cytochrome P450 11B2,IC50,26,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL362441,COc1ccc2c(c1)CCC/C2=C\c1cccnc1,Cytochrome P450 11B2,IC50,57,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL176098,COc1ccc2c(c1)CCC/C2=C/c1cccnc1,Cytochrome P450 11B2,IC50,878,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL425323,CCOc1ccc2c(c1)CC/C2=C\c1cccnc1,Cytochrome P450 11B2,IC50,79,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL176886,CCOc1ccc2c(c1)CC/C2=C/c1cccnc1,Cytochrome P450 11B2,IC50,248,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL368305,Cc1cccc2c1CC/C2=C\c1cccnc1,Cytochrome P450 11B2,IC50,108,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL366490,Fc1cccc2c1CC/C2=C\c1cccnc1,Cytochrome P450 11B2,IC50,21,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL176287,Clc1cccc2c1CC/C2=C\c1cccnc1,Cytochrome P450 11B2,IC50,9,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL369623,Clc1cccc2c1CC/C2=C/c1cccnc1,Cytochrome P450 11B2,IC50,31,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL175791,COc1cccc2c1/C(=C/c1cccnc1)CC2,Cytochrome P450 11B2,IC50,27,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL157101,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,Cytochrome P450 11B2,IC50,81,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL175962,C(=C1\CCc2ccccc21)\c1ccncc1,Cytochrome P450 11B2,IC50,8,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL179149,C(=C1/CCc2ccccc21)\c1ccncc1,Cytochrome P450 11B2,IC50,18,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL360026,C(=C1\CCCc2ccccc21)\c1ccncc1,Cytochrome P450 11B2,IC50,15,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL424960,Fc1ccc2c(c1)CC/C2=C\c1ccncc1,Cytochrome P450 11B2,IC50,15,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL179144,Fc1ccc2c(c1)CC/C2=C/c1ccncc1,Cytochrome P450 11B2,IC50,29,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL175554,Clc1ccc2c(c1)CC/C2=C\c1ccncc1,Cytochrome P450 11B2,IC50,18,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL175799,Clc1ccc2c(c1)CC/C2=C/c1ccncc1,Cytochrome P450 11B2,IC50,36,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL366773,Brc1ccc2c(c1)CC/C2=C\c1ccncc1,Cytochrome P450 11B2,IC50,24,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL179222,Brc1ccc2c(c1)CC/C2=C/c1ccncc1,Cytochrome P450 11B2,IC50,56,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL359942,COc1ccc2c(c1)CC/C2=C\c1ccncc1,Cytochrome P450 11B2,IC50,59,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL175609,COc1ccc2c(c1)CC/C2=C/c1ccncc1,Cytochrome P450 11B2,IC50,55,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL175979,COc1ccc2c(c1)CCC/C2=C\c1ccncc1,Cytochrome P450 11B2,IC50,22,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL363621,C(=C1/CCc2ccccc21)\c1cccnc1,Cytochrome P450 11B2,IC50,92,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL193606,C(=C1\CCCc2ccccc21)\c1cccnc1,Cytochrome P450 11B2,IC50,22,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL365120,C(=C1/CCCc2ccccc21)\c1cccnc1,Cytochrome P450 11B2,IC50,141,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL193997,Fc1ccc2c(c1)CC/C2=C\c1cccnc1,Cytochrome P450 11B2,IC50,7,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL383806,Fc1ccc2c(c1)CC/C2=C/c1cccnc1,Cytochrome P450 11B2,IC50,11,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL383807,Clc1ccc2c(c1)CC/C2=C\c1cccnc1,Cytochrome P450 11B2,IC50,26,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL193652,Clc1ccc2c(c1)CC/C2=C/c1cccnc1,Cytochrome P450 11B2,IC50,73,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL194440,Brc1ccc2c(c1)CC/C2=C\c1cccnc1,Cytochrome P450 11B2,IC50,37,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL193496,COc1ccc2c(c1)CCC/C2=C/c1ccncc1,Cytochrome P450 11B2,IC50,56,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL365314,COc1ccc2c(c1)/C(=C/c1ccncc1)CC2,Cytochrome P450 11B2,IC50,3,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL370281,COc1ccc2c(c1)/C(=C\c1ccncc1)CC2,Cytochrome P450 11B2,IC50,26,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL193858,COc1cc2c(cc1OC)/C(=C/c1ccncc1)CCC2,Cytochrome P450 11B2,IC50,11,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL371742,Cc1ccc2c(c1)/C(=C/c1ccncc1)CC2,Cytochrome P450 11B2,IC50,4,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL192077,Cc1ccc2c(c1)/C(=C\c1ccncc1)CC2,Cytochrome P450 11B2,IC50,8,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL192155,COc1ccc2c(c1)CC/C2=C\c1cncs1,Cytochrome P450 11B2,IC50,17,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL195354,COc1ccc2c(c1)CC/C2=C/c1cncs1,Cytochrome P450 11B2,IC50,5,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL195248,Fc1ccc2c(c1)CC/C2=C\c1cncnc1,Cytochrome P450 11B2,IC50,6,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL364956,Fc1ccc2c(c1)CC/C2=C/c1cncnc1,Cytochrome P450 11B2,IC50,0,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL195580,Fc1ccc2c(c1)CC/C2=C\c1cccc2ncccc12,Cytochrome P450 11B2,IC50,14,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL195653,Fc1ccc2c(c1)CC/C2=C/c1cccc2ncccc12,Cytochrome P450 11B2,IC50,31,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL370530,Fc1ccc2c(c1)CC/C2=C\c1cccc2cnccc12,Cytochrome P450 11B2,IC50,57,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL363849,Fc1ccc2c(c1)CC/C2=C/c1cccc2cnccc12,Cytochrome P450 11B2,IC50,65,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL371509,Fc1ccc2c(c1)CC/C2=C\c1ccnc2ccccc12,Cytochrome P450 11B2,IC50,20,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL371275,Fc1ccc2c(c1)CC/C2=C/c1ccnc2ccccc12,Cytochrome P450 11B2,IC50,14,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL194928,C(=C1c2ccccc2-c2ccccc21)c1cccnc1,Cytochrome P450 11B2,IC50,6,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL370317,C(=C(c1ccccc1)c1ccccc1)c1cccnc1,Cytochrome P450 11B2,IC50,9,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL383145,C(=C1c2ccccc2-c2ccccc21)c1ccncc1,Cytochrome P450 11B2,IC50,5,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL381194,C(=C(c1ccccc1)c1ccccc1)c1ccncc1,Cytochrome P450 11B2,IC50,22,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL195688,CC1C/C(=C\c2cccnc2)c2ccccc21,Cytochrome P450 11B2,IC50,13,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL373074,CC1C/C(=C/c2cccnc2)c2ccccc21,Cytochrome P450 11B2,IC50,41,In vitro inhibitory concentration against human CYP11B2 expressed in V79 MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL827844
CHEMBL193555,C(=C1\CC(c2ccccc2)c2ccccc21)\c1cccnc1,Cytochrome P450 11B2,IC50,3,In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL828695
CHEMBL364080,C(=C1\CCc2ccccc21)\c1cccnc1,Cytochrome P450 11B2,IC50,11,In vitro inhibitory concentration against human CYP11B2 expressed in V79 MZh hamster fibroblasts incubated with 100 nM of substrate deoxy-corticosterone in presence of the compound,active,CHEMBL827844
CHEMBL365735,c1cncc(-c2ccc3ccccc3c2)c1,Cytochrome P450 11B2,IC50,28,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL362968,COc1ccc2cc(-c3cccnc3)ccc2c1,Cytochrome P450 11B2,IC50,6,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL195571,Oc1ccc2cc(-c3cccnc3)ccc2c1,Cytochrome P450 11B2,IC50,23,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL193534,Brc1ccc2cc(-c3cccnc3)ccc2c1,Cytochrome P450 11B2,IC50,15,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL193343,CCOc1ccc2cc(-c3cccnc3)ccc2c1,Cytochrome P450 11B2,IC50,12,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL196796,N#Cc1ccc2cc(-c3cccnc3)ccc2c1,Cytochrome P450 11B2,IC50,3,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL197576,COc1ccc2cc(-c3cccnc3)ccc2c1Cl,Cytochrome P450 11B2,IC50,13,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL196328,COc1ccc2cc(-c3cccnc3)ccc2c1Br,Cytochrome P450 11B2,IC50,33,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL381014,COc1ccc2c(Cl)c(-c3cccnc3)ccc2c1Cl,Cytochrome P450 11B2,IC50,28,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL371430,COc1ccc2ccc(-c3cccnc3)c(Cl)c2c1,Cytochrome P450 11B2,IC50,29,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL363626,COc1cc2ccccc2cc1-c1cccnc1,Cytochrome P450 11B2,IC50,500,Inhibitory concentration against human cytochrome P450 11B2 expressing in V79 MZh cells using [14C]deoxycorticosterone as substrate measured by screening assay,active,CHEMBL881480
CHEMBL438802,COC(=O)c1ccc2cc(-c3cccnc3)ccc2c1,Cytochrome P450 11B2,IC50,72,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL195996,c1ccc2cc(-n3ccnc3)ccc2c1,Cytochrome P450 11B2,IC50,39,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL194472,COc1cc2ccccc2cc1-n1ccnc1,Cytochrome P450 11B2,IC50,19,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL195629,COc1ccc2cc(-n3ccnc3)ccc2c1,Cytochrome P450 11B2,IC50,218,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL193556,c1ccc2ncc(-n3ccnc3)cc2c1,Cytochrome P450 11B2,IC50,604,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL370822,c1ccc2cc(-c3cnc[nH]3)ccc2c1,Cytochrome P450 11B2,IC50,296,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL193653,c1ccc2cc(-c3cnco3)ccc2c1,Cytochrome P450 11B2,IC50,12,"Inhibitory concentration against human cytochrome P450 11B2 expressed in fission yeast, incubated with [14C]deoxycorticosterone",active,CHEMBL881288
CHEMBL372747,c1cncc(-c2ccc3cccc4c3c2CC4)c1,Cytochrome P450 11B2,IC50,10,Inhibition of aldosterone synthase (CYP11B2) expressed in V79 hamster fibroblasts,active,CHEMBL863925
CHEMBL199683,c1cncc(-c2ccc3c4c(cccc24)CC3)c1,Cytochrome P450 11B2,IC50,14,Inhibition of aldosterone synthase (CYP11B2) expressed in V79 hamster fibroblasts,active,CHEMBL863925
CHEMBL205782,C1=C(c2cccnc2)Cc2ccccc21,Cytochrome P450 11B2,IC50,13,Inhibition of human CYP11B2 expressed in V79 11B2 cells,active,CHEMBL860940
CHEMBL206125,C(=C\c1cccnc1)\c1ccccc1,Cytochrome P450 11B2,IC50,735,Inhibition of human CYP11B2 expressed in V79 11B2 cells,active,CHEMBL860940
CHEMBL207751,COc1ccc2c(c1)CCC(n1ccnc1)=C2,Cytochrome P450 11B2,IC50,411,Inhibition of human CYP11B2 expressed in V79 11B2 cells,active,CHEMBL860940
CHEMBL208471,C1=C(n2ccnc2)CCc2ccccc21,Cytochrome P450 11B2,IC50,334,Inhibition of human CYP11B2 expressed in V79 11B2 cells,active,CHEMBL860940
CHEMBL377576,C1=C(n2ccnc2)Cc2ccccc21,Cytochrome P450 11B2,IC50,448,Inhibition of human CYP11B2 expressed in V79 11B2 cells,active,CHEMBL860940
CHEMBL205250,CCC1CC(c2cccnc2)=Cc2ccccc21,Cytochrome P450 11B2,IC50,176,Inhibition of human CYP11B2 expressed in V79 11B2 cells,active,CHEMBL860940
CHEMBL206070,CC1CC(c2cccnc2)=Cc2ccccc21,Cytochrome P450 11B2,IC50,13,Inhibition of human CYP11B2 expressed in V79 11B2 cells,active,CHEMBL860940
CHEMBL206550,CC1Cc2ccccc2C=C1c1cccnc1,Cytochrome P450 11B2,IC50,5,Inhibition of human CYP11B2 expressed in V79 11B2 cells,active,CHEMBL860940
CHEMBL205503,CCC1=C(c2cccnc2)CCc2ccccc21,Cytochrome P450 11B2,IC50,30,Inhibition of human CYP11B2 expressed in V79 11B2 cells,active,CHEMBL860940
CHEMBL206283,CC1=C(c2cccnc2)CCc2ccccc21,Cytochrome P450 11B2,IC50,7,Inhibition of human CYP11B2 expressed in V79 11B2 cells,active,CHEMBL860940
CHEMBL206273,COc1ccc2c(c1)C=C(c1cccnc1)CC2,Cytochrome P450 11B2,IC50,45,Inhibition of human CYP11B2 expressed in V79 11B2 cells,active,CHEMBL860940
CHEMBL206351,COc1ccc2c(c1)CCC(c1cccnc1)=C2,Cytochrome P450 11B2,IC50,2,Inhibition of human CYP11B2 expressed in V79 11B2 cells,active,CHEMBL860940
CHEMBL206300,COc1ccc2c(c1)C=C(c1cccnc1)C2,Cytochrome P450 11B2,IC50,4,Inhibition of human CYP11B2 expressed in V79 11B2 cells,active,CHEMBL860940
CHEMBL205881,C1=C(c2cccnc2)CCc2ccccc21,Cytochrome P450 11B2,IC50,7,Inhibition of human CYP11B2 expressed in V79 11B2 cells,active,CHEMBL860940
CHEMBL445259,CCOc1cncc(-c2ccc3cc(OC)ccc3c2)c1,Cytochrome P450 11B2,IC50,5.1,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL500145,COc1cncc(C2=Cc3ccc(OC)cc3CC2C)c1,Cytochrome P450 11B2,IC50,1.2,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL502818,COc1cncc(-c2cc3ccc(OC)cc3cc2C)c1,Cytochrome P450 11B2,IC50,3.8,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL447591,COc1cncc(-c2ccc3cc(OC)ccc3c2)c1,Cytochrome P450 11B2,IC50,4.2,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL500636,COc1ccc2cc(-c3cncc(O)c3)ccc2c1,Cytochrome P450 11B2,IC50,94,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL453169,COc1ccc2cc(-c3cnccc3N)ccc2c1,Cytochrome P450 11B2,IC50,13,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL500665,Cc1ccncc1-c1ccc2cc(C#N)ccc2c1,Cytochrome P450 11B2,IC50,0.6,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL500664,COc1ccc2cc(-c3cnccc3C)ccc2c1,Cytochrome P450 11B2,IC50,0.8,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL500663,N#Cc1ccc2c(c1)CCC(c1cccnc1)=C2,Cytochrome P450 11B2,IC50,4.5,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL502266,COc1ccc2c(c1)CC(C)C(c1cccnc1)=C2,Cytochrome P450 11B2,IC50,3.3,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL499871,COc1ccc2cc(-c3cccnc3)c(C)cc2c1,Cytochrome P450 11B2,IC50,7,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL499044,COc1ccc2c(c1)CC(C)C(c1cncc3ccccc13)=C2,Cytochrome P450 11B2,IC50,0.5,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL525785,COc1ccc2cc(-c3cncc4ccccc34)c(C)cc2c1,Cytochrome P450 11B2,IC50,3.1,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL500394,COc1ccc2cc(-c3cncc4ccccc34)ccc2c1,Cytochrome P450 11B2,IC50,0.6,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL500393,COc1ccc2cc(-c3cncc(-c4ccccc4)c3)ccc2c1,Cytochrome P450 11B2,IC50,4.8,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL500392,COc1ccc2cc(-c3cncc(C(C)OC)c3)ccc2c1,Cytochrome P450 11B2,IC50,0.2,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL500395,COc1ccc2cc(-c3cncc(C(C)O)c3)ccc2c1,Cytochrome P450 11B2,IC50,0.5,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL500676,COCc1ccncc1-c1ccc2cc(OC)ccc2c1,Cytochrome P450 11B2,IC50,2.2,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL449894,COc1ccc2cc(-c3cnccc3CO)ccc2c1,Cytochrome P450 11B2,IC50,22,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL500421,COCc1cncc(-c2ccc3cc(OC)ccc3c2)c1,Cytochrome P450 11B2,IC50,0.2,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL448064,COc1ccc2cc(-c3cncc(CO)c3)ccc2c1,Cytochrome P450 11B2,IC50,9.1,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL526339,COC(=O)Cc1cncc(-c2ccc3cc(OC)ccc3c2)c1,Cytochrome P450 11B2,IC50,6.9,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL502824,COc1ccc2cc(-c3cncc(C(C)=O)c3)ccc2c1,Cytochrome P450 11B2,IC50,2.1,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL502823,COc1ccc2cc(-c3cncc(C(N)=O)c3)ccc2c1,Cytochrome P450 11B2,IC50,94,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL500146,COC(=O)c1cncc(-c2ccc3cc(OC)ccc3c2)c1,Cytochrome P450 11B2,IC50,0.8,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL1002226
CHEMBL496469,Br.Oc1ccc(-c2ccc3c(c2)CCCC3c2ccncc2)cc1F,Cytochrome P450 11B2,IC50,587,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,active,CHEMBL1004811
CHEMBL496456,Cl.Fc1ccc(-c2ccc3c(c2)CCCC3c2ccncc2)cc1F,Cytochrome P450 11B2,IC50,567,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,active,CHEMBL1004811
CHEMBL496289,Cl.Fc1ccc(-c2ccc3c(c2)CCCC3c2ccncc2)cc1,Cytochrome P450 11B2,IC50,518,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,active,CHEMBL1004811
CHEMBL496288,Cl.Fc1ccc(-c2ccc3c(c2)CCC3c2ccncc2)cc1,Cytochrome P450 11B2,IC50,543,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,active,CHEMBL1004811
CHEMBL496286,Br.Oc1ccc(-c2ccc3c(c2)CCC=C3c2ccncc2)cc1F,Cytochrome P450 11B2,IC50,991,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,active,CHEMBL1004811
CHEMBL497481,Cl.Fc1ccc(-c2ccc3c(c2)CCC=C3c2ccncc2)cc1F,Cytochrome P450 11B2,IC50,311,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,active,CHEMBL1004811
CHEMBL497480,Cl.Fc1ccc(-c2ccc3c(c2)CCC=C3c2ccncc2)cc1,Cytochrome P450 11B2,IC50,121,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,active,CHEMBL1004811
CHEMBL496263,COc1ccc(-c2ccc3c(c2)CCCC3(O)c2ccncc2)cc1F,Cytochrome P450 11B2,IC50,945,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,active,CHEMBL1004811
CHEMBL498652,OC1(c2ccncc2)CCCc2cc(-c3ccc(F)cc3)ccc21,Cytochrome P450 11B2,IC50,840,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,active,CHEMBL1004811
CHEMBL539168,COc1ccc(-c2ccc3c(c2)CCC3(O)c2ccncc2)cc1F,Cytochrome P450 11B2,IC50,436,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,active,CHEMBL1004811
CHEMBL498472,OC1(c2ccncc2)CCc2cc(-c3ccc(F)cc3)ccc21,Cytochrome P450 11B2,IC50,816,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,active,CHEMBL1004811
CHEMBL492892,O=C(c1ccc(OC(F)(F)F)cc1)c1cc2ccccc2cc1-c1cccnc1,Cytochrome P450 11B2,IC50,28,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL492891,N#Cc1ccc(C(=O)c2cc3ccccc3cc2-c2cccnc2)cc1,Cytochrome P450 11B2,IC50,30,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL501779,COc1ccc(C(=O)c2cc3ccccc3cc2-c2cccnc2)cc1F,Cytochrome P450 11B2,IC50,65,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL494515,COc1ccc(C(=O)c2cc3ccccc3cc2-c2cccnc2)cc1,Cytochrome P450 11B2,IC50,119,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL494315,COc1ccc(Cc2cc3cc(OC)ccc3cc2-c2cncc3ccccc23)cc1,Cytochrome P450 11B2,IC50,5,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL522860,COc1ccc(Cc2cc3ccccc3cc2-c2cncc3ccccc23)cc1,Cytochrome P450 11B2,IC50,3,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL495333,COc1cncc(-c2cc3ccc(OC)cc3cc2Cc2ccccc2)c1,Cytochrome P450 11B2,IC50,24,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL493089,COc1ccc(Cc2cc3cc(OC)ccc3cc2-c2cncc(OC)c2)cc1,Cytochrome P450 11B2,IC50,7.6,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL446775,COc1ccc(Cc2cc3ccccc3cc2-c2cncc(OC)c2)cc1,Cytochrome P450 11B2,IC50,7.7,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL494713,COc1ccc(Cc2cc3cc(OC)ccc3cc2-c2cccnc2)cc1,Cytochrome P450 11B2,IC50,11,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL494712,FC(F)(F)Oc1ccc(Cc2cc3ccccc3cc2-c2cccnc2)cc1,Cytochrome P450 11B2,IC50,3.9,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL524011,N#Cc1ccc(Cc2cc3ccccc3cc2-c2cccnc2)cc1,Cytochrome P450 11B2,IC50,2.7,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL493082,COc1ccc(Cc2cc3ccccc3cc2-c2cccnc2)cc1,Cytochrome P450 11B2,IC50,7.8,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL523196,COc1ccc2cc(-c3cccnc3)c(Cc3ccccc3)cc2c1,Cytochrome P450 11B2,IC50,53,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL493485,c1ccc(Cc2cc3ccccc3cc2-c2cccnc2)cc1,Cytochrome P450 11B2,IC50,154,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL516643,O=c1c(C(c2ccc([N+](=O)[O-])cc2)n2ccnc2)coc2ccccc12,Cytochrome P450 11B2,IC50,187,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL158635,COc1ccc2c(=O)c(Cn3ccnc3)c(-c3ccccc3)oc2c1,Cytochrome P450 11B2,IC50,124,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL212473,COc1ccc(-c2oc3ccccc3c(=O)c2Cn2ccnc2)cc1,Cytochrome P450 11B2,IC50,11,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL377766,O=c1c(Cn2ccnc2)c(-c2ccc(Br)cc2)oc2ccccc12,Cytochrome P450 11B2,IC50,25,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL213588,O=c1c(Cn2ccnc2)c(-c2ccc([N+](=O)[O-])cc2)oc2ccccc12,Cytochrome P450 11B2,IC50,95,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL213587,O=c1c(Cn2ccnc2)c(-c2ccccc2)oc2ccccc12,Cytochrome P450 11B2,IC50,28,Inhibition of human adrenal corticoid CYP11B2 expressed in chinese hamster V79 MZh cells,active,CHEMBL971586
CHEMBL461457,c1cncc(-c2ccc3c(c2)CCCC3)c1,Cytochrome P450 11B2,IC50,29,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL461458,OC1CCc2cc(-c3cccnc3)ccc2C1,Cytochrome P450 11B2,IC50,44,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL460178,COC1CCc2cc(-c3cccnc3)ccc2C1,Cytochrome P450 11B2,IC50,3.3,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL459969,CCOC1CCc2cc(-c3cccnc3)ccc2C1,Cytochrome P450 11B2,IC50,30,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL459970,N#CC1CCc2cc(-c3cccnc3)ccc2C1,Cytochrome P450 11B2,IC50,5.1,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL461884,N#CC1=Cc2ccc(-c3cccnc3)cc2CC1,Cytochrome P450 11B2,IC50,1.6,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL461885,CN1CCOc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,101,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL462092,c1cncc(-c2ccc3c(c2)OCCO3)c1,Cytochrome P450 11B2,IC50,154,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL462093,O=C1CCc2cc(-c3cccnc3)ccc2C1,Cytochrome P450 11B2,IC50,7.8,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL448743,O=C1CCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,4.4,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL499007,COc1cncc(-c2ccc3c(c2)CCC(=O)C3)c1,Cytochrome P450 11B2,IC50,1.8,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL62811,O=C1CCc2cc(-c3cccnc3)ccc2N1,Cytochrome P450 11B2,IC50,28,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL459071,O=C1Cc2cc(-c3cccnc3)ccc2N1,Cytochrome P450 11B2,IC50,14,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL446083,CN1C(=O)CCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,2.6,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL457425,CCN1C(=O)CCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,22,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL457640,O=C1CCc2cc(-c3cccnc3)cc(Cl)c2N1,Cytochrome P450 11B2,IC50,3.8,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL457858,O=C1CCc2cc(-c3cccnc3)cc([N+](=O)[O-])c2N1,Cytochrome P450 11B2,IC50,64,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL457646,COc1cncc(-c2ccc3c(c2)CCC(=O)N3)c1,Cytochrome P450 11B2,IC50,2.7,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL457856,COc1cncc(-c2ccc3c(c2)CCC(=O)N3C)c1,Cytochrome P450 11B2,IC50,0.2,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL456390,O=C1CCc2cc(-c3cncc4ccccc34)ccc2N1,Cytochrome P450 11B2,IC50,0.2,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL451505,CN1C(=O)CCc2cc(-c3cncc4ccccc34)ccc21,Cytochrome P450 11B2,IC50,0.1,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL511329,S=C1CCc2cc(-c3cccnc3)ccc2N1,Cytochrome P450 11B2,IC50,3.1,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL508155,S=C1CCc2cc(-c3cccnc3)cc(Cl)c2N1,Cytochrome P450 11B2,IC50,4.2,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL509971,O=C1CSc2cc(-c3cccnc3)ccc2N1,Cytochrome P450 11B2,IC50,12,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,active,CHEMBL989835
CHEMBL349822,N#Cc1ccc(Cn2ccnc2)cc1,Cytochrome P450 11B2,IC50,372,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL377770,Fc1ccc(Cn2ccnc2)cc1,Cytochrome P450 11B2,IC50,330,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL441367,Clc1ccc(Cn2ccnc2)cc1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL211207,Brc1ccc(Cn2ccnc2)cc1,Cytochrome P450 11B2,IC50,479,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL590987,OCc1ccc(Cn2ccnc2)cc1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL598389,Nc1ccc(Cn2ccnc2)cc1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL163922,N#Cc1cccc(Cn2ccnc2)c1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL598390,Fc1cccc(Cn2ccnc2)c1,Cytochrome P450 11B2,IC50,815,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL608437,Clc1cccc(Cn2ccnc2)c1,Cytochrome P450 11B2,IC50,457,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL598391,Brc1cccc(Cn2ccnc2)c1,Cytochrome P450 11B2,IC50,365,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL597369,Nc1cccc(Cn2ccnc2)c1,Cytochrome P450 11B2,IC50,600,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL608140,COC(=O)CCc1cncn1Cc1ccccc1,Cytochrome P450 11B2,IC50,193,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL591229,COC(=O)CCc1cncn1Cc1ccc(C#N)cc1,Cytochrome P450 11B2,IC50,3.5,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL599622,COC(=O)CCc1cncn1Cc1ccc(F)cc1,Cytochrome P450 11B2,IC50,50,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL599623,COC(=O)CCc1cncn1Cc1ccc(Cl)cc1,Cytochrome P450 11B2,IC50,177,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL592614,COC(=O)CCc1cncn1Cc1ccc(Br)cc1,Cytochrome P450 11B2,IC50,4,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL599624,COC(=O)CCc1cncn1Cc1ccc(OC)cc1,Cytochrome P450 11B2,IC50,121,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL610794,OCCCc1cncn1Cc1ccccc1,Cytochrome P450 11B2,IC50,286,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL598399,N#Cc1ccc(Cn2cncc2CCCO)cc1,Cytochrome P450 11B2,IC50,13,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL591465,OCCCc1cncn1Cc1ccc(F)cc1,Cytochrome P450 11B2,IC50,16,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL598606,OCCCc1cncn1Cc1ccc(Cl)cc1,Cytochrome P450 11B2,IC50,55,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL598810,OCCCc1cncn1Cc1ccc(Br)cc1,Cytochrome P450 11B2,IC50,6.2,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL597577,COc1ccc(Cn2cncc2CCCO)cc1,Cytochrome P450 11B2,IC50,59,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL463582,c1ccc(Cn2cncc2-c2ccccc2)cc1,Cytochrome P450 11B2,IC50,11,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL597578,N#Cc1ccc(Cn2cncc2-c2ccccc2)cc1,Cytochrome P450 11B2,IC50,1.7,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL610501,Fc1ccc(Cn2cncc2-c2ccccc2)cc1,Cytochrome P450 11B2,IC50,11,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL597101,Clc1ccc(Cn2cncc2-c2ccccc2)cc1,Cytochrome P450 11B2,IC50,5.8,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL597173,Brc1ccc(Cn2cncc2-c2ccccc2)cc1,Cytochrome P450 11B2,IC50,5.1,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL591697,COc1ccc(Cn2cncc2-c2ccccc2)cc1,Cytochrome P450 11B2,IC50,14,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL599222,COC(=O)OCc1cncn1Cc1ccc(C#N)cc1,Cytochrome P450 11B2,IC50,44,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL591698,COC(=O)c1cncn1Cc1ccc(C#N)cc1,Cytochrome P450 11B2,IC50,7,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL162496,Cc1cncn1Cc1ccc(C#N)cc1,Cytochrome P450 11B2,IC50,12,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL599223,N#Cc1ccc(Cn2cncc2Br)cc1,Cytochrome P450 11B2,IC50,23,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL611680,N#Cc1ccc(Cn2cncc2C=O)cc1,Cytochrome P450 11B2,IC50,62,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL599601,N#Cc1ccc(Cn2cncc2CO)cc1,Cytochrome P450 11B2,IC50,29,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL599602,N#Cc1ccc(Cn2cncc2-c2ccncc2)cc1,Cytochrome P450 11B2,IC50,407,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL599603,N#Cc1ccc(Cn2cncc2-c2ccccc2F)cc1,Cytochrome P450 11B2,IC50,2.3,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL610513,Cc1ccccc1-c1cncn1Cc1ccc(C#N)cc1,Cytochrome P450 11B2,IC50,3.7,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL598789,N#Cc1ccc(Cn2cncc2-c2cccc(F)c2)cc1,Cytochrome P450 11B2,IC50,5.5,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL607862,Cc1cccc(-c2cncn2Cc2ccc(C#N)cc2)c1,Cytochrome P450 11B2,IC50,5.2,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL598790,N#Cc1ccc(Cn2cncc2-c2ccc(F)cc2)cc1,Cytochrome P450 11B2,IC50,25,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL607567,Cc1ccc(-c2cncn2Cc2ccc(C#N)cc2)cc1,Cytochrome P450 11B2,IC50,117,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL287677,N#Cc1ccc([C@H]2CCCc3cncn32)cc1,Cytochrome P450 11B2,IC50,6,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL31215,N#Cc1ccc([C@@H]2CCCc3cncn32)cc1,Cytochrome P450 11B2,IC50,171,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL681,CCOC(=O)c1cncn1[C@H](C)c1ccccc1,Cytochrome P450 11B2,IC50,1.7,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,active,CHEMBL1072072
CHEMBL1172882,Oc1cccc(-c2ccc(Cc3ccncc3)cc2)c1,Cytochrome P450 11B2,IC50,261,Inhibition of human CYP11B2 expressed in hamster V79MZh cells,active,CHEMBL1177586
CHEMBL1173260,Oc1ccc(-c2ccc(Cc3ccncc3)cc2)cc1F,Cytochrome P450 11B2,IC50,110,Inhibition of human CYP11B2 expressed in hamster V79MZh cells,active,CHEMBL1177586
CHEMBL1172779,Oc1ccc(-c2ccc(Cc3ccncc3)cc2)cc1O,Cytochrome P450 11B2,IC50,948,Inhibition of human CYP11B2 expressed in hamster V79MZh cells,active,CHEMBL1177586
CHEMBL1172847,CC(C)=C(c1ccncc1)c1ccc(-c2ccc(O)c(O)c2)cc1,Cytochrome P450 11B2,IC50,974,Inhibition of human CYP11B2 expressed in hamster V79MZh cells,active,CHEMBL1177586
CHEMBL1171987,Nc1cccc(-c2ccc(Cc3ccncc3)cc2)c1,Cytochrome P450 11B2,IC50,921,Inhibition of human CYP11B2 expressed in hamster V79MZh cells,active,CHEMBL1177586
CHEMBL1173327,Nc1ccc(-c2ccc(Cc3ccncc3)cc2)cc1N,Cytochrome P450 11B2,IC50,368,Inhibition of human CYP11B2 expressed in hamster V79MZh cells,active,CHEMBL1177586
CHEMBL1209476,CC(C)CC1n2cncc2CN(Cc2ccc(F)cc2)S1(=O)=O,Cytochrome P450 11B2,IC50,2.5,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209553,CC(C)CC1n2cncc2CN(Cc2ccc(Cl)cc2)S1(=O)=O,Cytochrome P450 11B2,IC50,5.2,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209554,CC(C)CC1n2cncc2CN(Cc2ccccc2)S1(=O)=O,Cytochrome P450 11B2,IC50,18.6,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209555,CC(C)CC1n2cncc2CN(Cc2ccc(OC(F)(F)F)cc2)S1(=O)=O,Cytochrome P450 11B2,IC50,104,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209556,CC(C)CC1n2cncc2CN(Cc2ccc(C(F)(F)F)cc2)S1(=O)=O,Cytochrome P450 11B2,IC50,121,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209557,CC(C)CC1n2cncc2CN(C2CC2)S1(=O)=O,Cytochrome P450 11B2,IC50,1000,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209558,CC(C)CC1n2cncc2CN(CC2CC2)S1(=O)=O,Cytochrome P450 11B2,IC50,758,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209623,CC(C)CC1n2cncc2CN(Cc2cccs2)S1(=O)=O,Cytochrome P450 11B2,IC50,117,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209624,CC(C)CC1n2cncc2CN(C2(c3ccc(Cl)cc3)CC2)S1(=O)=O,Cytochrome P450 11B2,IC50,628,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209625,CC(C)CC1n2cncc2CN([C@@H](C)c2ccc(Cl)cc2)S1(=O)=O,Cytochrome P450 11B2,IC50,9.4,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209626,CC(C)CC1n2cncc2CN([C@H](C)c2ccc(Cl)cc2)S1(=O)=O,Cytochrome P450 11B2,IC50,61.7,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209627,C[C@@H](c1ccc(Cl)cc1)N1Cc2cncn2C(CC(C)(C)O)S1(=O)=O,Cytochrome P450 11B2,IC50,11.4,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209628,C[C@@H](c1ccc(Cl)cc1)N1Cc2cncn2C(CC2(C)COC2)S1(=O)=O,Cytochrome P450 11B2,IC50,7.8,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209693,COC(C)(C)CC1n2cncc2CN([C@@H](C)c2ccc(Cl)cc2)S1(=O)=O,Cytochrome P450 11B2,IC50,0.9,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209694,CC(C)OCC1n2cncc2CN([C@@H](C)c2ccc(Cl)cc2)S1(=O)=O,Cytochrome P450 11B2,IC50,0.8,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1208801,C[C@@H](c1ccc(Cl)cc1)N1Cc2cncn2C(CC2CC2)S1(=O)=O,Cytochrome P450 11B2,IC50,1.3,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209695,C[C@@H](c1ccc(Cl)cc1)N1Cc2cncn2C(C[C@@H](O)c2ccccc2)S1(=O)=O,Cytochrome P450 11B2,IC50,2.4,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209696,C[C@@H](c1ccc(Cl)cc1)N1Cc2cncn2C(C[C@H](O)c2ccccc2)S1(=O)=O,Cytochrome P450 11B2,IC50,0.3,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1209775,N#Cc1ccc(C2C(=O)N(Cc3ccccc3)Cc3cncn32)cc1,Cytochrome P450 11B2,IC50,40,Inhibition of human recombinant CYP11B2 by cell-based assay,active,CHEMBL1211863
CHEMBL1215664,Oc1ccc(-c2ccc(C(O)c3ccncc3)cc2)cc1,Cytochrome P450 11B2,IC50,341,Inhibition of human CYP11B2 expressed in hamster fibroblast,active,CHEMBL1219273
CHEMBL1215665,Nc1ccc(-c2ccc(Cc3ccncc3)cc2)cc1,Cytochrome P450 11B2,IC50,406,Inhibition of human CYP11B2 expressed in hamster fibroblast,active,CHEMBL1219273
CHEMBL1215730,CC(=O)Nc1cccc(-c2ccc(Cc3ccncc3)cc2)c1,Cytochrome P450 11B2,IC50,567,Inhibition of human CYP11B2 expressed in hamster fibroblast,active,CHEMBL1219273
CHEMBL1215732,Fc1cccc(-c2ccc(Cc3ccncc3)cc2)c1,Cytochrome P450 11B2,IC50,515,Inhibition of human CYP11B2 expressed in hamster fibroblast,active,CHEMBL1219273
CHEMBL1214660,Fc1ccc(-c2ccc(Cc3ccncc3)cc2)cc1F,Cytochrome P450 11B2,IC50,273,Inhibition of human CYP11B2 expressed in hamster fibroblast,active,CHEMBL1219273
CHEMBL1214735,c1cc(Cc2ccc(-c3ccsc3)cc2)ccn1,Cytochrome P450 11B2,IC50,331,Inhibition of human CYP11B2 expressed in hamster fibroblast,active,CHEMBL1219273
CHEMBL1214736,c1csc(-c2ccc(Cc3ccncc3)cc2)c1,Cytochrome P450 11B2,IC50,796,Inhibition of human CYP11B2 expressed in hamster fibroblast,active,CHEMBL1219273
CHEMBL1214737,c1cc(Cc2ccc(-c3ccc4[nH]ccc4c3)cc2)ccn1,Cytochrome P450 11B2,IC50,231,Inhibition of human CYP11B2 expressed in hamster fibroblast,active,CHEMBL1219273
CHEMBL1645418,O=C(Nc1cccnc1)c1cc(F)c(F)cc1F,Cytochrome P450 11B2,IC50,166,Inhibition of human aldosterone synthase expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate,active,CHEMBL1646712
CHEMBL1645416,O=C(Nc1cccnc1)c1ccc(F)c(F)c1,Cytochrome P450 11B2,IC50,53.5,Inhibition of human aldosterone synthase expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate,active,CHEMBL1646712
CHEMBL1645413,O=C(Nc1cccnc1)c1ccc([N+](=O)[O-])cc1,Cytochrome P450 11B2,IC50,145,Inhibition of human aldosterone synthase expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate,active,CHEMBL1646712
CHEMBL1645412,N#Cc1ccc(C(=O)Nc2cccnc2)cc1,Cytochrome P450 11B2,IC50,78,Inhibition of human aldosterone synthase expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate,active,CHEMBL1646712
CHEMBL1645409,O=C(Nc1cccnc1)c1ccc(Br)cc1,Cytochrome P450 11B2,IC50,104,Inhibition of human aldosterone synthase expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate,active,CHEMBL1646712
CHEMBL1645408,O=C(Nc1cccnc1)c1ccc(Cl)cc1,Cytochrome P450 11B2,IC50,65,Inhibition of human aldosterone synthase expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate,active,CHEMBL1646712
CHEMBL1645407,O=C(Nc1cccnc1)c1ccc(F)cc1,Cytochrome P450 11B2,IC50,82,Inhibition of human aldosterone synthase expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate,active,CHEMBL1646712
CHEMBL934,CC(C)(C(=O)c1cccnc1)c1cccnc1,Cytochrome P450 11B2,IC50,72,Inhibition of human aldosterone synthase expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate,active,CHEMBL1646712
CHEMBL1651508,c1ccc(C(Cn2ccnc2)(c2ccccc2)c2ccccc2)cc1,Cytochrome P450 11B2,IC50,8,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651507,c1ccc(C(c2ccccc2)(c2ccccc2)n2ccnc2)cc1,Cytochrome P450 11B2,IC50,11,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651495,Cc1c(C)c(C)c(Cn2ccnc2)c(C)c1C,Cytochrome P450 11B2,IC50,23,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1649605,Cc1cc(C)c(Cn2ccnc2)c(C)c1,Cytochrome P450 11B2,IC50,30,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651505,c1cn(CC23CC4CC(CC(C4)C2)C3)cn1,Cytochrome P450 11B2,IC50,30,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651496,c1ccc(-c2ccccc2Cn2ccnc2)cc1,Cytochrome P450 11B2,IC50,39,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651492,Cc1ccccc1Cn1ccnc1,Cytochrome P450 11B2,IC50,62,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651494,Cc1cc(C)cc(Cn2ccnc2)c1,Cytochrome P450 11B2,IC50,77,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1444873,Clc1ccc(Cn2cnc3ccccc32)cc1,Cytochrome P450 11B2,IC50,107,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651493,Cc1cccc(Cn2ccnc2)c1,Cytochrome P450 11B2,IC50,110,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651513,c1ccc(-c2ccc(Cn3ccnc3)o2)cc1,Cytochrome P450 11B2,IC50,372,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1328035,Cc1ccccc1Cn1cnc2ccccc21,Cytochrome P450 11B2,IC50,262,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651497,c1ccc(-c2cccc(Cn3ccnc3)c2)cc1,Cytochrome P450 11B2,IC50,265,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL403598,c1ccc(-c2csc(Cn3ccnc3)c2)cc1,Cytochrome P450 11B2,IC50,277,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651509,c1ccc(C(CCn2ccnc2)(c2ccccc2)c2ccccc2)cc1,Cytochrome P450 11B2,IC50,290,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1450329,Cc1cccc(Cn2cnc3ccccc32)c1,Cytochrome P450 11B2,IC50,309,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL212741,Cc1ccc(Cn2ccnc2)cc1,Cytochrome P450 11B2,IC50,320,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651498,c1ccc(-c2cc(Cn3ccnc3)cc(-c3ccccc3)c2)cc1,Cytochrome P450 11B2,IC50,332,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651514,c1ccc(-c2ccc(Cn3ccnc3)s2)cc1,Cytochrome P450 11B2,IC50,353,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1428763,Cc1ccc(Cn2cnc3ccccc32)cc1,Cytochrome P450 11B2,IC50,520,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651499,Cc1cc(C)cc(Cn2cnc3ccccc32)c1,Cytochrome P450 11B2,IC50,632,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1235146,c1ccc(-c2ccc(Cn3ccnc3)cc2)cc1,Cytochrome P450 11B2,IC50,637,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651506,c1ccc2c(c1)ncn2CC12CC3CC(CC(C3)C1)C2,Cytochrome P450 11B2,IC50,677,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL347547,c1ccc(Cn2cnc3ccccc32)cc1,Cytochrome P450 11B2,IC50,865,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1507088,Cc1cc(C)c(Cn2cnc3ccccc32)c(C)c1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651500,Cc1c(C)c(C)c(Cn2cnc3ccccc32)c(C)c1C,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651501,c1ccc(-c2ccccc2Cn2cnc3ccccc32)cc1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651504,c1ccc(-c2cc(Cn3cnc4ccccc43)cc(-c3ccccc3)c2)cc1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651510,c1ccc(C(c2ccccc2)(c2ccccc2)n2cnc3ccccc32)cc1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651511,c1ccc(C(Cn2cnc3ccccc32)(c2ccccc2)c2ccccc2)cc1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL1651512,c1ccc(C(CCn2cnc3ccccc32)(c2ccccc2)c2ccccc2)cc1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,active,CHEMBL1656353
CHEMBL225499,O=c1cc(Cn2ccnc2)c2ccc(OCc3ccccc3)cc2o1,Cytochrome P450 11B2,IC50,289,"Inhibition of human CYP11B2 expressed in Chinese hamster V79MZ cells using [1,2-3H]11-deoxycorticosterone/11-deoxycorticosterone",active,CHEMBL1694078
CHEMBL1765205,O=C1CCc2cc(-c3cccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,1.1,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765206,O=C1CCc2cc(-c3cccnc3)cc3c2N1CCC3,Cytochrome P450 11B2,IC50,2.4,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765207,COc1cncc(-c2cc3c4c(c2)CCN4C(=O)CC3)c1,Cytochrome P450 11B2,IC50,0.6,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765208,COc1cncc(-c2cc3c4c(c2)CCC(=O)N4CCC3)c1,Cytochrome P450 11B2,IC50,0.9,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765209,CCOc1cncc(-c2cc3c4c(c2)CCN4C(=O)CC3)c1,Cytochrome P450 11B2,IC50,1,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765210,CC(C)Oc1cncc(-c2cc3c4c(c2)CCN4C(=O)CC3)c1,Cytochrome P450 11B2,IC50,2.2,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765211,O=C1CCc2cc(-c3cncc(O)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,4.3,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765212,O=C1CCc2cc(-c3cncc(F)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,4.4,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765213,O=C1CCc2cc(-c3cncc(C(F)(F)F)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,5.9,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765214,O=C1CCc2cc(-c3cncc4ccccc34)cc3c2N1CC3,Cytochrome P450 11B2,IC50,0.2,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765215,O=C1CCc2cc(-c3cncc4ccccc34)cc3c2N1CCC3,Cytochrome P450 11B2,IC50,0.2,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765217,O=C1CCc2cc(-c3cncnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,56,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765218,O=C1CCc2cc(-n3ccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,89,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765219,O=C1CCc2cc(-c3cncc(-c4ccccc4)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,1.3,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765220,O=C1CCc2cc(-c3cncc(-c4ccccc4F)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,0.7,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765221,O=C1CCc2cc(-c3cncc(-c4cccc(F)c4)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,1.4,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765222,O=C1CCc2cc(-c3cncc(-c4ccc(F)cc4)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,0.9,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765223,O=C1CCc2cc(-c3cncc(-c4cc(F)ccc4F)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,3.6,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765224,O=C1CCc2cc(-c3cncc(-c4ccc(F)c(F)c4)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,2.3,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765225,O=C1CCc2cc(-c3cncc(-c4cc(F)cc(F)c4)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,18,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765226,COc1ccccc1-c1cncc(-c2cc3c4c(c2)CCN4C(=O)CC3)c1,Cytochrome P450 11B2,IC50,2.4,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765227,COc1cccc(-c2cncc(-c3cc4c5c(c3)CCN5C(=O)CC4)c2)c1,Cytochrome P450 11B2,IC50,4.6,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765228,COc1ccc(-c2cncc(-c3cc4c5c(c3)CCN5C(=O)CC4)c2)cc1,Cytochrome P450 11B2,IC50,1.4,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765229,O=C1CCc2cc(-c3cncc(-c4cccc(O)c4)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,1.2,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765230,O=C1CCc2cc(-c3cncc(-c4cccc(OC(F)(F)F)c4)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,16,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765231,O=C1CCc2cc(-c3cncc(-c4cccc(C(F)(F)F)c4)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,33,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1765232,S=C1CCc2cc(-c3cccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,1.2,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells assessed as conversion of [4-14C]-11-deoxycorticosterone substrate by HPTLC assay,active,CHEMBL1768362
CHEMBL1556445,c1cc(Cn2ccnc2)ccn1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL1440486,c1cncc(Cn2ccnc2)c1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011240,N#Cc1ncccc1Cn1ccnc1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011241,Brc1ccc(Cn2ccnc2)cn1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011242,Brc1ncccc1Cn1ccnc1,Cytochrome P450 11B2,IC50,911,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011243,Clc1ncc(Cn2ccnc2)cc1Br,Cytochrome P450 11B2,IC50,576,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011245,Fc1cccc(-c2ccc(Cn3ccnc3)cn2)c1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011246,Oc1ccc(-c2ccc(Cn3ccnc3)cn2)cc1F,Cytochrome P450 11B2,IC50,237,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL258097,COc1ccc(-c2ccc(Cn3ccnc3)cn2)cc1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL255759,COc1ccc(-c2ccc(Cn3ccnc3)cn2)cc1OC,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011248,Nc1ccc(-c2ccc(Cn3ccnc3)cn2)cc1,Cytochrome P450 11B2,IC50,528,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011249,Cc1ccc(-c2ccc(Cn3ccnc3)cn2)cc1N,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011250,N#Cc1cccc(-c2ccc(Cn3ccnc3)cn2)c1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011251,N#Cc1ccc(-c2ccc(Cn3ccnc3)cn2)cc1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011252,O=Cc1ccc(-c2ccc(Cn3ccnc3)cn2)cc1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011254,c1ccc2cc(-c3ccc(Cn4ccnc4)cn3)ccc2c1,Cytochrome P450 11B2,IC50,782,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011255,c1ccc(-c2cc(Cn3ccnc3)cnc2-c2ccccc2)cc1,Cytochrome P450 11B2,IC50,851,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011257,c1cc(-c2ccc(Cn3ccnc3)cn2)ccn1,Cytochrome P450 11B2,IC50,487,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011259,COc1ccc(-c2ccc(Cn3ccnc3)cn2)cn1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011260,c1ccc2c(-c3ccc(Cn4ccnc4)cn3)cncc2c1,Cytochrome P450 11B2,IC50,914,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011263,Clc1ccc(-c2ccc(Cn3ccnc3)cn2)s1,Cytochrome P450 11B2,IC50,929,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011264,O=Cc1ccc(-c2ccc(Cn3ccnc3)cn2)s1,Cytochrome P450 11B2,IC50,968,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011430,Clc1ncc(Cn2ccnc2)cc1-c1cccs1,Cytochrome P450 11B2,IC50,416,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011431,c1csc(-c2ncccc2Cn2ccnc2)c1,Cytochrome P450 11B2,IC50,251,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011432,c1ccc2sc(-c3ccc(Cn4ccnc4)cn3)cc2c1,Cytochrome P450 11B2,IC50,281,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011436,c1ccc2oc(-c3ccc(Cn4ccnc4)cn3)cc2c1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2011437,c1coc(-c2cc(Cn3ccnc3)cnc2-c2ccco2)c1,Cytochrome P450 11B2,IC50,830,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,active,CHEMBL2015356
CHEMBL2163652,CC(c1cc2c3c(c1)CCN3C(=O)CC2)(n1ccnc1)n1ccnc1,Cytochrome P450 11B2,IC50,851,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163648,N#Cc1ccc(C(c2cc3c4c(c2)CCN4C(=O)CC3)n2ccnc2)cc1,Cytochrome P450 11B2,IC50,308,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163647,N#Cc1cccc(C(c2cc3c4c(c2)CCN4C(=O)CC3)n2ccnc2)c1,Cytochrome P450 11B2,IC50,304,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163646,COc1ccc(C(c2cc3c4c(c2)CCN4C(=O)CC3)n2ccnc2)cc1,Cytochrome P450 11B2,IC50,104,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163641,C=C(c1cc2c3c(c1)CCN3C(=O)CC2)n1ccnc1,Cytochrome P450 11B2,IC50,100,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163645,COc1cccc(C(c2cc3c4c(c2)CCN4C(=O)CC3)n2ccnc2)c1,Cytochrome P450 11B2,IC50,88,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163650,O=C1CCc2cc(C(c3ccco3)n3ccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,47,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163649,O=C1CCc2cc(C(c3ccccc3)n3ccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,33,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163644,O=C1CCc2cc(C(c3ccc(F)cc3)n3ccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,29,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163639,O=C1CCc2cc(C(C3CC3)n3ccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,24,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163642,O=C1CCc2cc(C(c3ccccc3F)n3ccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,19,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163651,O=C1CCc2cc(C(c3cccs3)n3ccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,18,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163643,O=C1CCc2cc(C(c3cccc(F)c3)n3ccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,18,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163636,CC(c1cc2c3c(c1)CCN3C(=O)CC2)n1ccnc1,Cytochrome P450 11B2,IC50,15,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163637,CCC(c1cc2c3c(c1)CCN3C(=O)CC2)n1ccnc1,Cytochrome P450 11B2,IC50,5.8,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163640,O=C1CCc2cc(C(C3CCC3)n3ccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,4.2,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2163638,CC(C)C(c1cc2c3c(c1)CCN3C(=O)CC2)n1ccnc1,Cytochrome P450 11B2,IC50,3.8,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells using deoxycorticosterone substrate,active,CHEMBL2169295
CHEMBL2165325,O=C1CCc2cc(-c3cccnc3)cc(-c3ccsc3)c2N1,Cytochrome P450 11B2,IC50,208,Inhibition of human CYP11B2 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,active,CHEMBL2166347
CHEMBL2165322,O=C1CCc2cc(-c3cccnc3)cc(Br)c2N1,Cytochrome P450 11B2,IC50,12,Inhibition of human CYP11B2 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,active,CHEMBL2166347
CHEMBL2165321,CN1C(=O)CCc2cc(-c3cccnc3)c(OCc3ccccc3)cc21,Cytochrome P450 11B2,IC50,178,Inhibition of human CYP11B2 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,active,CHEMBL2166347
CHEMBL2165320,O=C1CCc2cc(-c3cccnc3)c(OCc3ccccc3)cc2N1,Cytochrome P450 11B2,IC50,22,Inhibition of human CYP11B2 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,active,CHEMBL2166347
CHEMBL2165319,CN1C(=O)CCc2cc(-c3cccnc3)c(OC3CCCC3)cc21,Cytochrome P450 11B2,IC50,759,Inhibition of human CYP11B2 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,active,CHEMBL2166347
CHEMBL2165317,CCOc1cc2c(cc1-c1cccnc1)CCC(=O)N2C,Cytochrome P450 11B2,IC50,19,Inhibition of human CYP11B2 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,active,CHEMBL2166347
CHEMBL2165316,CCOc1cc2c(cc1-c1cccnc1)CCC(=O)N2,Cytochrome P450 11B2,IC50,674,Inhibition of human CYP11B2 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,active,CHEMBL2166347
CHEMBL2165315,COc1cc2c(cc1-c1cccnc1)CCC(=O)N2C,Cytochrome P450 11B2,IC50,19,Inhibition of human CYP11B2 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,active,CHEMBL2166347
CHEMBL2165314,COc1cc2c(cc1-c1cccnc1)CCC(=O)N2,Cytochrome P450 11B2,IC50,268,Inhibition of human CYP11B2 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,active,CHEMBL2166347
CHEMBL2165313,O=C1CCc2cc(-c3cccnc3)c(O)cc2N1,Cytochrome P450 11B2,IC50,312,Inhibition of human CYP11B2 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,active,CHEMBL2166347
CHEMBL2312962,Cc1cccc(C(c2ccncc2)c2cc3c4c(c2)CCN4C(=O)CC3)c1,Cytochrome P450 11B2,IC50,41,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312961,O=C1CCc2cc(C(c3ccncc3)c3ccc(Cl)cc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,32,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312960,O=C1CCc2cc(C(c3ccncc3)c3cccc(Cl)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,51,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312959,O=C1CCc2cc(C(c3ccncc3)c3ccc(F)cc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,56,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312958,O=C1CCc2cc(C(c3ccncc3)c3cccc(F)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,88,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312957,COc1ccc(C(c2ccncc2)c2cc3c4c(c2)CCN4C(=O)CC3)cc1,Cytochrome P450 11B2,IC50,74,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312956,COc1cccc(C(c2ccncc2)c2cc3c4c(c2)CCN4C(=O)CC3)c1,Cytochrome P450 11B2,IC50,139,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312955,COc1ccccc1C(c1ccncc1)c1cc2c3c(c1)CCN3C(=O)CC2,Cytochrome P450 11B2,IC50,128,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312954,O=C1CCc2cc(C(c3ccccc3)c3ccncc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,390,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312953,O=C1CCc2cc(C(O)(c3ccccc3)c3ccncc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,85,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312951,CC(C)C(c1ccncc1)c1cc2c3c(c1)CCN3C(=O)CC2,Cytochrome P450 11B2,IC50,750,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312950,CC(c1ccncc1)c1cc2c3c(c1)CCN3C(=O)CC2,Cytochrome P450 11B2,IC50,74,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312949,C=C(c1ccncc1)c1cc2c3c(c1)CCN3C(=O)CC2,Cytochrome P450 11B2,IC50,96,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2311553,O=C1CCc2cc(Cc3ccncc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,204,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312948,O=C1CCc2cc(C(O)c3ccncc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,563,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312972,O=C1CCc2cc(C(c3ccc(F)cc3)c3cccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,587,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312968,O=C1CCc2cc(C(c3ccccc3)c3cccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,132,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312967,CC(c1cccnc1)c1cc2c3c(c1)CCN3C(=O)CC2,Cytochrome P450 11B2,IC50,37,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312966,C=C(c1cccnc1)c1cc2c3c(c1)CCN3C(=O)CC2,Cytochrome P450 11B2,IC50,468,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2312965,O=C1CCc2cc(Cc3cccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,74,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",active,CHEMBL2321523
CHEMBL2333337,Nc1ccc(Cn2ccnc2)c2c(=O)c3ccccc3oc12,Cytochrome P450 11B2,IC50,676.5,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL2333336,O=c1c2ccccc2oc2c(O)ccc(Cn3ccnc3)c12,Cytochrome P450 11B2,IC50,235.3,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL2333335,O=c1c2ccccc2oc2c(OC3CCCC3)ccc(Cn3ccnc3)c12,Cytochrome P450 11B2,IC50,99.7,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL2333334,O=c1c2ccccc2oc2c(OCC3CC3)ccc(Cn3ccnc3)c12,Cytochrome P450 11B2,IC50,24.1,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL2333333,CCC(C)Oc1ccc(Cn2ccnc2)c2c(=O)c3ccccc3oc12,Cytochrome P450 11B2,IC50,15.3,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL2333332,CC(C)CCOc1ccc(Cn2ccnc2)c2c(=O)c3ccccc3oc12,Cytochrome P450 11B2,IC50,25.2,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL2333331,CC(C)Oc1ccc(Cn2ccnc2)c2c(=O)c3ccccc3oc12,Cytochrome P450 11B2,IC50,19.1,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL2333330,CCOc1ccc(Cn2ccnc2)c2c(=O)c3ccccc3oc12,Cytochrome P450 11B2,IC50,14.8,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL2333329,COc1ccc(Cn2ccnc2)c2c(=O)c3ccccc3oc12,Cytochrome P450 11B2,IC50,41.1,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL2333328,O=c1c2ccccc2oc2c(-c3ccccc3)ccc(Cn3ccnc3)c12,Cytochrome P450 11B2,IC50,103.9,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL2333327,O=c1c2ccccc2oc2c(I)ccc(Cn3ccnc3)c12,Cytochrome P450 11B2,IC50,23.5,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL2333326,O=c1c2ccccc2oc2c(Cl)ccc(Cn3ccnc3)c12,Cytochrome P450 11B2,IC50,3,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL442373,N#Cc1ccc(Cn2ccnc2)c2c(=O)c3ccccc3oc12,Cytochrome P450 11B2,IC50,19.5,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL78322,O=c1c2ccccc2oc2c(Br)ccc(Cn3ccnc3)c12,Cytochrome P450 11B2,IC50,8.5,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL307160,O=c1c2ccccc2oc2c([N+](=O)[O-])ccc(Cn3ccnc3)c12,Cytochrome P450 11B2,IC50,31.1,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL1083652,O=c1c2ccccc2oc2cccc(Cn3ccnc3)c12,Cytochrome P450 11B2,IC50,114.3,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2340954
CHEMBL2331700,CCc1c(F)cncc1-c1cc2c(c(F)c1F)-n1c(C)nnc1CC2,Cytochrome P450 11B2,IC50,41,Inhibition of human Cyp11B2 transfected in chinese hamster V79MZ cells using deoxycorticosterone as substrate incubated for 60 mins prior to substrate addition measured after 50 mins by HPLC analysis,active,CHEMBL2344627
CHEMBL2331699,Cc1nnc2n1-c1c(F)cc(-c3cncc(F)c3)cc1CC2,Cytochrome P450 11B2,IC50,89,Inhibition of human Cyp11B2 transfected in chinese hamster V79MZ cells using deoxycorticosterone as substrate incubated for 60 mins prior to substrate addition measured after 50 mins by HPLC analysis,active,CHEMBL2344627
CHEMBL2331702,COc1c(C)cncc1-c1cc2c(cc1F)-n1c(C)nnc1CC2,Cytochrome P450 11B2,IC50,32,Inhibition of human Cyp11B2 transfected in chinese hamster V79MZ cells using deoxycorticosterone as substrate incubated for 60 mins prior to substrate addition measured after 50 mins by HPLC analysis,active,CHEMBL2344627
CHEMBL2331701,Cc1nnc2n1-c1cc(Cl)c(-c3cncc4ccccc34)cc1CC2,Cytochrome P450 11B2,IC50,17,Inhibition of human Cyp11B2 transfected in chinese hamster V79MZ cells using deoxycorticosterone as substrate incubated for 60 mins prior to substrate addition measured after 50 mins by HPLC analysis,active,CHEMBL2344627
CHEMBL2331703,Cc1nnc2n1-c1c(Cl)cc(-c3cnccc3C3CC3)cc1CC2,Cytochrome P450 11B2,IC50,48,Inhibition of human Cyp11B2 transfected in chinese hamster V79MZ cells using deoxycorticosterone as substrate incubated for 60 mins prior to substrate addition measured after 50 mins by HPLC analysis,active,CHEMBL2344627
CHEMBL2331705,Cc1nnc2n1-c1c(Cl)cc(-c3cnccc3C(F)(F)F)cc1CC2,Cytochrome P450 11B2,IC50,22,Inhibition of human Cyp11B2 transfected in chinese hamster V79MZ cells using deoxycorticosterone as substrate incubated for 60 mins prior to substrate addition measured after 50 mins by HPLC analysis,active,CHEMBL2344627
CHEMBL2331704,COC(C)(C)c1cncc(-c2ccc3c(c2)CCc2nnc(C)n2-3)c1,Cytochrome P450 11B2,IC50,5,Inhibition of human Cyp11B2 transfected in chinese hamster V79MZ cells using deoxycorticosterone as substrate incubated for 60 mins prior to substrate addition measured after 50 mins by HPLC analysis,active,CHEMBL2344627
CHEMBL2331706,Cc1nnc2n1-c1ccc(-c3cncc4ccccc34)cc1CC2,Cytochrome P450 11B2,IC50,5,Inhibition of human Cyp11B2 transfected in chinese hamster V79MZ cells using deoxycorticosterone as substrate incubated for 60 mins prior to substrate addition measured after 50 mins by HPLC analysis,active,CHEMBL2344627
CHEMBL193863,COc1ccc2ccc(-c3cccnc3)cc2c1,Cytochrome P450 11B2,IC50,68,Inhibition of human CYP11B2,active,CHEMBL2421737
CHEMBL2420688,Oc1ccc2ccc(-c3cncc4ccccc34)c(Cl)c2c1,Cytochrome P450 11B2,IC50,66,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2420687,COc1ccc2ccc(-c3cncc4ccccc34)c(Cl)c2c1,Cytochrome P450 11B2,IC50,54,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2420686,Oc1ccc2ccc(-c3cncnc3)c(Cl)c2c1,Cytochrome P450 11B2,IC50,22,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2420685,COc1ccc2ccc(-c3cncnc3)c(Cl)c2c1,Cytochrome P450 11B2,IC50,72,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2420684,Oc1cncc(-c2ccc3ccc(O)cc3c2Cl)c1,Cytochrome P450 11B2,IC50,27,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2420683,COc1ccc2ccc(-c3cncc(O)c3)c(Cl)c2c1,Cytochrome P450 11B2,IC50,13,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2420682,COc1cncc(-c2ccc3ccc(O)cc3c2Cl)c1,Cytochrome P450 11B2,IC50,15,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2420681,COc1cncc(-c2ccc3ccc(OC)cc3c2Cl)c1,Cytochrome P450 11B2,IC50,24,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2420680,Oc1ccc2ccc(-c3cncc(F)c3)c(Cl)c2c1,Cytochrome P450 11B2,IC50,33,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2420679,COc1ccc2ccc(-c3cncc(F)c3)c(Cl)c2c1,Cytochrome P450 11B2,IC50,38,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2420678,Oc1ccc2ccc(-c3cccnc3)c(Cl)c2c1F,Cytochrome P450 11B2,IC50,25,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2420677,COc1ccc2ccc(-c3cccnc3)c(Cl)c2c1F,Cytochrome P450 11B2,IC50,28,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2420676,Oc1ccc2ccc(-c3cccnc3)c(F)c2c1,Cytochrome P450 11B2,IC50,30,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2420675,COc1ccc2ccc(-c3cccnc3)c(F)c2c1,Cytochrome P450 11B2,IC50,17,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2420674,Oc1ccc2ccc(-c3cccnc3)c(Cl)c2c1,Cytochrome P450 11B2,IC50,26,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2421742
CHEMBL2417616,c1ccc(-c2cncc(Cc3ccc(-c4ccccc4)nc3)c2)cc1,Cytochrome P450 11B2,IC50,0.5,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417615,Oc1cncc(Cc2ccc(-c3ccccc3)nc2)c1,Cytochrome P450 11B2,IC50,836,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417614,COc1cncc(Cc2ccc(-c3ccccc3)nc2)c1,Cytochrome P450 11B2,IC50,25,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417612,Fc1cncc(Cc2ccc(-c3ccccc3)nc2)c1,Cytochrome P450 11B2,IC50,419,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417553,Cc1cncc(Cc2ccc(-c3ccccc3)nc2)c1,Cytochrome P450 11B2,IC50,33,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417637,Cc1ccncc1Cc1ccc(-c2ccccc2)nc1,Cytochrome P450 11B2,IC50,19,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417635,c1ccc(-c2ccc(Cc3cncc4ccccc34)cn2)cc1,Cytochrome P450 11B2,IC50,23,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417634,c1ccc(-c2ccc(Cc3ccncc3)cn2)cc1,Cytochrome P450 11B2,IC50,621,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417633,c1ccc(-c2ccc(Cc3cccnc3)cn2)cc1,Cytochrome P450 11B2,IC50,322,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417632,c1ccc(-c2ncc(Cn3ccnc3)c3ccccc23)cc1,Cytochrome P450 11B2,IC50,302,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417628,c1ccc2c(-c3ccc(C(C4CC4)n4ccnc4)cn3)cccc2c1,Cytochrome P450 11B2,IC50,220,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417627,CC(c1ccc(-c2cccc3ccccc23)nc1)n1ccnc1,Cytochrome P450 11B2,IC50,273,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417626,c1cn(C(c2ccc(-c3ccsc3)nc2)C2CC2)cn1,Cytochrome P450 11B2,IC50,31,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417625,CC(c1ccc(-c2ccsc2)nc1)n1ccnc1,Cytochrome P450 11B2,IC50,151,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417624,c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cn2)cc1,Cytochrome P450 11B2,IC50,110,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417623,c1ccc(-c2ccc(C(c3ccco3)n3ccnc3)cn2)cc1,Cytochrome P450 11B2,IC50,74,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417622,CC(C)C(c1ccc(-c2ccccc2)nc1)n1ccnc1,Cytochrome P450 11B2,IC50,28,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417621,c1ccc(-c2ccc(C(C3CC3)n3ccnc3)cn2)cc1,Cytochrome P450 11B2,IC50,25,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417620,CCC(c1ccc(-c2ccccc2)nc1)n1ccnc1,Cytochrome P450 11B2,IC50,92,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL2417619,CC(c1ccc(-c2ccccc2)nc1)n1ccnc1,Cytochrome P450 11B2,IC50,200,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL2423498
CHEMBL3099696,Cc1cc(C#N)ccc1[C@H]1CCc2cncn21,Cytochrome P450 11B2,IC50,0.9,Inhibition of human recombinant CYP11B2 using 11-deoxycorticosterone as substrate by cell-based assay,active,CHEMBL3101041
CHEMBL3099695,N#Cc1ccc([C@H]2CCc3cncn32)c(F)c1,Cytochrome P450 11B2,IC50,0.7,Inhibition of human recombinant CYP11B2 using 11-deoxycorticosterone as substrate by cell-based assay,active,CHEMBL3101041
CHEMBL3099689,N#Cc1ccc([C@@]2(C(=O)OCc3ccc(F)cc3)CCc3cncn32)c(Cl)c1,Cytochrome P450 11B2,IC50,3.8,Inhibition of human recombinant CYP11B2 using 11-deoxycorticosterone as substrate by cell-based assay,active,CHEMBL3101041
CHEMBL3099683,N#Cc1ccc([C@H]2CCCCc3cncn32)c(F)c1,Cytochrome P450 11B2,IC50,3.2,Inhibition of human recombinant CYP11B2 using 11-deoxycorticosterone as substrate by cell-based assay,active,CHEMBL3101041
CHEMBL3099704,N#Cc1ccc([C@H]2CCCCc3cncn32)c(-c2ccc(F)cc2)c1,Cytochrome P450 11B2,IC50,0.4,Inhibition of human recombinant CYP11B2 using 11-deoxycorticosterone as substrate by cell-based assay,active,CHEMBL3101041
CHEMBL3099697,N#Cc1ccc([C@H]2CCc3cncn32)c(Br)c1,Cytochrome P450 11B2,IC50,10,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099694,COc1cc(C#N)ccc1[C@H]1CCc2cncn21,Cytochrome P450 11B2,IC50,5,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099693,N#Cc1ccc([C@H]2CCc3cncn32)c(Cl)c1,Cytochrome P450 11B2,IC50,13,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099692,Fc1ccc(-c2ccccc2[C@H]2CCc3cncn32)cc1,Cytochrome P450 11B2,IC50,140,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099691,c1ccc(-c2ccccc2[C@H]2CCc3cncn32)cc1,Cytochrome P450 11B2,IC50,441,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099690,COc1cc(C#N)ccc1[C@@]1(C(=O)N(C)Cc2ccc(F)cc2)CCc2cncn21,Cytochrome P450 11B2,IC50,5,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099688,COC(=O)[C@]1(c2ccc(C#N)cc2F)CCc2cncn21,Cytochrome P450 11B2,IC50,351,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099687,COC(=O)[C@]1(c2ccc(C#N)cc2OC)CCc2cncn21,Cytochrome P450 11B2,IC50,3,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099686,COC(=O)[C@]1(c2ccc(C#N)cc2Cl)CCc2cncn21,Cytochrome P450 11B2,IC50,17,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099685,COc1cc(C#N)ccc1[C@H]1CCCCc2cncn21,Cytochrome P450 11B2,IC50,520,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099684,N#Cc1ccc([C@H]2CCCCc3cncn32)c(Cl)c1,Cytochrome P450 11B2,IC50,16,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099682,c1ccc(-c2ccccc2[C@H]2CCCCc3cncn32)cc1,Cytochrome P450 11B2,IC50,2,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099604,Fc1ccc(-c2ccccc2[C@H]2CCCCc3cncn32)cc1,Cytochrome P450 11B2,IC50,2,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099703,COc1cc(C#N)ccc1C1CCCc2cncn21,Cytochrome P450 11B2,IC50,390,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099702,Cc1cc(C#N)ccc1C1CCCc2cncn21,Cytochrome P450 11B2,IC50,464,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099701,N#Cc1ccc(C2CCCc3cncn32)c(Cl)c1,Cytochrome P450 11B2,IC50,792,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099700,N#Cc1ccc([C@H]2CCCc3cncn32)c(F)c1,Cytochrome P450 11B2,IC50,87,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099699,c1ccc(-c2ccccc2[C@H]2CCCc3cncn32)cc1,Cytochrome P450 11B2,IC50,37,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3099698,N#Cc1ccc([C@H]2CCCc3cncn32)c(-c2ccccc2)c1,Cytochrome P450 11B2,IC50,56,Inhibition of CYP11B2 in human NCI-H295R cells assessed as inhibition of angiotensin-2-induced aldosterone production after 24 hrs by RIA,active,CHEMBL3101168
CHEMBL3287169,CC(=O)N1CCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,60,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287170,CCC(=O)N1CCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,228,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3286405,COc1cccc(C(=O)N2CCc3cc(-c4cccnc4)ccc32)c1,Cytochrome P450 11B2,IC50,607,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287178,CC(=O)N1CCc2cc(-c3cncc4ccccc34)ccc21,Cytochrome P450 11B2,IC50,0.7,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287179,CCC(=O)N1CCc2cc(-c3cncc4ccccc34)ccc21,Cytochrome P450 11B2,IC50,2.8,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287180,O=C(C1CC1)N1CCc2cc(-c3cncc4ccccc34)ccc21,Cytochrome P450 11B2,IC50,30,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287181,CC(C)C(=O)N1CCc2cc(-c3cncc4ccccc34)ccc21,Cytochrome P450 11B2,IC50,152,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287182,CC(=O)N1CCc2cc(-c3cncc(C#N)c3)ccc21,Cytochrome P450 11B2,IC50,426,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287183,CC(=O)N1CCc2cc(-c3cncc(F)c3)ccc21,Cytochrome P450 11B2,IC50,61,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287184,CC(=O)c1cncc(-c2ccc3c(c2)CCN3C(C)=O)c1,Cytochrome P450 11B2,IC50,36,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287185,COc1cncc(-c2ccc3c(c2)CCN3C(C)=O)c1,Cytochrome P450 11B2,IC50,16,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287186,CC(=O)N1CCc2cc(-c3cncc(C(C)O)c3)ccc21,Cytochrome P450 11B2,IC50,55,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287187,CC(=O)N1CCc2cc(-c3cncc(-c4ccccc4)c3)ccc21,Cytochrome P450 11B2,IC50,3,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287188,CC(=O)N1CCc2cc(-c3cnccc3C)ccc21,Cytochrome P450 11B2,IC50,2.2,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287189,CCC(=O)N1CCc2cc(-c3cnccc3C)ccc21,Cytochrome P450 11B2,IC50,14,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287190,CC(=O)n1ccc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,23,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287191,CCC(=O)n1ccc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,77,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287192,CC(=O)n1ccc2cc(-c3cncc4ccccc34)ccc21,Cytochrome P450 11B2,IC50,0.6,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287193,CC(=O)n1ccc2cc(-c3cnccc3C)ccc21,Cytochrome P450 11B2,IC50,1.7,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL3287194,CCC(=O)n1ccc2cc(-c3cnccc3C)ccc21,Cytochrome P450 11B2,IC50,13,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,active,CHEMBL3293049
CHEMBL1688893,Cc1cccc(COc2ccc3c(Cn4ccnc4)cc(=O)oc3c2)c1,Cytochrome P450 11B2,IC50,250,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL1688891,O=c1cc(Cn2ccnc2)c2ccc(OCc3cccc(F)c3)cc2o1,Cytochrome P450 11B2,IC50,200,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL1688890,O=c1cc(Cn2ccnc2)c2ccc(OCc3cccc(Cl)c3)cc2o1,Cytochrome P450 11B2,IC50,101,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL1688892,O=c1cc(Cn2ccnc2)c2ccc(OCc3cccc(C(F)(F)F)c3)cc2o1,Cytochrome P450 11B2,IC50,150,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL1688894,O=c1cc(Cn2ccnc2)c2ccc(OCc3cccc(OC(F)(F)F)c3)cc2o1,Cytochrome P450 11B2,IC50,125,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL1688895,O=c1cc(Cn2ccnc2)c2ccc(OCc3cccc([N+](=O)[O-])c3)cc2o1,Cytochrome P450 11B2,IC50,100,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL3359952,COc1cccc(COc2ccc3c(Cn4ccnc4)cc(=O)oc3c2)c1,Cytochrome P450 11B2,IC50,127,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL1688897,O=c1cc(Cn2ccnc2)c2ccc(OCc3ccc(Cl)cc3)cc2o1,Cytochrome P450 11B2,IC50,200,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL1688899,O=c1cc(Cn2ccnc2)c2ccc(OCc3ccc(OC(F)(F)F)cc3)cc2o1,Cytochrome P450 11B2,IC50,250,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL3359953,O=c1cc(Cn2ccnc2)c2ccc(OCc3ccc([N+](=O)[O-])cc3)cc2o1,Cytochrome P450 11B2,IC50,86,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL1688898,COc1ccc(COc2ccc3c(Cn4ccnc4)cc(=O)oc3c2)cc1,Cytochrome P450 11B2,IC50,124,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL3359954,CCCOc1ccc(COc2ccc3c(Cn4ccnc4)cc(=O)oc3c2)cc1,Cytochrome P450 11B2,IC50,77,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL3359955,CC(C)Oc1ccc(COc2ccc3c(Cn4ccnc4)cc(=O)oc3c2)cc1,Cytochrome P450 11B2,IC50,82,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL3359956,O=c1cc(Cn2ccnc2)c2ccc(OCCc3ccccc3)cc2o1,Cytochrome P450 11B2,IC50,899,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL1688900,O=c1cc(Cn2ccnc2)c2ccc(OCc3cc(F)cc(F)c3)cc2o1,Cytochrome P450 11B2,IC50,200,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL1688901,O=c1cc(Cn2ccnc2)c2ccc(OCc3ccc(F)c(F)c3)cc2o1,Cytochrome P450 11B2,IC50,100,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL3359957,COc1ccc(COc2ccc3c(Cn4ccnc4)cc(=O)oc3c2)cc1OC,Cytochrome P450 11B2,IC50,82,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL3359958,COc1cc(COc2ccc3c(Cn4ccnc4)cc(=O)oc3c2)cc(OC)c1OC,Cytochrome P450 11B2,IC50,147,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL3359959,O=C(Cn1ccnc1)c1cccc(OCc2ccccc2)c1,Cytochrome P450 11B2,IC50,500,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL3359960,O=C(Cn1ccnc1)c1ccc(OCc2ccccc2)cc1,Cytochrome P450 11B2,IC50,588,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL3359961,O=C(Cn1ccnc1)c1ccc(OCc2cccc(OC(F)(F)F)c2)cc1,Cytochrome P450 11B2,IC50,497,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL3359962,O=C(Cn1ccnc1)c1ccc(OCc2cccc([N+](=O)[O-])c2)cc1,Cytochrome P450 11B2,IC50,192,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL3359963,N#Cc1cccc(COc2ccc(C(=O)Cn3ccnc3)cc2)c1,Cytochrome P450 11B2,IC50,222,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL3359964,O=C(Cn1ccnc1)c1ccc(OCc2ccc(OC(F)(F)F)cc2)cc1,Cytochrome P450 11B2,IC50,669,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",active,CHEMBL3385624
CHEMBL3354849,[O-][S+](c1ccccc1)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,33,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354850,COc1ccc([S+]([O-])c2c(O)c(-c3cccnc3)cc3ccccc23)cc1,Cytochrome P450 11B2,IC50,48,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354851,COc1cccc([S+]([O-])c2c(O)c(-c3cccnc3)cc3ccccc23)c1,Cytochrome P450 11B2,IC50,27,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354852,COc1ccccc1[S+]([O-])c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,64,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354853,[O-][S+](c1ccc(Cl)cc1)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,22,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354854,[O-][S+](c1cccc(Cl)c1)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,60,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354855,[O-][S+](c1ccccc1Cl)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,22,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354856,[O-][S+](c1ccc(F)cc1)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,33,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354857,[O-][S+](c1cccc(F)c1)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,39,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354858,[O-][S+](c1ccc(OC(F)(F)F)cc1)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,32,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354859,[O-][S+](c1cccc(OC(F)(F)F)c1)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,14,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354860,[O-][S+](c1ccccc1OC(F)(F)F)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,56,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354861,[O-][S+](c1ccc(C(F)(F)F)cc1)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,25,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354862,[O-][S+](c1cccc(C(F)(F)F)c1)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,43,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354863,[O-][S+](c1ccccc1C(F)(F)F)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,53,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354865,N#Cc1cccc([S+]([O-])c2c(O)c(-c3cccnc3)cc3ccccc23)c1,Cytochrome P450 11B2,IC50,46,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354866,[O-][S+](c1ccc(Cl)c(Cl)c1)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,33,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354867,[O-][S+](c1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,33,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354868,[O-][S+](c1cc(Cl)cc(Cl)c1)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,47,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354869,[O-][S+](c1ccc(F)c(Cl)c1)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,53,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3354870,[O-][S+](c1cccs1)c1c(O)c(-c2cccnc2)cc2ccccc12,Cytochrome P450 11B2,IC50,192,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [3H]-11-deoxycorticosterone as substrate after 1 hr by HPLC analysis,active,CHEMBL3371779
CHEMBL3313970,c1ccc2c(-c3cccc4cncn34)cccc2c1,Cytochrome P450 11B2,IC50,50,Inhibition of human aldosterone synthase in homogenized rat glomerulosa tissue,active,CHEMBL3366823
CHEMBL3313982,CC1(C)c2cc(Cl)ccc2C(=O)N1c1cncc(C2CCCN(S(C)(=O)=O)C2)n1,Cytochrome P450 11B2,IC50,2.8,Inhibition of human CYP11B2 expressed in G402 cells,active,CHEMBL3366822
CHEMBL3313981,CCS(=O)(=O)N(Cc1cncc(-c2cccc(Cl)c2Cl)c1)C1CC1,Cytochrome P450 11B2,IC50,5,Inhibition of human CYP11B2 expressed in NCI-H295R cells assessed as reduction in aldosterone formation,active,CHEMBL3366821
CHEMBL3313967,CC(O)c1c(F)cncc1-c1cc2cc(Cl)c(F)cc2o1,Cytochrome P450 11B2,IC50,2.5,Inhibition of human CYP11B2 expressed in NCI-H295R cells assessed as reduction in aldosterone formation,active,CHEMBL3366821
CHEMBL3313968,Cn1c(=O)oc2cc(-c3cncc(C(O)C(F)(F)F)c3)ccc21,Cytochrome P450 11B2,IC50,1.4,Inhibition of human CYP11B2 expressed in NCI-H295R cells assessed as reduction in aldosterone formation,active,CHEMBL3366821
CHEMBL3313977,Cn1c(-c2cncc3ccccc23)nc2ccc(F)c(F)c21,Cytochrome P450 11B2,IC50,0.15,Inhibition of human aldosterone synthase expressed in V79 MZ cells,active,CHEMBL3366798
CHEMBL3313978,Cc1cncc(-c2cc3n(n2)CCC(=O)N3)c1,Cytochrome P450 11B2,IC50,2.2,Inhibition of human aldosterone synthase expressed in V79 MZ cells,active,CHEMBL3366798
CHEMBL3313976,CCS(=O)(=O)NCc1cncc(-c2c(C)c3ccccc3n2C)c1,Cytochrome P450 11B2,IC50,5,Inhibition of human aldosterone synthase,active,CHEMBL3366814
CHEMBL3313975,CCOC(=O)c1cncn1C1c2ccccc2C(=O)OC1(C)C,Cytochrome P450 11B2,IC50,3,Inhibition of human aldosterone synthase,active,CHEMBL3366814
CHEMBL3313971,CC1CCCC(c2ccc(C#N)cc2-c2ccc(F)cc2)n2cncc21,Cytochrome P450 11B2,IC50,2,Inhibition of human aldosterone synthase,active,CHEMBL3366814
CHEMBL3313980,c1cncc(C2CCCCCCC2)c1,Cytochrome P450 11B2,IC50,21,Inhibition of human aldosterone synthase expressed in V79 MZ cells,active,CHEMBL3366798
CHEMBL3313969,Cc1ccncc1-c1cc(F)c2c(c1)CCc1nnc(C)n1-2,Cytochrome P450 11B2,IC50,4.2,Inhibition of human aldosterone synthase expressed in V79 MZ cells,active,CHEMBL3366798
CHEMBL388978,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,Cytochrome P450 11B2,IC50,11,Inhibition of human aldosterone synthase expressed in V79 MZ cells assessed as inhibition of aldosterone synthesis,active,CHEMBL3366440
CHEMBL24014,Oc1ccc2c(c1)CC(Cc1ccncc1)C2,Cytochrome P450 11B2,IC50,59,Inhibition of human aldosterone synthase by cell based assay,active,CHEMBL3366819
CHEMBL3313979,COc1cccc2c1CCC1C(c3cnc[nH]3)C21,Cytochrome P450 11B2,IC50,41,Inhibition of human aldosterone synthase by cell based assay,active,CHEMBL3366819
CHEMBL3337667,CCS(=O)(=O)N1CCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,500,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337666,CS(=O)(=O)N1CCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,320,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337665,O=S(=O)(c1cccc(F)c1)N1CCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,850,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337664,COc1cccc(S(=O)(=O)N2CCc3cc(-c4cccnc4)ccc32)c1,Cytochrome P450 11B2,IC50,251,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337672,COc1cccc(S(=O)(=O)Nc2ccc(-c3cccnc3)cc2)c1,Cytochrome P450 11B2,IC50,850,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337673,COc1cccc(S(=O)(=O)N(C)c2ccc(-c3cccnc3)cc2)c1,Cytochrome P450 11B2,IC50,239,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337676,COc1cccc(S(=O)(=O)N2CCCc3cc(-c4cccnc4)ccc32)c1,Cytochrome P450 11B2,IC50,85,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337677,O=S(=O)(c1ccccc1)N1CCCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,295,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337678,COc1ccc(S(=O)(=O)N2CCCc3cc(-c4cccnc4)ccc32)cc1,Cytochrome P450 11B2,IC50,519,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337679,Cc1cccc(S(=O)(=O)N2CCCc3cc(-c4cccnc4)ccc32)c1,Cytochrome P450 11B2,IC50,205,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337680,Cc1ccc(S(=O)(=O)N2CCCc3cc(-c4cccnc4)ccc32)cc1,Cytochrome P450 11B2,IC50,555,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337681,O=S(=O)(c1cccc(OC(F)(F)F)c1)N1CCCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,322,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337683,O=S(=O)(c1cccc(F)c1)N1CCCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,196,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337684,O=S(=O)(c1ccc(F)cc1)N1CCCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,260,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337685,O=S(=O)(c1cccc(Cl)c1)N1CCCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,344,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337686,O=S(=O)(c1ccc(Cl)cc1)N1CCCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,469,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337687,O=S(=O)(c1cccc(C(F)(F)F)c1)N1CCCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,607,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337689,N#Cc1cccc(S(=O)(=O)N2CCCc3cc(-c4cccnc4)ccc32)c1,Cytochrome P450 11B2,IC50,429,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337690,N#Cc1ccc(S(=O)(=O)N2CCCc3cc(-c4cccnc4)ccc32)cc1,Cytochrome P450 11B2,IC50,557,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337691,O=S(=O)(c1cccs1)N1CCCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,259,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337694,COc1cccc(S(=O)(=O)N2CCCc3cc(Cc4ccncc4)ccc32)c1,Cytochrome P450 11B2,IC50,5,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3337695,COc1cccc(S(=O)(=O)N2CCCc3cc(Cc4cccnc4)ccc32)c1,Cytochrome P450 11B2,IC50,8,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",active,CHEMBL3388885
CHEMBL3397597,O=C1COc2cc(-c3cccnc3)ccc2N1,Cytochrome P450 11B2,IC50,41,Inhibition of CYP11B2 in human V79MZ cells using [3H]-11-deoxycorticosterone as substrate incubated for 1 hr prior to substrate addition measured after 45 mins by HPLC analysis,active,CHEMBL3399802
CHEMBL3397599,CN1C(=O)COc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,11,Inhibition of CYP11B2 in human V79MZ cells using [3H]-11-deoxycorticosterone as substrate incubated for 1 hr prior to substrate addition measured after 45 mins by HPLC analysis,active,CHEMBL3399802
CHEMBL3397600,O=C1COc2cc(-c3cncc4ccccc34)ccc2N1,Cytochrome P450 11B2,IC50,0.5,Inhibition of CYP11B2 in human V79MZ cells using [3H]-11-deoxycorticosterone as substrate incubated for 1 hr prior to substrate addition measured after 45 mins by HPLC analysis,active,CHEMBL3399802
CHEMBL3397601,O=C1CNc2cc(-c3cccnc3)ccc2N1,Cytochrome P450 11B2,IC50,366,Inhibition of CYP11B2 in human V79MZ cells using [3H]-11-deoxycorticosterone as substrate incubated for 1 hr prior to substrate addition measured after 45 mins by HPLC analysis,active,CHEMBL3399802
CHEMBL3397602,CN1CC(=O)Nc2ccc(-c3cccnc3)cc21,Cytochrome P450 11B2,IC50,89,Inhibition of CYP11B2 in human V79MZ cells using [3H]-11-deoxycorticosterone as substrate incubated for 1 hr prior to substrate addition measured after 45 mins by HPLC analysis,active,CHEMBL3399802
CHEMBL3397603,O=C1CNc2cc(-c3cncc4ccccc34)ccc2N1,Cytochrome P450 11B2,IC50,1.1,Inhibition of CYP11B2 in human V79MZ cells using [3H]-11-deoxycorticosterone as substrate incubated for 1 hr prior to substrate addition measured after 45 mins by HPLC analysis,active,CHEMBL3399802
CHEMBL3397604,O=C1Nc2ccc(-c3cccnc3)cc2CO1,Cytochrome P450 11B2,IC50,24,Inhibition of CYP11B2 in human V79MZ cells using [3H]-11-deoxycorticosterone as substrate incubated for 1 hr prior to substrate addition measured after 45 mins by HPLC analysis,active,CHEMBL3399802
CHEMBL3397605,O=C1Nc2ccc(-c3cncc4ccccc34)cc2CO1,Cytochrome P450 11B2,IC50,0.3,Inhibition of CYP11B2 in human V79MZ cells using [3H]-11-deoxycorticosterone as substrate incubated for 1 hr prior to substrate addition measured after 45 mins by HPLC analysis,active,CHEMBL3399802
CHEMBL3397606,O=C1NCc2cc(-c3cccnc3)ccc2N1,Cytochrome P450 11B2,IC50,228,Inhibition of CYP11B2 in human V79MZ cells using [3H]-11-deoxycorticosterone as substrate incubated for 1 hr prior to substrate addition measured after 45 mins by HPLC analysis,active,CHEMBL3399802
CHEMBL3397607,O=C1NCc2cc(-c3cncc4ccccc34)ccc2N1,Cytochrome P450 11B2,IC50,2.2,Inhibition of CYP11B2 in human V79MZ cells using [3H]-11-deoxycorticosterone as substrate incubated for 1 hr prior to substrate addition measured after 45 mins by HPLC analysis,active,CHEMBL3399802
CHEMBL3397609,CN1c2ccc(-c3cccnc3)cc2OCS1(=O)=O,Cytochrome P450 11B2,IC50,193,Inhibition of CYP11B2 in human V79MZ cells using [3H]-11-deoxycorticosterone as substrate incubated for 1 hr prior to substrate addition measured after 45 mins by HPLC analysis,active,CHEMBL3399802
CHEMBL3415175,Cc1c(F)cncc1-c1cc(F)c2c(c1)CCc1nncn1-2,Cytochrome P450 11B2,IC50,42.5,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415174,Fc1cncc(-c2cc(F)c3c(c2)CCc2nncn2-3)c1,Cytochrome P450 11B2,IC50,335,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415173,Cc1c(F)cncc1-c1cc(F)c2c(c1)CCc1nnc(C)n1-2,Cytochrome P450 11B2,IC50,19.5,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415172,Cc1nnc2n1-c1c(F)cc(-c3cncc4ccccc34)cc1CC2,Cytochrome P450 11B2,IC50,2.2,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415171,Cc1nnc2n1-c1c(F)cc(-c3cncc(-c4ccccc4)c3)cc1CC2,Cytochrome P450 11B2,IC50,7.1,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415169,Cc1nnc2n1-c1c(F)cc(-c3cncc(C(F)(F)F)c3)cc1CC2,Cytochrome P450 11B2,IC50,57.2,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415168,CC(=O)c1cncc(-c2cc(F)c3c(c2)CCc2nnc(C)n2-3)c1,Cytochrome P450 11B2,IC50,87.6,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415167,Cc1nnc2n1-c1c(F)cc(-c3cncc(C(C)O)c3)cc1CC2,Cytochrome P450 11B2,IC50,28.3,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415166,COc1cncc(-c2cc(F)c3c(c2)CCc2nnc(C)n2-3)c1,Cytochrome P450 11B2,IC50,20.3,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415163,O=C(c1ccccc1)c1nnc2n1-c1c(F)cc(-c3cccnc3)cc1CC2,Cytochrome P450 11B2,IC50,707.7,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415157,CCc1nnc2n1-c1c(F)cc(-c3cccnc3)cc1CC2,Cytochrome P450 11B2,IC50,541.7,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415156,CCc1nnc2n1-c1cc(F)c(-c3cccnc3)cc1CC2,Cytochrome P450 11B2,IC50,979.3,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415155,Cc1nnc2n1-c1c(F)cc(-c3cccnc3)cc1CC2,Cytochrome P450 11B2,IC50,62.5,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415154,Cc1nnc2n1-c1cc(F)c(-c3cccnc3)cc1CC2,Cytochrome P450 11B2,IC50,131.4,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415153,Fc1cc(-c2cccnc2)cc2c1-n1cnnc1CC2,Cytochrome P450 11B2,IC50,172.2,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3415152,Fc1cc2c(cc1-c1cccnc1)CCc1nncn1-2,Cytochrome P450 11B2,IC50,244,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,active,CHEMBL3418338
CHEMBL3421763,CC(=O)Nc1ccc(-c2cccnc2)c(OCc2ccccc2)c1,Cytochrome P450 11B2,IC50,643,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421634,O=C(Nc1ccc(-c2cccnc2)c(OCc2ccccc2)c1)c1ccc(F)cc1,Cytochrome P450 11B2,IC50,756,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421764,Nc1ccc(-c2cccnc2)c(OCc2ccccc2)c1,Cytochrome P450 11B2,IC50,260,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421765,O=[N+]([O-])c1ccc(-c2cccnc2)c(OCc2ccccc2)c1,Cytochrome P450 11B2,IC50,17,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421766,O=[N+]([O-])c1ccc(-c2cccnc2)c(OCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,53,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421767,O=[N+]([O-])c1ccc(-c2cccnc2)c(OCCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,15,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421768,O=[N+]([O-])c1ccc(-c2ccncc2)c(OCc2ccccc2)c1,Cytochrome P450 11B2,IC50,87,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421769,O=[N+]([O-])c1ccc(-c2ccncc2)c(OCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,7,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421770,O=[N+]([O-])c1ccc(-c2ccncc2)c(OCCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,18,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421771,O=[N+]([O-])c1ccc(-c2cccnc2)cc1OCCc1ccccc1,Cytochrome P450 11B2,IC50,447,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421772,O=[N+]([O-])c1ccc(-c2ccncc2)cc1OCCc1ccccc1,Cytochrome P450 11B2,IC50,714,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421773,Fc1ccc(-c2cccnc2)c(OCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,84,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421774,Fc1ccc(-c2ccncc2)c(OCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,74,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421775,COc1ccc(-c2cccnc2)c(OCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,230,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421776,COc1ccc(-c2ccncc2)c(OCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,70,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421777,FC(F)(F)c1ccc(-c2cccnc2)c(OCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,945,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421778,FC(F)(F)c1ccc(-c2ccncc2)c(OCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,24,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421779,N#Cc1ccc(-c2cccnc2)c(OCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,63,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421780,N#Cc1ccc(-c2ccncc2)c(OCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,23,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421781,CN(C)C(=O)c1ccc(-c2cccnc2)c(OCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,299,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421782,CN(C)C(=O)c1ccc(-c2ccncc2)c(OCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,816,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421785,O=[N+]([O-])c1ccc(Cc2cccnc2)c(OCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,246,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3421786,O=[N+]([O-])c1ccc(Cc2ccncc2)c(OCCc2ccccc2)c1,Cytochrome P450 11B2,IC50,16,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,active,CHEMBL3424480
CHEMBL3582483,COc1c(C)cncc1-c1nc2cc(F)c(F)cc2n1C1CC1,Cytochrome P450 11B2,IC50,0.6,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582482,Cc1cncc(-c2nc3cc(F)c(F)cc3n2C2CC2)c1C,Cytochrome P450 11B2,IC50,0.2,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582481,Cc1c(F)cncc1-c1nc2cc(F)c(F)cc2n1C1CC1,Cytochrome P450 11B2,IC50,0.5,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582480,Fc1cc2nc(-c3cnccc3C(F)(F)F)n(C3CC3)c2cc1F,Cytochrome P450 11B2,IC50,8.1,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582479,Cc1ccncc1-c1nc2cc(F)c(F)cc2n1C1CC1,Cytochrome P450 11B2,IC50,10.2,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582478,CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1,Cytochrome P450 11B2,IC50,2.3,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582477,CC(C)(O)c1cncc(-c2nc3cc(F)c(F)cc3n2C2CC2)c1,Cytochrome P450 11B2,IC50,0.3,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582476,N#Cc1cc2c(cc1F)nc(-c1cncc(F)c1)n2C1CC1,Cytochrome P450 11B2,IC50,1,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582475,Fc1cncc(-c2nc3cc(F)c(Cl)cc3n2C2CC2)c1,Cytochrome P450 11B2,IC50,0.8,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582474,COc1cncc(-c2nc3cc(F)c(F)cc3n2C2CC2)c1,Cytochrome P450 11B2,IC50,0.4,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582473,N#Cc1cncc(-c2nc3cc(F)c(F)cc3n2C2CC2)c1,Cytochrome P450 11B2,IC50,22.3,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582472,Fc1cncc(-c2nc3cc(F)c(F)cc3n2C2CC2)c1,Cytochrome P450 11B2,IC50,4.7,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582471,N#Cc1cc2c(cc1F)nc(-c1cccnc1)n2C1CC1,Cytochrome P450 11B2,IC50,0.6,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582470,Fc1cc2nc(-c3cccnc3)n(C3CC3)c2cc1Cl,Cytochrome P450 11B2,IC50,0.4,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582469,Fc1cc2nc(-c3cccnc3)n(C3CC3)c2cc1F,Cytochrome P450 11B2,IC50,2.1,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582468,COc1ccc2nc(-c3cccnc3)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,24,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582467,N#Cc1ccc2nc(-c3cccnc3)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,1.2,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582466,FC(F)(F)c1ccc2nc(-c3cccnc3)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,254,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582465,Clc1ccc2nc(-c3cccnc3)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,2.2,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582464,CS(=O)(=O)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582462,COc1ccc2c(c1)nc(-c1cccnc1)n2C1CC1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582460,Fc1cccc2nc(-c3cccnc3)n(C3CC3)c12,Cytochrome P450 11B2,IC50,107,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582459,Fc1ccc2c(c1)nc(-c1cccnc1)n2C1CC1,Cytochrome P450 11B2,IC50,28,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582458,Fc1cccc2c1nc(-c1cccnc1)n2C1CC1,Cytochrome P450 11B2,IC50,219,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582457,c1cncc(-c2nc3ccccc3n2C2CC2)c1,Cytochrome P450 11B2,IC50,49,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582456,Fc1ccc2nc(-c3cccnc3)n(Cc3ccccc3)c2c1,Cytochrome P450 11B2,IC50,607,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582455,Fc1ccc2nc(-c3cccnc3)n(CC(F)(F)F)c2c1,Cytochrome P450 11B2,IC50,561,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582452,CC1(n2c(-c3cccnc3)nc3ccc(F)cc32)CC1,Cytochrome P450 11B2,IC50,16,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582451,Fc1ccc2nc(-c3cccnc3)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,4,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582450,CC(C)n1c(-c2cccnc2)nc2ccc(F)cc21,Cytochrome P450 11B2,IC50,138,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582449,CCn1c(-c2cccnc2)nc2ccc(F)cc21,Cytochrome P450 11B2,IC50,35,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3582447,Cn1c(-c2cccnc2)nc2ccc(F)cc21,Cytochrome P450 11B2,IC50,12,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,active,CHEMBL3583831
CHEMBL3623821,N#Cc1ccc(-c2cccnc2)cc1,Cytochrome P450 11B2,IC50,40,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells using 11-deoxycorticosterone as substrate assessed as formation of aldosterone after 16 hrs by HTRF assay,active,CHEMBL3626114
CHEMBL3623822,N#Cc1ccc(-c2cncc3c2CCCC3N)cc1,Cytochrome P450 11B2,IC50,42,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells using 11-deoxycorticosterone as substrate assessed as formation of aldosterone after 16 hrs by HTRF assay,active,CHEMBL3626114
CHEMBL3623823,CC(=O)NC1CCCc2c(-c3ccc(C#N)cc3)cncc21,Cytochrome P450 11B2,IC50,21,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells using 11-deoxycorticosterone as substrate assessed as formation of aldosterone after 16 hrs by HTRF assay,active,CHEMBL3626114
CHEMBL3623824,CCC(=O)NC1CCCc2c(-c3ccc(C#N)cc3)cncc21,Cytochrome P450 11B2,IC50,25,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells using 11-deoxycorticosterone as substrate assessed as formation of aldosterone after 16 hrs by HTRF assay,active,CHEMBL3626114
CHEMBL3623825,CC(C)C(=O)NC1CCCc2c(-c3ccc(C#N)cc3)cncc21,Cytochrome P450 11B2,IC50,123,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells using 11-deoxycorticosterone as substrate assessed as formation of aldosterone after 16 hrs by HTRF assay,active,CHEMBL3626114
CHEMBL3623826,CCC(=O)NC1CCCc2c(-c3ccc(F)c(F)c3)cncc21,Cytochrome P450 11B2,IC50,47,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells using 11-deoxycorticosterone as substrate assessed as formation of aldosterone after 16 hrs by HTRF assay,active,CHEMBL3626114
CHEMBL3623827,CCC(=O)NC1CCCc2c(-c3cc(F)c(F)cc3F)cncc21,Cytochrome P450 11B2,IC50,27,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells using 11-deoxycorticosterone as substrate assessed as formation of aldosterone after 16 hrs by HTRF assay,active,CHEMBL3626114
CHEMBL3623828,CCC(=O)NC1CCCc2c(-c3ccc(Cl)cc3F)cncc21,Cytochrome P450 11B2,IC50,28,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells using 11-deoxycorticosterone as substrate assessed as formation of aldosterone after 16 hrs by HTRF assay,active,CHEMBL3626114
CHEMBL3623829,CCC(=O)NC1CCCc2c(-c3ccc(Cl)c(F)c3)cncc21,Cytochrome P450 11B2,IC50,14,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells using 11-deoxycorticosterone as substrate assessed as formation of aldosterone after 16 hrs by HTRF assay,active,CHEMBL3626114
CHEMBL3623830,CCC(=O)N[C@@H]1CCCc2c(-c3ccc(C#N)cc3)cncc21,Cytochrome P450 11B2,IC50,9,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells using 11-deoxycorticosterone as substrate assessed as formation of aldosterone after 16 hrs by HTRF assay,active,CHEMBL3626114
CHEMBL3623831,CCC(=O)N[C@H]1CCCc2c(-c3ccc(C#N)cc3)cncc21,Cytochrome P450 11B2,IC50,942,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells using 11-deoxycorticosterone as substrate assessed as formation of aldosterone after 16 hrs by HTRF assay,active,CHEMBL3626114
CHEMBL3622159,c1cncc(-c2ccc3c(c2)CCc2nncn2-3)c1,Cytochrome P450 11B2,IC50,300,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622430,Cc1nnc2n1-c1ccc(-c3cccnc3)cc1CC2,Cytochrome P450 11B2,IC50,423,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622431,c1cncc(-c2ccc3c(c2)CCc2nnc(C4CC4)n2-3)c1,Cytochrome P450 11B2,IC50,487,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622432,FC(F)(F)c1nnc2n1-c1ccc(-c3cccnc3)cc1CC2,Cytochrome P450 11B2,IC50,506,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622434,c1ccc(-c2nnc3n2-c2ccc(-c4cccnc4)cc2CC3)cc1,Cytochrome P450 11B2,IC50,103,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622435,Cc1nnc2n1-c1ccc(-c3cncc(F)c3)cc1CC2,Cytochrome P450 11B2,IC50,558,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622436,Cc1nnc2n1-c1ccc(-c3cncc(C(F)(F)F)c3)cc1CC2,Cytochrome P450 11B2,IC50,486,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622437,COC(=O)c1cncc(-c2ccc3c(c2)CCc2nnc(C)n2-3)c1,Cytochrome P450 11B2,IC50,58,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622441,Cc1nnc2n1-c1ccc(-c3cncc(S(=O)(=O)c4ccccc4)c3)cc1CC2,Cytochrome P450 11B2,IC50,40,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622442,Cc1nnc2n1-c1ccc(-c3cncc(C(C)(C)O)c3)cc1CC2,Cytochrome P450 11B2,IC50,283,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622443,COC(=O)C(C)(C)c1cncc(-c2ccc3c(c2)CCc2nnc(C)n2-3)c1,Cytochrome P450 11B2,IC50,19,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622444,CC(C)(O)c1cncc(-c2ccc3c(c2)CCc2nnc(C(F)(F)F)n2-3)c1,Cytochrome P450 11B2,IC50,526,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622445,Cc1nnc2n1-c1ccc(-c3cncc([C@](C)(O)C(F)(F)F)c3)cc1CC2,Cytochrome P450 11B2,IC50,64,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622446,Cc1nnc2n1-c1ccc(-c3cncc([C@@](C)(O)C(F)(F)F)c3)cc1CC2,Cytochrome P450 11B2,IC50,109,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622447,C[C@](O)(c1cncc(-c2ccc3c(c2)CCc2nnc(C(F)(F)F)n2-3)c1)C(F)(F)F,Cytochrome P450 11B2,IC50,461,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3622448,C[C@@](O)(c1cncc(-c2ccc3c(c2)CCc2nnc(C(F)(F)F)n2-3)c1)C(F)(F)F,Cytochrome P450 11B2,IC50,476,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,active,CHEMBL3624350
CHEMBL3746125,Cc1c(-c2cccnc2)[nH]c2ccccc12,Cytochrome P450 11B2,IC50,21,Inhibition of CYP11B2 in human H285R cells assessed as decrease in [125I] angiotensin-2-induced aldosterone secretion after 24 hrs by RIA,active,CHEMBL3750668
CHEMBL3747584,Cc1c(-c2cccnc2)n(C)c2ccccc12,Cytochrome P450 11B2,IC50,9,Inhibition of CYP11B2 in human H285R cells assessed as decrease in [125I] angiotensin-2-induced aldosterone secretion after 24 hrs by RIA,active,CHEMBL3750668
CHEMBL3746868,Cn1c(-c2cccnc2)c(C#N)c2ccccc21,Cytochrome P450 11B2,IC50,90,Inhibition of CYP11B2 in human H285R cells assessed as decrease in [125I] angiotensin-2-induced aldosterone secretion after 24 hrs by RIA,active,CHEMBL3750668
CHEMBL3747269,Cn1c(-c2cccnc2)c(C#N)c2ccc(Cl)cc21,Cytochrome P450 11B2,IC50,4,Inhibition of CYP11B2 in human H285R cells assessed as decrease in [125I] angiotensin-2-induced aldosterone secretion after 24 hrs by RIA,active,CHEMBL3750668
CHEMBL3746175,CN(C)S(=O)(=O)Oc1cncc(-c2c(C#N)c3ccccc3n2C)c1,Cytochrome P450 11B2,IC50,39,Inhibition of CYP11B2 in human H285R cells assessed as decrease in [125I] angiotensin-2-induced aldosterone secretion after 24 hrs by RIA,active,CHEMBL3750668
CHEMBL3746924,CCS(=O)(=O)Nc1cncc(-c2c(C#N)c3ccccc3n2C)c1,Cytochrome P450 11B2,IC50,380,Inhibition of CYP11B2 in human H285R cells assessed as decrease in [125I] angiotensin-2-induced aldosterone secretion after 24 hrs by RIA,active,CHEMBL3750668
CHEMBL3747069,CCS(=O)(=O)Nc1cncc(-c2c(C#N)c3ccc(Cl)cc3n2C)c1,Cytochrome P450 11B2,IC50,13,Inhibition of CYP11B2 in human H285R cells assessed as decrease in [125I] angiotensin-2-induced aldosterone secretion after 24 hrs by RIA,active,CHEMBL3750668
CHEMBL3747562,CCS(=O)(=O)NCc1cncc(-c2c(C#N)c3ccc(Cl)cc3n2C)c1,Cytochrome P450 11B2,IC50,5.8,Inhibition of CYP11B2 in human H285R cells assessed as decrease in [125I] angiotensin-2-induced aldosterone secretion after 24 hrs by RIA,active,CHEMBL3750668
CHEMBL3747503,CCS(=O)(=O)NCc1cncc(-c2cc3cnc(Cl)cc3n2C)c1,Cytochrome P450 11B2,IC50,169,Inhibition of CYP11B2 in human H285R cells assessed as decrease in [125I] angiotensin-2-induced aldosterone secretion after 24 hrs by RIA,active,CHEMBL3750668
CHEMBL3746080,CCS(=O)(=O)NCc1cncc(-c2cc3ccc(Cl)nc3n2C)c1,Cytochrome P450 11B2,IC50,7,Inhibition of CYP11B2 in human H285R cells assessed as decrease in [125I] angiotensin-2-induced aldosterone secretion after 24 hrs by RIA,active,CHEMBL3750668
CHEMBL3793091,O=c1c(Cc2ccncc2)coc2cc(F)ccc12,Cytochrome P450 11B2,IC50,317.3,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",active,CHEMBL3795161
CHEMBL3794430,O=c1c(Cc2ccncc2)coc2ccccc12,Cytochrome P450 11B2,IC50,953.6,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",active,CHEMBL3795161
CHEMBL3794417,O=c1cc(Cc2ccncc2)oc2cc(F)ccc12,Cytochrome P450 11B2,IC50,643.2,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",active,CHEMBL3795161
CHEMBL3792515,O=c1c(Cn2ccnc2)coc2ccccc12,Cytochrome P450 11B2,IC50,521.5,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",active,CHEMBL3795161
CHEMBL3794161,COc1ccc2c(=O)c(Cn3ccnc3)coc2c1,Cytochrome P450 11B2,IC50,767.9,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",active,CHEMBL3795161
CHEMBL3793904,O=c1c(Cn2ccnc2)coc2cc(F)ccc12,Cytochrome P450 11B2,IC50,213.8,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",active,CHEMBL3795161
CHEMBL3793941,O=c1cc(Cn2ccnc2)oc2ccccc12,Cytochrome P450 11B2,IC50,499.5,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",active,CHEMBL3795161
CHEMBL3793139,O=c1cc(Cn2ccnc2)oc2cc(F)ccc12,Cytochrome P450 11B2,IC50,619.8,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",active,CHEMBL3795161
CHEMBL3792819,O=c1c(Cc2c[nH]cn2)coc2ccccc12,Cytochrome P450 11B2,IC50,121.2,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",active,CHEMBL3795161
CHEMBL3793576,O=c1c(Cc2c[nH]cn2)coc2cc(F)ccc12,Cytochrome P450 11B2,IC50,94.9,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",active,CHEMBL3795161
CHEMBL3916770,c1ccc2c(N3CCC4(CCCC4)CC3)cncc2c1,Cytochrome P450 11B2,IC50,106,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL3871210
CHEMBL3928391,c1ccc2c(N3CCC4(CCCCC4)CC3)cncc2c1,Cytochrome P450 11B2,IC50,554,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL3871210
CHEMBL3889825,c1ccc2c(N3CCC4(CCOC4)CC3)cncc2c1,Cytochrome P450 11B2,IC50,13,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL3871210
CHEMBL3917839,c1ccc2c(N3CCC4(CCCO4)CC3)cncc2c1,Cytochrome P450 11B2,IC50,704,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL3871210
CHEMBL3898746,c1ccc2c(N3CCC4(CC3)COC4)cncc2c1,Cytochrome P450 11B2,IC50,42,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL3871210
CHEMBL3926792,CN1CC2(CCN(c3cncc4ccccc34)CC2)CC1=O,Cytochrome P450 11B2,IC50,228,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL3871210
CHEMBL3982906,CN1CC2(CCN(c3cncc(N4CC(C)(C)C4)n3)CC2)CC1=O,Cytochrome P450 11B2,IC50,94,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL3871210
CHEMBL3954239,CC1(C)CN(c2cncc(N3CCC4(CC3)CNC(=O)C4)n2)C1,Cytochrome P450 11B2,IC50,34,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL3871210
CHEMBL3894033,CC1(C)CN(c2cncc(N3CCC4(CCC(=O)N4)CC3)n2)C1,Cytochrome P450 11B2,IC50,73,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL3871210
CHEMBL3962968,CN1CC2(CCN(c3cncc([C@](C)(O)C(F)(F)F)c3)CC2)CC1=O,Cytochrome P450 11B2,IC50,32,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL3871210
CHEMBL3902981,CN1CC2(CCN(c3cncc([C@@](C)(O)C(F)(F)F)c3)CC2)CC1=O,Cytochrome P450 11B2,IC50,448,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL3871210
CHEMBL3973937,C[C@](O)(c1cncc(N2CCC3(CCOC3)CC2)c1)C(F)(F)F,Cytochrome P450 11B2,IC50,13,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL3871210
CHEMBL3938856,CC(C)(O)c1cncc(-c2nc3ccc(F)cn3c2C2CC2)c1,Cytochrome P450 11B2,IC50,13,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3968397,Cc1c(-c2cncc(C(C)(C)O)c2)nc2ccc(F)cn12,Cytochrome P450 11B2,IC50,1.2,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3947646,CC(C)(O)c1cncc(-c2cn3cc(F)ccc3n2)c1,Cytochrome P450 11B2,IC50,52,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3976931,CC(C)(O)c1cncc(-c2nc3ccc(F)cn3c2Cl)c1,Cytochrome P450 11B2,IC50,1.2,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3895156,CC(C)(O)c1cncc(-c2nc3ccc(F)cn3c2C#N)c1,Cytochrome P450 11B2,IC50,23,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3923127,C[C@](O)(c1cncc(-c2nc3ccc(F)cn3c2C2CC2)c1)C(F)(F)F,Cytochrome P450 11B2,IC50,6.6,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3935155,C[C@@](O)(c1cncc(-c2nc3ccc(F)cn3c2C2CC2)c1)C(F)(F)F,Cytochrome P450 11B2,IC50,4.7,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3930836,COC(=O)c1cncc(-c2nc3ccc(F)cn3c2C2CC2)c1,Cytochrome P450 11B2,IC50,2.5,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3893614,Fc1cncc(-c2nc3ccc(F)cn3c2C2CC2)c1,Cytochrome P450 11B2,IC50,25,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3921629,N#Cc1cncc(-c2nc3ccc(F)cn3c2C2CC2)c1,Cytochrome P450 11B2,IC50,160,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3902584,Fc1ccc2nc(-c3cncc(C(F)(F)F)c3)c(C3CC3)n2c1,Cytochrome P450 11B2,IC50,10,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3930572,COc1cncc(-c2nc3ccc(F)cn3c2C2CC2)c1,Cytochrome P450 11B2,IC50,4,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3911595,Cc1cncc(-c2nc3ccc(F)cn3c2C2CC2)c1,Cytochrome P450 11B2,IC50,3.3,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3939565,Fc1ccc2nc(-c3cncc(-c4ccccc4)c3)c(C3CC3)n2c1,Cytochrome P450 11B2,IC50,6.6,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3920534,CCS(=O)(=O)NCc1cncc(-c2nc3ccc(F)cn3c2C2CC2)c1,Cytochrome P450 11B2,IC50,33,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3948337,Fc1ccc2nc(-c3cncc4ccccc34)c(C3CC3)n2c1,Cytochrome P450 11B2,IC50,0.6,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3971797,C[C@](O)(c1cncc(-c2nc3cc(F)ccn3c2C2CC2)c1)C(F)(F)F,Cytochrome P450 11B2,IC50,26,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3942187,C[C@](O)(c1cncc(-c2nc3ccc(C#N)cn3c2C2CC2)c1)C(F)(F)F,Cytochrome P450 11B2,IC50,5.8,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3960669,Fc1cncc(-c2nc3cc(F)ccn3c2C2CC2)c1,Cytochrome P450 11B2,IC50,98,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3933209,Fc1cncc(-c2nc3ccc(Cl)cn3c2C2CC2)c1,Cytochrome P450 11B2,IC50,23,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3951973,Fc1cncc(-c2nc3cc(F)c(Cl)cn3c2C2CC2)c1,Cytochrome P450 11B2,IC50,7.3,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3924257,Cc1c(F)cncc1-c1nc2ccc(F)cn2c1C1CC1,Cytochrome P450 11B2,IC50,7.9,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3919759,CCc1c(F)cncc1-c1nc2ccc(F)cn2c1C1CC1,Cytochrome P450 11B2,IC50,6.6,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured after 3 hrs by HTRF assay,active,CHEMBL3872119
CHEMBL3939718,NC(=O)N1CCc2cc(-c3cccnc3)cnc21,Cytochrome P450 11B2,IC50,28,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3977687,NC(=O)N1CCCc2cc(-c3cccnc3)cnc21,Cytochrome P450 11B2,IC50,15.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3945057,CC(=O)N1CCCc2cc(-c3cccnc3)cnc21,Cytochrome P450 11B2,IC50,21,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3912502,CC(=O)N1CCc2cc(-c3cccnc3)cnc21,Cytochrome P450 11B2,IC50,120,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3953785,Cc1ccncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3893531,NC(=O)N1CCCc2cc(-c3cncc(Cl)c3)cnc21,Cytochrome P450 11B2,IC50,6.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3905962,NC(=O)N1CCOc2cc(-c3cccnc3)cnc21,Cytochrome P450 11B2,IC50,9.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3918302,COc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,3.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3892813,NC(=O)N1CCCc2cc(-c3cncc(F)c3)cnc21,Cytochrome P450 11B2,IC50,11.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3920812,N#CCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,7.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3898209,CS(=O)(=O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,140,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3929726,NC(=O)N1CCCc2cc(-c3cncnc3)cnc21,Cytochrome P450 11B2,IC50,130,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3907242,NC(=O)N1CCCc2cc(-c3cncc(-c4ccccc4)c3)cnc21,Cytochrome P450 11B2,IC50,5.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3935185,NC(=O)N1CCCc2cc(-c3cncc(C(F)(F)F)c3)cnc21,Cytochrome P450 11B2,IC50,12,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3891562,COCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,7.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3900566,CC(=O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,11,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3928523,CC(O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,10,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3960079,Cc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3936076,NC(=O)N1CCCc2cc(-c3cncc(C(=O)O)c3)cnc21,Cytochrome P450 11B2,IC50,1000,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3980398,N#Cc1ccncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,7.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3951475,COC(=O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3975524,Cn1c(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)cc2ccccc21,Cytochrome P450 11B2,IC50,31,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3942729,NC(=O)N1CCCc2cc(-c3cnccc3F)cnc21,Cytochrome P450 11B2,IC50,3.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3967040,N#Cc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,164.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3937308,NC(=O)N1CCOc2cc(-c3cncc(F)c3)cnc21,Cytochrome P450 11B2,IC50,18,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3898876,CC(=O)N1CCOc2cc(-c3cncc(F)c3)cnc21,Cytochrome P450 11B2,IC50,37,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3896825,NC(=O)N1CCCc2cc(-c3cnccc3Cl)cnc21,Cytochrome P450 11B2,IC50,5.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3966439,NC(=O)N1CCCc2cc(-c3cnccn3)cnc21,Cytochrome P450 11B2,IC50,110,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3891561,NC(=O)N1CCCc2cc(-c3cncc(-c4ccc(F)cc4)c3)cnc21,Cytochrome P450 11B2,IC50,5.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3951898,Cn1cc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)cn1,Cytochrome P450 11B2,IC50,13,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL4112193,C[C@@H](O)c1c(F)cncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,22.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3915041,C[C@H](O)c1c(F)cncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,47.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3975913,NC(=O)N1CCCc2cc(-c3cnccc3-c3ccc(F)cc3)cnc21,Cytochrome P450 11B2,IC50,90,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3909704,Cn1cc(-c2ccncc2-c2cnc3c(c2)CCCN3C(N)=O)cn1,Cytochrome P450 11B2,IC50,1000,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3986593,CS(=O)(=O)c1ccc(-c2ccncc2-c2cnc3c(c2)CCCN3C(N)=O)cc1,Cytochrome P450 11B2,IC50,1000,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3900640,CS(=O)(=O)c1ccc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)cc1,Cytochrome P450 11B2,IC50,4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3953972,NC(=O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,120,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3892086,CC(=O)NCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,23.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3961066,CCS(=O)(=O)NCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,22.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3901051,NC(=O)N1CCCc2cc(-c3cncc(CO)c3)cnc21,Cytochrome P450 11B2,IC50,9.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3975375,NC(=O)N1CCC(F)(F)c2cc(-c3cccnc3)cnc21,Cytochrome P450 11B2,IC50,79,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3946918,NC(=O)N1CCC(O)c2cc(-c3cccnc3)cnc21,Cytochrome P450 11B2,IC50,370,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3919117,NC(=O)N1CCCc2cc(-c3cncc(C4=CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,36,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3984396,NC(=O)N1CCCc2cc(-c3cncc(C4=CCSCC4)c3)cnc21,Cytochrome P450 11B2,IC50,22,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3924553,CC(C)(C)OC(=O)N1CC=C(c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)CC1,Cytochrome P450 11B2,IC50,110,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3925664,NC(=O)N1CCCc2cc(-c3cncc(C4CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,22.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3938363,NC(=O)N1CCOCc2cc(-c3cncc(C(F)(F)F)c3)cnc21,Cytochrome P450 11B2,IC50,250,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3897951,COc1ccncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,21,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3929892,COC(=O)c1ccncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,37,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3964259,Cn1c(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2C#N)cc2ccccc21,Cytochrome P450 11B2,IC50,5.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3924719,CC(=O)NCc1ccncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,95.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3925276,COCc1ccncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,6.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3952963,NC(=O)N1CCCc2cc(-c3cncc(-c4ccc(C(=O)N5CCOCC5)cc4)c3)cnc21,Cytochrome P450 11B2,IC50,14.9,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3930692,NC(=O)N1CCCc2cc(-c3cncc(COc4ccc(F)cc4)c3)cnc21,Cytochrome P450 11B2,IC50,5.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3961657,CNC(=O)c1ccc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)cc1,Cytochrome P450 11B2,IC50,5.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3948808,NC(=O)N1CCCc2cc(-c3cncc(C4CCNCC4)c3)cnc21,Cytochrome P450 11B2,IC50,490,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3959385,NC(=O)N1CCCc2cc(-c3cncc(C4=CCS(=O)(=O)CC4)c3)cnc21,Cytochrome P450 11B2,IC50,72.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3949070,NC(=O)N1CCCc2cc(-c3cncc(C4CCS(=O)(=O)CC4)c3)cnc21,Cytochrome P450 11B2,IC50,35.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3917726,CCS(=O)(=O)NCc1ccncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,650,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3940286,NC(=O)N1CCCc2cc(-c3cnccc3COc3ccc(F)cc3)cnc21,Cytochrome P450 11B2,IC50,27,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3912297,CN(C)C(=O)c1ccc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)cc1,Cytochrome P450 11B2,IC50,5.9,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3963049,CC(C)(O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,16.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3895048,NC(=O)c1ccc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)cc1,Cytochrome P450 11B2,IC50,6.9,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3954315,CS(=O)(=O)CCCOCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,17,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3926683,NC(=O)N1CCCc2cc(-c3cnccc3C(F)(F)F)cnc21,Cytochrome P450 11B2,IC50,5.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3956510,NC(=O)N1CCCc2cc(-c3cnccc3CO)cnc21,Cytochrome P450 11B2,IC50,12,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3953287,NC(=O)c1ccncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,310,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3958062,NC(=O)N1CCCc2cc(-c3cncc(COc4ccccc4)c3)cnc21,Cytochrome P450 11B2,IC50,6.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3965459,NC(=O)N1CCCc2cc(-c3cncc(-c4ccc(C(=O)NCCO)cc4)c3)cnc21,Cytochrome P450 11B2,IC50,6.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3900634,CC(=O)NCCNC(=O)c1ccc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)cc1,Cytochrome P450 11B2,IC50,20,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3975016,CC(=O)N1CCC(OCc2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)CC1,Cytochrome P450 11B2,IC50,15.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3946550,CN(C)C(=O)Cc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,19,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3968689,CC(=O)N1CCCc2cc(-c3cncc(C(F)(F)F)c3)cnc21,Cytochrome P450 11B2,IC50,17.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3984014,NC(=O)N1CCCc2cc(-c3cncc(COC4CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,6.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3902341,CN(C)C(=O)COCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,26.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3925248,NC(=O)N1CCCc2cc(-c3cncc(C4(O)CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,66.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3897203,CC(=O)N1CCC(c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)CC1,Cytochrome P450 11B2,IC50,83.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3968019,NC(=O)N1CCCc2cc(-c3cncc(O)c3)cnc21,Cytochrome P450 11B2,IC50,5.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3893385,NC(=O)N1CCCc2cc(-c3cncc(OCC4CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,4.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3953657,CS(=O)(=O)CCCOc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,15.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3982358,CC(=O)N1CCC(Oc2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)CC1,Cytochrome P450 11B2,IC50,12,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3916886,NC(=O)N1CCc2cc(-c3cncc(C(F)(F)F)c3)cnc21,Cytochrome P450 11B2,IC50,57.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3977562,CC(C)(O)COCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,15.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3911456,CS(=O)(=O)CCCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,15.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3939428,NC(=O)N1CCCc2cc(-c3cncc(CN4CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,39.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3902456,NC(=O)N1CCCc2cc(-c3cncc(CN4CCNC(=O)C4)c3)cnc21,Cytochrome P450 11B2,IC50,74.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3926926,NC(=O)N1CCCc2cc(-c3cncc(CN4CCC(O)C4)c3)cnc21,Cytochrome P450 11B2,IC50,102.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3904905,NC(=O)N1CCCc2cc(-c3cncc(N4CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,22.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3911753,CC(O)(c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1)C(F)(F)F,Cytochrome P450 11B2,IC50,12.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3954945,CN1CCN(c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)CC1,Cytochrome P450 11B2,IC50,41.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3927321,CC(C)(O)C1CCN(c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)CC1,Cytochrome P450 11B2,IC50,12.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3949692,NC(=O)N1CCCc2cc(-c3cncc(C4(O)CCC4)c3)cnc21,Cytochrome P450 11B2,IC50,5.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3918374,CC(C)(CO)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,11,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3940934,CC(=O)N1CCC(OCc2cncc(-c3cnc4c(c3)CCN4C(N)=O)c2)CC1,Cytochrome P450 11B2,IC50,17,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3912933,CC(C)C(O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,8.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3973514,NC(=O)N1CCCc2cc(-c3cncc(COCCN4CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,19.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3947417,COC(C)(C)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,21.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3983631,CC(C)C(C)(O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,11.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3931640,NC(=O)N1CCCc2cc(-c3cncc(C4(O)COC4)c3)cnc21,Cytochrome P450 11B2,IC50,27,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3922802,CNC(=O)N1CCCc2cc(-c3cccnc3)cnc21,Cytochrome P450 11B2,IC50,120,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3900254,NC(=O)N1CCCc2cc(-c3cncc(C(=O)N4CCCC4)c3)cnc21,Cytochrome P450 11B2,IC50,250,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3927037,CS(=O)(=O)Nc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,20,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3965258,NC(=O)N1CCCc2cc(-c3cncc(Oc4ccccc4)c3)cnc21,Cytochrome P450 11B2,IC50,10.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3909152,CN(Cc1ccccc1)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,15.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3921614,CNC(=O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,44,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3939873,CC(=O)Nc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,85,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3911894,NC(=O)N1CCCc2cc(-c3cncc(C(=O)N4CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,620,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3948634,CCOc1ccncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,11.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3953935,NC(=O)N1CCCc2cc(-c3ccc(Cl)nc3)cnc21,Cytochrome P450 11B2,IC50,1000,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3962673,NC(=O)N1CCCc2cc(-c3cncc(NCc4ccccc4)c3)cnc21,Cytochrome P450 11B2,IC50,3.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3938745,CCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,5.9,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3941535,N#Cc1cccc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)c1,Cytochrome P450 11B2,IC50,45,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3904557,NC(=O)c1ccccc1-c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,151,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3919041,NC(=O)c1cccc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)c1,Cytochrome P450 11B2,IC50,11.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3946850,COCc1cccc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)c1,Cytochrome P450 11B2,IC50,25.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3945833,COCc1ccccc1-c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,10.9,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3908015,Cc1c(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)cnn1C,Cytochrome P450 11B2,IC50,7.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3931970,CC(=O)Nc1cccc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)c1,Cytochrome P450 11B2,IC50,8.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3971477,NC(=O)N1CCCc2cc(-c3cncc(-c4ccc(S(N)(=O)=O)cc4)c3)cnc21,Cytochrome P450 11B2,IC50,2.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3966246,NC(=O)N1CCCc2cc(-c3cncc(-c4cnn(CCN5CCOCC5)c4)c3)cnc21,Cytochrome P450 11B2,IC50,24,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3946323,CNS(=O)(=O)c1cccc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)c1,Cytochrome P450 11B2,IC50,7.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3921979,Cc1ccc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)cn1,Cytochrome P450 11B2,IC50,6.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3937454,N#CCc1cccc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)c1,Cytochrome P450 11B2,IC50,3.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3909509,Cc1cc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)ccn1,Cytochrome P450 11B2,IC50,10.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3944672,NC(=O)N1CCCc2cc(-c3cncc(-c4cccc(CO)c4)c3)cnc21,Cytochrome P450 11B2,IC50,6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3945692,N#CCc1ccc(-c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)cc1,Cytochrome P450 11B2,IC50,3.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3901026,CS(=O)(=O)c1ccccc1-c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,64.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3971650,NC(=O)N1CCCc2cc(-c3cncc(-c4ccccc4CO)c3)cnc21,Cytochrome P450 11B2,IC50,4.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3957762,Cn1nccc1-c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,17,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3963902,NC(=O)N1CCCc2cc(-c3cncc(-c4cc[nH]n4)c3)cnc21,Cytochrome P450 11B2,IC50,15.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3930166,CNS(=O)(=O)c1ccccc1-c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,92,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3897329,NC(=O)N1CCCc2cc(-c3cncc(-c4ccc(N5CCOCC5)nc4)c3)cnc21,Cytochrome P450 11B2,IC50,5.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3968477,NC(=O)N1CCCc2cc(-c3cncc(-c4ccncc4)c3)cnc21,Cytochrome P450 11B2,IC50,8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3906298,NC(=O)N1CCCc2cc(-c3cncc(-c4cccc(S(=O)(=O)NCCO)c4)c3)cnc21,Cytochrome P450 11B2,IC50,13.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3980071,NC(=O)N1CCCc2cc(-c3cncc(-c4ccc(S(=O)(=O)NCCO)cc4)c3)cnc21,Cytochrome P450 11B2,IC50,7.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3952190,N#Cc1c(Cl)cncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,3.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3891874,N#Cc1c(-c2ccc(F)cc2)cncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,7.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3975874,CC(O)c1c(Cl)cncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,21.9,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3979451,NC(=O)N1CCCc2cc(-c3cncc(C4(O)CCOC4)c3)cnc21,Cytochrome P450 11B2,IC50,27.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3905589,NC(=O)N1CCCc2cc(-c3cncc(C4COC4)c3)cnc21,Cytochrome P450 11B2,IC50,14.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3967809,CS(=O)(=O)CCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,17.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3896648,NC(=O)Nc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,257.9,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3956763,NC(=O)N1CCCc2cc(-c3cncc(N)c3)cnc21,Cytochrome P450 11B2,IC50,16.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3899854,NC(=O)N1CCCc2cc(-c3cncc(C4CCC(=O)N4)c3)cnc21,Cytochrome P450 11B2,IC50,47,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3951520,NC(=O)N1CCCc2cc(-c3cncc(C4CCCN4)c3)cnc21,Cytochrome P450 11B2,IC50,295.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3965514,CC(=O)N1CCCC(OCc2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)C1,Cytochrome P450 11B2,IC50,25.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3944830,CC(O)c1ccncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,28.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3985120,NC(=O)Cc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,65.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3973726,CNC(=O)Cc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,15.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3901795,NC(=O)N1CCCc2cc(-c3cncc(CC(=O)N4CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,30,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3933271,CC(OCc1ccccc1)c1c(C#N)cncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,83.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3891961,NC(=O)N1CCCc2cc(-c3cncc(C4(O)CCCOC4)c3)cnc21,Cytochrome P450 11B2,IC50,23.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3968542,NC(=O)N1CCCc2cc(-c3cncc(CC(=O)O)c3)cnc21,Cytochrome P450 11B2,IC50,249,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3906375,NC(=O)N1CCCc2cc(-c3cncc(C(O)C(F)(F)F)c3)cnc21,Cytochrome P450 11B2,IC50,5.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3977047,CC(=O)N1CCCC(OCc2cncc(-c3cnc4c(c3)CCN4C(N)=O)c2)C1,Cytochrome P450 11B2,IC50,48.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3943458,NC(=O)N1CCCc2cc(-c3cncc(CC(=O)N4CCC(F)(F)CC4)c3)cnc21,Cytochrome P450 11B2,IC50,13.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3919056,CN(CC1CCOC1)C(=O)Cc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,19.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL4113433,NC(=O)N1CCCc2cc(-c3cncc(CC(=O)N4CC[C@@H](O)C4)c3)cnc21,Cytochrome P450 11B2,IC50,40,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3927962,NC(=O)N1CCCc2cc(-c3cncc(CC(=O)N4CC[C@H](O)C4)c3)cnc21,Cytochrome P450 11B2,IC50,35,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3889765,CC(O)c1c(Cl)cncc1-c1cnc2c(c1)CCN2C(N)=O,Cytochrome P450 11B2,IC50,27.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3930388,NC(=O)N1CCc2cc(-c3cncc(CC(=O)N4CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,63.9,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3954500,NC(=O)N1CCCc2cc(-c3cncc(CC(=O)NC4CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,40,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3963910,CC(C)(C(=O)N1CCOCC1)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,147.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL4107798,CC(=O)N1CCC[C@@H](Oc2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)C1,Cytochrome P450 11B2,IC50,42.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3953473,CC(=O)N1CCC(OCc2cncc(-c3cnc4c(c3)CCCN4C(C)=O)c2Cl)CC1,Cytochrome P450 11B2,IC50,34.9,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3982193,CC(C)(O)c1c(F)cncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,37,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3917618,NC(=O)N1CCCc2cc(-c3cncc(F)c3C3(O)CCC3)cnc21,Cytochrome P450 11B2,IC50,154.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3923647,NC(=O)N1CCCc2cc(-c3cncc(F)c3C3(O)COC3)cnc21,Cytochrome P450 11B2,IC50,209,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3901438,CCC(O)c1c(F)cncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,61.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3972542,CC(C)C(O)c1c(F)cncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,403.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3924867,CCS(=O)(=O)NC(c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1)C1CC1,Cytochrome P450 11B2,IC50,54.9,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3900387,CS(=O)(=O)Cc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,20.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL4108408,C[C@@H](N)c1c(F)cncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,424.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3985614,NC(=O)N1CCCc2cc(-c3cncc(CN4CCOCC4=O)c3)cnc21,Cytochrome P450 11B2,IC50,18.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3923719,NC(=O)N1CCCc2cc(-c3cncc(CNC(=O)C4CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,50.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3912488,CCS(=O)(=O)NC(C)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,22.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3962275,CC(=O)NC(C)(C)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,58.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3909999,COC(=O)c1c(F)cncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,37.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3898801,CC(C)(O)C(=O)NCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,35,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3973050,NCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,374.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL4110165,CCS(=O)(=O)N[C@H](C)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,19.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3900006,CCS(=O)(=O)N[C@@H](C)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,26.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL4110564,CCS(=O)(=O)N(C)[C@H](C)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,9.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3912552,CCS(=O)(=O)N(C)[C@@H](C)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,9.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3913595,CC1(C)CC(O)(c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)CCO1,Cytochrome P450 11B2,IC50,89.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3965658,CN(Cc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1)C(=O)C1CCOCC1,Cytochrome P450 11B2,IC50,47.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3922593,NC(=O)N1CCCc2cc(-c3cncc(COCC(=O)N4CCCC4)c3)cnc21,Cytochrome P450 11B2,IC50,10.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3891029,CNC(=O)COCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,18.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3960988,NC(=O)N1CCCc2cc(-c3cncc(COCC(=O)N4CCCCC4)c3)cnc21,Cytochrome P450 11B2,IC50,4.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3958416,CC1(O)CCN(C(=O)COCc2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)CC1,Cytochrome P450 11B2,IC50,41,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3902834,NC(=O)N1CCCc2cc(-c3cncc(COCC(=O)N4CCC5(CC4)CC5)c3)cnc21,Cytochrome P450 11B2,IC50,7.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3942356,NC(=O)N1CCCc2cc(-c3cncc(COCC(=O)N4CCC(F)(F)CC4)c3)cnc21,Cytochrome P450 11B2,IC50,8.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3908295,NC(=O)N1CCCc2cc(-c3cncc(COCC(=O)N4CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,22,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL4110324,CC(=O)N[C@H](C)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,42.9,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3917251,CC(=O)N[C@@H](C)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,50.9,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3945154,CC1OCCN(Cc2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)C1=O,Cytochrome P450 11B2,IC50,19.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3935886,NC(=O)N1CCCc2cc(-c3cncc(CN4CCOCC4=O)c3Cl)cnc21,Cytochrome P450 11B2,IC50,32,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3953880,NC(=O)N1CCCc2cc(-c3cncc(C4CC4)c3)cnc21,Cytochrome P450 11B2,IC50,4.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL4108839,CC(=O)N(C)[C@H](C)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,36.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3938698,CC(=O)N(C)[C@@H](C)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,42.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3952206,NC(=O)N1CCCc2cc(-c3cncc(CN4CCCS4(=O)=O)c3)cnc21,Cytochrome P450 11B2,IC50,14.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3924523,NC(=O)N1CCCc2cc(-c3cncc(CN4CCCCS4(=O)=O)c3)cnc21,Cytochrome P450 11B2,IC50,10.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3946891,CC(=O)N1CCC(c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2C#N)CC1,Cytochrome P450 11B2,IC50,147,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3915535,CC(O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1Cl,Cytochrome P450 11B2,IC50,11.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3938097,CC(c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1)N1CCOCC1=O,Cytochrome P450 11B2,IC50,57.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3927907,CCN(CC)C(=O)COCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,9,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3903448,CC1(C)CCN(C(=O)COCc2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)C1,Cytochrome P450 11B2,IC50,6.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3960330,NC(=O)N1CCc2cc(-c3cncc(CN4CCOCC4=O)c3)cnc21,Cytochrome P450 11B2,IC50,36.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3922977,CC1(C)CC(O)(c2cncc(-c3cnc4c(c3)CCN4C(N)=O)c2)CCO1,Cytochrome P450 11B2,IC50,169.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3934445,CC(=O)N1CCC[C@H](Oc2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)C1,Cytochrome P450 11B2,IC50,60.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3912941,CC(=O)N1CCC(OCc2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)C1,Cytochrome P450 11B2,IC50,31,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3937386,CC(=O)N1CCC(OCc2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2Cl)CC1,Cytochrome P450 11B2,IC50,10,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3900434,CC(=O)N1CCCC1c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,140.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3928383,CS(=O)(=O)N1CCCC1c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,34.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3925012,CN1C(=O)CCC1c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,52.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3956078,CC(C#N)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,4.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3928160,NC(=O)N1CCCc2cc(-c3cncc(N4CCCC4=O)c3)cnc21,Cytochrome P450 11B2,IC50,53.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3909359,CC(C)(C#N)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,14.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3972323,N#CC1(c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)CC1,Cytochrome P450 11B2,IC50,3.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3942704,NC(=O)N1CCCc2cc(-c3cncc(C4(C(N)=O)CC4)c3)cnc21,Cytochrome P450 11B2,IC50,31.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3980375,N#CC1(c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)CCOCC1,Cytochrome P450 11B2,IC50,15.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3954864,NC(=O)N1CCCc2cc(-c3cncc(N4CCOC4=O)c3)cnc21,Cytochrome P450 11B2,IC50,16.9,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3984775,CN1CCN(c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)C1=O,Cytochrome P450 11B2,IC50,50.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3959564,NC(=O)N1CCCc2cc(-c3cncc(CN4CCCC4=O)c3)cnc21,Cytochrome P450 11B2,IC50,6.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3976688,NC(=O)N1CCCc2cc(-c3cncc(N4CCOCC4=O)c3)cnc21,Cytochrome P450 11B2,IC50,79.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3947420,NC(=O)N1CCCc2cc(-c3cncc(CN4CCOC4=O)c3)cnc21,Cytochrome P450 11B2,IC50,14.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3891728,CN1CCN(Cc2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)C1=O,Cytochrome P450 11B2,IC50,16.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3963550,CC(=O)N1CCCc2cc(-c3cncc(CN4CCOCC4=O)c3)cnc21,Cytochrome P450 11B2,IC50,33,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3973153,CC(=O)N1CCC(Oc2cncc(-c3cnc4c(c3)CCCN4C(C)=O)c2)CC1,Cytochrome P450 11B2,IC50,28.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3902112,CC(=O)N1CCCc2cc(-c3cncc(CC(=O)N4CCOCC4)c3)cnc21,Cytochrome P450 11B2,IC50,33.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL4108275,CC(=O)N[C@H](C)c1cncc(-c2cnc3c(c2)CCCN3C(C)=O)c1,Cytochrome P450 11B2,IC50,67.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL4110751,CC(=O)N1CCCc2cc(-c3cncc([C@@H](C)NS(C)(=O)=O)c3)cnc21,Cytochrome P450 11B2,IC50,19.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3956756,NC(=O)N1CCCc2cc(-c3cncc(OCCN4CCOC4=O)c3)cnc21,Cytochrome P450 11B2,IC50,39.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3985417,CN(C)CCCOc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,62.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3962163,NC(=O)N1CCCc2cc(-c3cncc(OCC4COCCO4)c3)cnc21,Cytochrome P450 11B2,IC50,27.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3896637,Cn1nccc1COc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,11.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3938157,NC(=O)N1CCCc2cc(-c3cncc(OCc4cccnn4)c3)cnc21,Cytochrome P450 11B2,IC50,9.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3967734,Cc1ccncc1-c1cnc2c(c1)CCN2C(N)=O,Cytochrome P450 11B2,IC50,3.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3915466,N#Cc1ccncc1-c1cnc2c(c1)CCN2C(N)=O,Cytochrome P450 11B2,IC50,9.1,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3985227,NC(=O)N1CCc2cc(-c3cncc(CO)c3)cnc21,Cytochrome P450 11B2,IC50,17.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3924458,NC(=O)N1CCc2cc(-c3cnccc3C(F)(F)F)cnc21,Cytochrome P450 11B2,IC50,3.2,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3892941,C[C@H](O)c1c(F)cncc1-c1cnc2c(c1)CCN2C(N)=O,Cytochrome P450 11B2,IC50,43.6,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3933090,NC(=O)N1CCCc2cc(-c3cncc(CNC(=O)C4CC4)c3)cnc21,Cytochrome P450 11B2,IC50,12,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3901922,NC(=O)N1CCCc2cc(-c3cncc(CNC(=O)c4ncccc4Cl)c3)cnc21,Cytochrome P450 11B2,IC50,11,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3968560,NC(=O)N1CCCc2cc(-c3cncc(CNC(=O)C4CC4(F)F)c3)cnc21,Cytochrome P450 11B2,IC50,42,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3915098,CCC(=O)NCc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,18,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3980149,NC(=O)N1CCCc2cc(-c3cncc(CNC(=O)Cn4ccnc4)c3)cnc21,Cytochrome P450 11B2,IC50,42,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3951224,CC(NC(=O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1)c1nccs1,Cytochrome P450 11B2,IC50,340,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3981510,CN(CC1CCOCC1)C(=O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,37,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3914946,C[C@H](NC(=O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1)c1ccccn1,Cytochrome P450 11B2,IC50,490,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3976684,CN(C(=O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1)C1CCC1,Cytochrome P450 11B2,IC50,47,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3938380,COCCN(C)C(=O)c1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1,Cytochrome P450 11B2,IC50,270,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3933051,CS(=O)(=O)N1CCC(NC(=O)c2cncc(-c3cnc4c(c3)CCCN4C(N)=O)c2)C1,Cytochrome P450 11B2,IC50,59,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3957069,NC(=O)N1CCCc2c1ncc(-c1cncc(C3(O)CCOCC3)c1)c2Cl,Cytochrome P450 11B2,IC50,8.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3892465,Cc1c(-c2cncc(C3(O)CCOCC3)c2)cnc2c1CCCN2C(N)=O,Cytochrome P450 11B2,IC50,34.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3920458,Cc1nc2c(cc1-c1cncc(C3(O)CCOCC3)c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,48.5,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3947328,N#Cc1nc2c(cc1-c1cncc(C3(O)CCOCC3)c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,1000,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3938943,NC(=O)N1CCCc2c1ncc(-c1cncc(C3(O)CCOCC3)c1)c2F,Cytochrome P450 11B2,IC50,17.3,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3954158,NC(=O)N1CCCc2c1ncc(-c1cncc(CN3CCOCC3=O)c1)c2F,Cytochrome P450 11B2,IC50,20.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3929982,CC(=O)N1CCC(Oc2cncc(-c3cnc4c(c3F)CCCN4C(N)=O)c2)CC1,Cytochrome P450 11B2,IC50,22.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3945433,Cc1nc2c(cc1-c1cncc(CN3CCOCC3=O)c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,43.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3917547,CC(=O)N1CCC(Oc2cncc(-c3cc4c(nc3C)N(C(N)=O)CCC4)c2)CC1,Cytochrome P450 11B2,IC50,20.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3940098,NC(=O)N1CCCc2c1ncc(-c1cncc(CN3CCOCC3=O)c1)c2Cl,Cytochrome P450 11B2,IC50,5.8,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3908602,CC(=O)N1CCC(Oc2cncc(-c3cnc4c(c3Cl)CCCN4C(N)=O)c2)CC1,Cytochrome P450 11B2,IC50,23.4,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3931071,CC(=O)c1c(F)cncc1-c1cnc2c(c1)CCCN2C(N)=O,Cytochrome P450 11B2,IC50,9.7,"Aldosterone Synthase Inhibition Assay: The aldosterone synthase inhibition assay employs cynomolgus adrenal gland mitochondria as the source of aldosterone synthase (CYP11B2). Mitochondria are prepared from frozen cynomolgus monkey adrenal glands according to Method A described in by J. D. McGarry et al. (Biochem. J., 1983, 214, 21-28), with a final resuspension in the AT buffer described in R. Yamaguchi et al. (Cell Death and Differentiation, 2007, 14, 616-624), frozen as aliquots in liquid nitrogen and stored at -80° C. until use. Assays are performed in 96-well format in a final volume of 60 uL/well, containing 100 mM potassium phosphate, pH 7.4, 1% (v/v) DMSO, and additionally, 2 uM of corticosterone and 6 mg of mitochondrial protein. Reactions are started by the addition of NADPH to 1 mM and allowed to proceed for 60-90 minutes at 37° C. Reactions are terminated by the addition of 60 uL of acetonitrile. One hundred microliters are then transferred to a glass filter plate and centrifuged at 570xg.",active,CHEMBL3887526
CHEMBL3945789,Cc1nnc2n1-c1c(F)cc(-c3cncc(F)c3C3CC3)cc1CC2,Cytochrome P450 11B2,IC50,7.3,"Inhbition Assay: Compounds of the Examples 1 to 3 were assayed for V79-Human-CYP11B2 and V79-Human-CYP11B1 by modifying the protocol described in J. Steroid Biochem. Mol. Biol. 81; 173-179 (2002). V79MZh11B1 and V79MZh11B2 cells (8x105 cells/well) were grown on 24-well culture plates until confluence. Before testing, the DMEM culture medium was removed and 450 ul of fresh DMEM containing the inhibitor was added to each well. After a preincubation step of 60 min at 37° C., the reaction was started by the addition of 50 ul of DMEM in which the substrate deoxycorticosterone (containing 0.15 uCi of [1,2-3H]-deoxycorticosterone in ethanol, final test concentration 100 nM) was dissolved. Incubation times were 25 min for V79MZh11B1 and 50 min for V79MZh11B2 cells at 37° C., respectively. The enzyme reactions were stopped by extracting the supernatant with ethyl acetate. Samples were centrifuged (10.000 g, 5 min) and the solvent was pipetted into fresh cups. After evaporation of the solvent, the steroids were redissolved in 40 ul of methanol (50:50, v/v) and analyzed by HPLC. Detection and quantification of the steroids were performed using a radioflow detector.",active,CHEMBL3888109
CHEMBL3975161,Cc1nnc2n1-c1c(F)cc(-c3cncc(F)c3C(C)C)cc1CC2,Cytochrome P450 11B2,IC50,9.5,"Inhbition Assay: Compounds of the Examples 1 to 3 were assayed for V79-Human-CYP11B2 and V79-Human-CYP11B1 by modifying the protocol described in J. Steroid Biochem. Mol. Biol. 81; 173-179 (2002). V79MZh11B1 and V79MZh11B2 cells (8x105 cells/well) were grown on 24-well culture plates until confluence. Before testing, the DMEM culture medium was removed and 450 ul of fresh DMEM containing the inhibitor was added to each well. After a preincubation step of 60 min at 37° C., the reaction was started by the addition of 50 ul of DMEM in which the substrate deoxycorticosterone (containing 0.15 uCi of [1,2-3H]-deoxycorticosterone in ethanol, final test concentration 100 nM) was dissolved. Incubation times were 25 min for V79MZh11B1 and 50 min for V79MZh11B2 cells at 37° C., respectively. The enzyme reactions were stopped by extracting the supernatant with ethyl acetate. Samples were centrifuged (10.000 g, 5 min) and the solvent was pipetted into fresh cups. After evaporation of the solvent, the steroids were redissolved in 40 ul of methanol (50:50, v/v) and analyzed by HPLC. Detection and quantification of the steroids were performed using a radioflow detector.",active,CHEMBL3888109
CHEMBL3936908,Cc1nnc2n1-c1c(F)cc(-c3cncc(F)c3Cl)cc1CC2,Cytochrome P450 11B2,IC50,21.6,"Inhbition Assay: Compounds of the Examples 1 to 3 were assayed for V79-Human-CYP11B2 and V79-Human-CYP11B1 by modifying the protocol described in J. Steroid Biochem. Mol. Biol. 81; 173-179 (2002). V79MZh11B1 and V79MZh11B2 cells (8x105 cells/well) were grown on 24-well culture plates until confluence. Before testing, the DMEM culture medium was removed and 450 ul of fresh DMEM containing the inhibitor was added to each well. After a preincubation step of 60 min at 37° C., the reaction was started by the addition of 50 ul of DMEM in which the substrate deoxycorticosterone (containing 0.15 uCi of [1,2-3H]-deoxycorticosterone in ethanol, final test concentration 100 nM) was dissolved. Incubation times were 25 min for V79MZh11B1 and 50 min for V79MZh11B2 cells at 37° C., respectively. The enzyme reactions were stopped by extracting the supernatant with ethyl acetate. Samples were centrifuged (10.000 g, 5 min) and the solvent was pipetted into fresh cups. After evaporation of the solvent, the steroids were redissolved in 40 ul of methanol (50:50, v/v) and analyzed by HPLC. Detection and quantification of the steroids were performed using a radioflow detector.",active,CHEMBL3888109
CHEMBL3950454,COc1ccc2c(c1)CC(c1cccnc1)=C2,Cytochrome P450 11B2,IC50,4,"Inhibition Assay: V79 MZh11B1 and V79 MZh 11B2 cells (8˙10^5 cells per well) were grown to confluency on 24-well cell culture plates with 1.9 cm^2 culture area per well (Nunc, Roskilde, Denmark). Before the test, the DMEM culture medium present was removed, and 450 μl of fresh DMEM with inhibitor was added for at least three concentrations to each well to determine the IC50. After preincubation (60 min, 37 °C.), the reaction was started by adding 50 μl of DMEM with 2.5 μl of solution of the substrate 11-deoxycorticosterone (20 μM, containing 1.25 nCi of [4-14C]11-deoxycorticosterone in ethanol). Thereafter, the plate was stored at 37 °C. and 5% CO2 in a CO2 incubator. The V79 MZh 11B1 cells were incubated for 120 min, and the V79 MZh 11B2 cells were incubated for 40 min. Controls without inhibitor were treated in the same way. The enzyme reactions were quenched by extracting the supernatant with 500 μl of EtOAc. The samples were centrifuged (10,000 g, 2 min), the solvent was removed and evaporated. The residue was taken up in 10 μl of chloroform and analyzed by HPTLC (see below).",active,CHEMBL3888231
CHEMBL3983243,Cc1cncc(-c2nn3c(c2C)NC(=O)CC3)c1,Cytochrome P450 11B2,IC50,2.2,"V79-Human-CYP11B2 and V79-Human-CYP11B1 Assays: V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 cells were transfected with plasmids pTriEx3-Hygro-hCyp11B2 or pTriEx3-Hygro-hCyp11B1 using Lipofectamine2000 reagent. V79 cells that stably express the human CYP11B2 or human CYP11B1 enzyme were selected for and maintained in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin for ~2 weeks. Single cell clones were generated by infinite dilution in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin until single colonies were obtained. Clones V79-hCYP11B2-CLE9 and V79-hCYP11B1-8CLC7, were determined to produce the most aldosterone and cortisol, respectively, and were selected for inhibitor screening. For testing of inhibitors, cells were harvested at 80% confluency with 0.5% Trypsan-EDTA, washed once in PBS, and reconstituted in DMEM+0.1% BSA media at a cell concentration of 600,000 cells/mL for the CYP11B2 assay and 280,000 cells/mL for the CYP11B1 assay. 25 μL of cells were added to a 384 well tissue culture treated plate and mixed with 0.3 μL of inhibitor or DMSO (1% final DMSO concentration) for 1 hour at 37° C., 5% CO2. After pre-incubation with inhibitor, the reaction was initiated by adding 5 μL of substrate (final concentration of 125 nM 11-deoxycorticosterone for the CYP11B2 assay or 250 nM 11-deoxycortisol for the CYP11B1 assay). The reaction was carried out for 3 hours at 37° C., 5% CO2 and was stopped by harvesting the supernatants. The amount of product in the supernatant (aldosterone for CYP11B2 assay and cortisol for the CYP11B1 assay) was measured using HTRF-based assay kit (Aldosterone HTRF-CisBio#64ALDPEB, Cortisol HTRF-CisBio #63IDC002-CORT).",active,CHEMBL3888509
CHEMBL3913405,Cc1cncc(-c2nn3c(c2C)N(C)C(=O)CC3)c1,Cytochrome P450 11B2,IC50,9.8,"V79-Human-CYP11B2 and V79-Human-CYP11B1 Assays: V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 cells were transfected with plasmids pTriEx3-Hygro-hCyp11B2 or pTriEx3-Hygro-hCyp11B1 using Lipofectamine2000 reagent. V79 cells that stably express the human CYP11B2 or human CYP11B1 enzyme were selected for and maintained in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin for ~2 weeks. Single cell clones were generated by infinite dilution in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin until single colonies were obtained. Clones V79-hCYP11B2-CLE9 and V79-hCYP11B1-8CLC7, were determined to produce the most aldosterone and cortisol, respectively, and were selected for inhibitor screening. For testing of inhibitors, cells were harvested at 80% confluency with 0.5% Trypsan-EDTA, washed once in PBS, and reconstituted in DMEM+0.1% BSA media at a cell concentration of 600,000 cells/mL for the CYP11B2 assay and 280,000 cells/mL for the CYP11B1 assay. 25 μL of cells were added to a 384 well tissue culture treated plate and mixed with 0.3 μL of inhibitor or DMSO (1% final DMSO concentration) for 1 hour at 37° C., 5% CO2. After pre-incubation with inhibitor, the reaction was initiated by adding 5 μL of substrate (final concentration of 125 nM 11-deoxycorticosterone for the CYP11B2 assay or 250 nM 11-deoxycortisol for the CYP11B1 assay). The reaction was carried out for 3 hours at 37° C., 5% CO2 and was stopped by harvesting the supernatants. The amount of product in the supernatant (aldosterone for CYP11B2 assay and cortisol for the CYP11B1 assay) was measured using HTRF-based assay kit (Aldosterone HTRF-CisBio#64ALDPEB, Cortisol HTRF-CisBio #63IDC002-CORT).",active,CHEMBL3888509
CHEMBL3936160,CCc1c(-c2cncc(C)c2)nn2c1N(C)C(=O)CC2,Cytochrome P450 11B2,IC50,7.8,"V79-Human-CYP11B2 and V79-Human-CYP11B1 Assays: V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 cells were transfected with plasmids pTriEx3-Hygro-hCyp11B2 or pTriEx3-Hygro-hCyp11B1 using Lipofectamine2000 reagent. V79 cells that stably express the human CYP11B2 or human CYP11B1 enzyme were selected for and maintained in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin for ~2 weeks. Single cell clones were generated by infinite dilution in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin until single colonies were obtained. Clones V79-hCYP11B2-CLE9 and V79-hCYP11B1-8CLC7, were determined to produce the most aldosterone and cortisol, respectively, and were selected for inhibitor screening. For testing of inhibitors, cells were harvested at 80% confluency with 0.5% Trypsan-EDTA, washed once in PBS, and reconstituted in DMEM+0.1% BSA media at a cell concentration of 600,000 cells/mL for the CYP11B2 assay and 280,000 cells/mL for the CYP11B1 assay. 25 μL of cells were added to a 384 well tissue culture treated plate and mixed with 0.3 μL of inhibitor or DMSO (1% final DMSO concentration) for 1 hour at 37° C., 5% CO2. After pre-incubation with inhibitor, the reaction was initiated by adding 5 μL of substrate (final concentration of 125 nM 11-deoxycorticosterone for the CYP11B2 assay or 250 nM 11-deoxycortisol for the CYP11B1 assay). The reaction was carried out for 3 hours at 37° C., 5% CO2 and was stopped by harvesting the supernatants. The amount of product in the supernatant (aldosterone for CYP11B2 assay and cortisol for the CYP11B1 assay) was measured using HTRF-based assay kit (Aldosterone HTRF-CisBio#64ALDPEB, Cortisol HTRF-CisBio #63IDC002-CORT).",active,CHEMBL3888509
CHEMBL3908217,Cc1cncc(-c2nn3c(c2C2CC2)NC(=O)CC3)c1,Cytochrome P450 11B2,IC50,13.2,"V79-Human-CYP11B2 and V79-Human-CYP11B1 Assays: V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 cells were transfected with plasmids pTriEx3-Hygro-hCyp11B2 or pTriEx3-Hygro-hCyp11B1 using Lipofectamine2000 reagent. V79 cells that stably express the human CYP11B2 or human CYP11B1 enzyme were selected for and maintained in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin for ~2 weeks. Single cell clones were generated by infinite dilution in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin until single colonies were obtained. Clones V79-hCYP11B2-CLE9 and V79-hCYP11B1-8CLC7, were determined to produce the most aldosterone and cortisol, respectively, and were selected for inhibitor screening. For testing of inhibitors, cells were harvested at 80% confluency with 0.5% Trypsan-EDTA, washed once in PBS, and reconstituted in DMEM+0.1% BSA media at a cell concentration of 600,000 cells/mL for the CYP11B2 assay and 280,000 cells/mL for the CYP11B1 assay. 25 μL of cells were added to a 384 well tissue culture treated plate and mixed with 0.3 μL of inhibitor or DMSO (1% final DMSO concentration) for 1 hour at 37° C., 5% CO2. After pre-incubation with inhibitor, the reaction was initiated by adding 5 μL of substrate (final concentration of 125 nM 11-deoxycorticosterone for the CYP11B2 assay or 250 nM 11-deoxycortisol for the CYP11B1 assay). The reaction was carried out for 3 hours at 37° C., 5% CO2 and was stopped by harvesting the supernatants. The amount of product in the supernatant (aldosterone for CYP11B2 assay and cortisol for the CYP11B1 assay) was measured using HTRF-based assay kit (Aldosterone HTRF-CisBio#64ALDPEB, Cortisol HTRF-CisBio #63IDC002-CORT).",active,CHEMBL3888509
CHEMBL3917065,Cc1c(-c2cncc(F)c2)nn2c1N(C)C(=O)CC2,Cytochrome P450 11B2,IC50,19.1,"V79-Human-CYP11B2 and V79-Human-CYP11B1 Assays: V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 cells were transfected with plasmids pTriEx3-Hygro-hCyp11B2 or pTriEx3-Hygro-hCyp11B1 using Lipofectamine2000 reagent. V79 cells that stably express the human CYP11B2 or human CYP11B1 enzyme were selected for and maintained in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin for ~2 weeks. Single cell clones were generated by infinite dilution in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin until single colonies were obtained. Clones V79-hCYP11B2-CLE9 and V79-hCYP11B1-8CLC7, were determined to produce the most aldosterone and cortisol, respectively, and were selected for inhibitor screening. For testing of inhibitors, cells were harvested at 80% confluency with 0.5% Trypsan-EDTA, washed once in PBS, and reconstituted in DMEM+0.1% BSA media at a cell concentration of 600,000 cells/mL for the CYP11B2 assay and 280,000 cells/mL for the CYP11B1 assay. 25 μL of cells were added to a 384 well tissue culture treated plate and mixed with 0.3 μL of inhibitor or DMSO (1% final DMSO concentration) for 1 hour at 37° C., 5% CO2. After pre-incubation with inhibitor, the reaction was initiated by adding 5 μL of substrate (final concentration of 125 nM 11-deoxycorticosterone for the CYP11B2 assay or 250 nM 11-deoxycortisol for the CYP11B1 assay). The reaction was carried out for 3 hours at 37° C., 5% CO2 and was stopped by harvesting the supernatants. The amount of product in the supernatant (aldosterone for CYP11B2 assay and cortisol for the CYP11B1 assay) was measured using HTRF-based assay kit (Aldosterone HTRF-CisBio#64ALDPEB, Cortisol HTRF-CisBio #63IDC002-CORT).",active,CHEMBL3888509
CHEMBL3913653,CCc1c(-c2cncc(F)c2)nn2c1NC(=O)CC2,Cytochrome P450 11B2,IC50,11.7,"V79-Human-CYP11B2 and V79-Human-CYP11B1 Assays: V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 cells were transfected with plasmids pTriEx3-Hygro-hCyp11B2 or pTriEx3-Hygro-hCyp11B1 using Lipofectamine2000 reagent. V79 cells that stably express the human CYP11B2 or human CYP11B1 enzyme were selected for and maintained in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin for ~2 weeks. Single cell clones were generated by infinite dilution in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin until single colonies were obtained. Clones V79-hCYP11B2-CLE9 and V79-hCYP11B1-8CLC7, were determined to produce the most aldosterone and cortisol, respectively, and were selected for inhibitor screening. For testing of inhibitors, cells were harvested at 80% confluency with 0.5% Trypsan-EDTA, washed once in PBS, and reconstituted in DMEM+0.1% BSA media at a cell concentration of 600,000 cells/mL for the CYP11B2 assay and 280,000 cells/mL for the CYP11B1 assay. 25 μL of cells were added to a 384 well tissue culture treated plate and mixed with 0.3 μL of inhibitor or DMSO (1% final DMSO concentration) for 1 hour at 37° C., 5% CO2. After pre-incubation with inhibitor, the reaction was initiated by adding 5 μL of substrate (final concentration of 125 nM 11-deoxycorticosterone for the CYP11B2 assay or 250 nM 11-deoxycortisol for the CYP11B1 assay). The reaction was carried out for 3 hours at 37° C., 5% CO2 and was stopped by harvesting the supernatants. The amount of product in the supernatant (aldosterone for CYP11B2 assay and cortisol for the CYP11B1 assay) was measured using HTRF-based assay kit (Aldosterone HTRF-CisBio#64ALDPEB, Cortisol HTRF-CisBio #63IDC002-CORT).",active,CHEMBL3888509
CHEMBL3892559,Cc1c(-c2cncc(F)c2)nn2c1NC(=O)CC2,Cytochrome P450 11B2,IC50,30.9,"V79-Human-CYP11B2 and V79-Human-CYP11B1 Assays: V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 cells were transfected with plasmids pTriEx3-Hygro-hCyp11B2 or pTriEx3-Hygro-hCyp11B1 using Lipofectamine2000 reagent. V79 cells that stably express the human CYP11B2 or human CYP11B1 enzyme were selected for and maintained in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin for ~2 weeks. Single cell clones were generated by infinite dilution in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin until single colonies were obtained. Clones V79-hCYP11B2-CLE9 and V79-hCYP11B1-8CLC7, were determined to produce the most aldosterone and cortisol, respectively, and were selected for inhibitor screening. For testing of inhibitors, cells were harvested at 80% confluency with 0.5% Trypsan-EDTA, washed once in PBS, and reconstituted in DMEM+0.1% BSA media at a cell concentration of 600,000 cells/mL for the CYP11B2 assay and 280,000 cells/mL for the CYP11B1 assay. 25 μL of cells were added to a 384 well tissue culture treated plate and mixed with 0.3 μL of inhibitor or DMSO (1% final DMSO concentration) for 1 hour at 37° C., 5% CO2. After pre-incubation with inhibitor, the reaction was initiated by adding 5 μL of substrate (final concentration of 125 nM 11-deoxycorticosterone for the CYP11B2 assay or 250 nM 11-deoxycortisol for the CYP11B1 assay). The reaction was carried out for 3 hours at 37° C., 5% CO2 and was stopped by harvesting the supernatants. The amount of product in the supernatant (aldosterone for CYP11B2 assay and cortisol for the CYP11B1 assay) was measured using HTRF-based assay kit (Aldosterone HTRF-CisBio#64ALDPEB, Cortisol HTRF-CisBio #63IDC002-CORT).",active,CHEMBL3888509
CHEMBL3894521,O=C1CCn2nc(-c3cncc(F)c3)c(C3CC3)c2N1,Cytochrome P450 11B2,IC50,102.3,"V79-Human-CYP11B2 and V79-Human-CYP11B1 Assays: V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 cells were transfected with plasmids pTriEx3-Hygro-hCyp11B2 or pTriEx3-Hygro-hCyp11B1 using Lipofectamine2000 reagent. V79 cells that stably express the human CYP11B2 or human CYP11B1 enzyme were selected for and maintained in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin for ~2 weeks. Single cell clones were generated by infinite dilution in DMEM supplemented with 10% FBS and 400 μg/mL hygromycin until single colonies were obtained. Clones V79-hCYP11B2-CLE9 and V79-hCYP11B1-8CLC7, were determined to produce the most aldosterone and cortisol, respectively, and were selected for inhibitor screening. For testing of inhibitors, cells were harvested at 80% confluency with 0.5% Trypsan-EDTA, washed once in PBS, and reconstituted in DMEM+0.1% BSA media at a cell concentration of 600,000 cells/mL for the CYP11B2 assay and 280,000 cells/mL for the CYP11B1 assay. 25 μL of cells were added to a 384 well tissue culture treated plate and mixed with 0.3 μL of inhibitor or DMSO (1% final DMSO concentration) for 1 hour at 37° C., 5% CO2. After pre-incubation with inhibitor, the reaction was initiated by adding 5 μL of substrate (final concentration of 125 nM 11-deoxycorticosterone for the CYP11B2 assay or 250 nM 11-deoxycortisol for the CYP11B1 assay). The reaction was carried out for 3 hours at 37° C., 5% CO2 and was stopped by harvesting the supernatants. The amount of product in the supernatant (aldosterone for CYP11B2 assay and cortisol for the CYP11B1 assay) was measured using HTRF-based assay kit (Aldosterone HTRF-CisBio#64ALDPEB, Cortisol HTRF-CisBio #63IDC002-CORT).",active,CHEMBL3888509
CHEMBL23731,CCOC(=O)c1cncn1C(C)c1ccccc1,Cytochrome P450 11B2,IC50,0.1,"Cellular Inhibition Assay: V79MZ cells expressing human CYP11B1 and human CYP11B2 genes, respectively, were grown on 24-well cell culture plates (8×10^5 cells per well) with 1.9 cm^2 culture area per well in 1 ml DMEM culture medium until confluence. Before testing, the DMEM culture medium was removed and 450 μl of fresh DMEM, containing the inhibitor in at least three different concentrations for determining the IC50 value, was added to each well. Every value was determined at least three times. After a pre-incubation step of 60 min at 37° C., the reaction was started by the addition of 50 μl of DMEM containing the substrate 11-deoxycorticosterone (containing 0.15 μCi of [1,2-3H] 11-deoxycorticosterone, dissolved in ethanol, final concentration 100 nM). The V79MZh11B1 cells were incubated for 25 min, the V79MZh11B2 cells were incubated for 50 min. Controls were treated in the same way without inhibitors. The maximum DMSO concentration in each well was 1%. Enzyme reactions were stopped by extracting the supernatant with 500 μl ethyl acetate. Samples were centrifuged (10000×g, 2 min), and the solvent was pipetted into fresh cups. The solvent was evaporated and the steroids were redissolved in 40 μl of methanol and analyzed by HPLC using radioflow detection (Ehmer et al. J. Steroid Biochem. Mol. Biol. 2002, 81, 173-179 and Denner et al. Endocr. Res. 1995, 21, 443-448).",active,CHEMBL3888753
CHEMBL3952656,Clc1ncc(Cn2ccnc2)cc1-c1ccsc1,Cytochrome P450 11B2,IC50,416,"Cellular Inhibition Assay: V79MZ cells expressing human CYP11B1 and human CYP11B2 genes, respectively, were grown on 24-well cell culture plates (8×10^5 cells per well) with 1.9 cm^2 culture area per well in 1 ml DMEM culture medium until confluence. Before testing, the DMEM culture medium was removed and 450 μl of fresh DMEM, containing the inhibitor in at least three different concentrations for determining the IC50 value, was added to each well. Every value was determined at least three times. After a pre-incubation step of 60 min at 37° C., the reaction was started by the addition of 50 μl of DMEM containing the substrate 11-deoxycorticosterone (containing 0.15 μCi of [1,2-3H] 11-deoxycorticosterone, dissolved in ethanol, final concentration 100 nM). The V79MZh11B1 cells were incubated for 25 min, the V79MZh11B2 cells were incubated for 50 min. Controls were treated in the same way without inhibitors. The maximum DMSO concentration in each well was 1%. Enzyme reactions were stopped by extracting the supernatant with 500 μl ethyl acetate. Samples were centrifuged (10000×g, 2 min), and the solvent was pipetted into fresh cups. The solvent was evaporated and the steroids were redissolved in 40 μl of methanol and analyzed by HPLC using radioflow detection (Ehmer et al. J. Steroid Biochem. Mol. Biol. 2002, 81, 173-179 and Denner et al. Endocr. Res. 1995, 21, 443-448).",active,CHEMBL3888753
CHEMBL4104118,CCCC(O)c1cncnc1Nc1ccc(F)cc1,Cytochrome P450 11B2,IC50,75,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4088766,CS(=O)(=O)N1CCC(C(O)c2cncnc2Sc2ccc(F)cc2)CC1,Cytochrome P450 11B2,IC50,0.4,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4083387,CS(=O)(=O)N1CCC(C(O)c2cncnc2Cc2ccccc2)CC1,Cytochrome P450 11B2,IC50,83,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4061565,CS(=O)(=O)N1CCC(C(O)c2cncnc2Nc2cccc3ccccc23)CC1,Cytochrome P450 11B2,IC50,8,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4091167,CS(=O)(=O)N1CCC(C(O)c2cncnc2Nc2ccc(C(F)(F)F)cc2)CC1,Cytochrome P450 11B2,IC50,3,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4070230,CS(=O)(=O)N1CCC(C(O)c2cncnc2Nc2ccc(C#N)cc2)CC1,Cytochrome P450 11B2,IC50,2,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4064367,COc1ccc(Nc2ncncc2C(O)C2CCN(S(C)(=O)=O)CC2)cc1,Cytochrome P450 11B2,IC50,14,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4092081,Cc1ccc(Nc2ncncc2C(O)C2CCN(S(C)(=O)=O)CC2)cc1,Cytochrome P450 11B2,IC50,8,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4072943,CS(=O)(=O)N1CCC(C(O)c2cncnc2Nc2cccc(F)c2)CC1,Cytochrome P450 11B2,IC50,5,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4099824,CS(=O)(=O)N1CCC(C(O)c2cncnc2Nc2ccc(F)cc2)CC1,Cytochrome P450 11B2,IC50,3,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4079006,CS(=O)(=O)N1CCC(C(O)c2cncnc2Nc2ccccc2)CC1,Cytochrome P450 11B2,IC50,15,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4097020,O=S(=O)(c1cnccc1Nc1cccc(C(F)(F)F)c1)N1CCOCC1,Cytochrome P450 11B2,IC50,7,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4082403,CS(=O)(=O)N1CCC(C(O)(c2cncnc2Nc2ccc(F)cc2)C(F)(F)F)CC1,Cytochrome P450 11B2,IC50,4,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4065476,OC(c1ccccc1)c1cncnc1Nc1ccc(F)cc1,Cytochrome P450 11B2,IC50,30,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4077051,OC(c1cncnc1Nc1ccc(F)cc1)C1CCNCC1,Cytochrome P450 11B2,IC50,300,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4060559,CS(=O)(=O)N1CCC(O)(c2cncnc2Nc2ccc(F)cc2)CC1,Cytochrome P450 11B2,IC50,300,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4101118,CS(=O)(=O)N1CCC(CC(O)c2cncnc2Nc2ccc(F)cc2)CC1,Cytochrome P450 11B2,IC50,192,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4075207,CS(=O)(=O)N1CCC(C(O)c2cncnc2Nc2ccc(F)cc2)C1,Cytochrome P450 11B2,IC50,144,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4067686,CS(=O)(=O)N1CCC(C(=O)c2cncnc2Nc2ccc(F)cc2)CC1,Cytochrome P450 11B2,IC50,109,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4070323,CC(O)(c1cncnc1Nc1ccc(F)cc1)C1CCN(S(C)(=O)=O)CC1,Cytochrome P450 11B2,IC50,2,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4093575,CC(C)C(O)(c1cncnc1Nc1ccc(F)cc1)C1CCN(S(C)(=O)=O)CC1,Cytochrome P450 11B2,IC50,5,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4072871,CCCCC(O)(c1cncnc1Nc1ccc(F)cc1)C1CCN(S(C)(=O)=O)CC1,Cytochrome P450 11B2,IC50,48,Inhibition of human CYP11B2 expressed in HEK293A cells using deoxycorticosterone as substrate pretreated for 1 hr followed by substrate addition measured after 1 hr by HTRF assay,active,CHEMBL4012481
CHEMBL4067404,Cc1cncc(Cc2ccc(-c3ccccc3F)nc2)c1,Cytochrome P450 11B2,IC50,27,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4096366,Cc1cncc(Cc2ccc(-c3cccc(NS(C)(=O)=O)c3)nc2)c1,Cytochrome P450 11B2,IC50,16,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4078318,Cc1cncc(Cc2ccc(-c3ccoc3)nc2)c1,Cytochrome P450 11B2,IC50,28,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4104108,Cc1cncc(Cc2ccc(-c3cnn(C)c3)nc2)c1,Cytochrome P450 11B2,IC50,182,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4086201,Cc1cncc(Cc2ccc(-c3ccnn3C)nc2)c1,Cytochrome P450 11B2,IC50,97,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4088179,Cc1cncc(Cc2ccc(N3CCOCC3)nc2)c1,Cytochrome P450 11B2,IC50,90,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4059931,Cc1cncc(Cc2ccc(NC3CC3)nc2)c1,Cytochrome P450 11B2,IC50,32,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4095910,Cc1cncc(Cc2ccc(Sc3ccccc3)nc2)c1,Cytochrome P450 11B2,IC50,30,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4068593,Cc1cncc(Cc2ccc(S(=O)(=O)c3ccccc3)nc2)c1,Cytochrome P450 11B2,IC50,173,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4103666,Cc1cncc(Cc2ccc(Sc3ccccc3F)nc2)c1,Cytochrome P450 11B2,IC50,24,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4079408,Cc1cncc(Cc2ccc(S(=O)(=O)c3ccccc3F)nc2)c1,Cytochrome P450 11B2,IC50,17,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4099271,c1ccc(-c2nscc2Cn2ccnc2)cc1,Cytochrome P450 11B2,IC50,174,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4072324,c1ccc(-c2cc(Cn3ccnc3)sn2)cc1,Cytochrome P450 11B2,IC50,120,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4104045,c1ccc(-c2ncc(Cn3ccnc3)s2)cc1,Cytochrome P450 11B2,IC50,459,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4086130,c1ccc(-c2ncc(Cn3ccnc3)o2)cc1,Cytochrome P450 11B2,IC50,520,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4078239,c1ccc(-c2ncc(Cn3ccnc3)[se]2)cc1,Cytochrome P450 11B2,IC50,657,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4074925,Cn1c(Cn2ccnc2)cnc1-c1ccccc1,Cytochrome P450 11B2,IC50,507,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4101613,Cn1nc(-c2ccccc2)cc1Cn1ccnc1,Cytochrome P450 11B2,IC50,215,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4066317,Cc1cncc(Cc2csnc2-c2ccccc2)c1,Cytochrome P450 11B2,IC50,152,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4093884,Cc1cncc(Cc2cc(-c3ccccc3)ns2)c1,Cytochrome P450 11B2,IC50,8,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4070031,Cc1cncc(Cc2cnc(-c3ccccc3)s2)c1,Cytochrome P450 11B2,IC50,24,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4097224,Cc1cncc(Cc2cnc(-c3ccccc3)o2)c1,Cytochrome P450 11B2,IC50,116,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4079276,Cc1cncc(Cc2cc(-c3ccccc3)no2)c1,Cytochrome P450 11B2,IC50,82,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4097298,COc1cncc(Cc2cc(-c3ccccc3)no2)c1,Cytochrome P450 11B2,IC50,27,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4068439,Cc1cncc(Cc2cc(-c3ccccc3)nn2C)c1,Cytochrome P450 11B2,IC50,6,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4089578,Cc1cncc(Cc2cc(-c3ccccc3)n[nH]2)c1,Cytochrome P450 11B2,IC50,586,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",active,CHEMBL4016909
CHEMBL4067905,Fc1ccc2c(cnn2-c2cccnc2)c1,Cytochrome P450 11B2,IC50,217,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4089111,Fc1cncc(-n2ncc3cc(F)ccc32)c1,Cytochrome P450 11B2,IC50,456,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4078791,Fc1ccc2c(cnn2-c2cncc(C(F)(F)F)c2)c1,Cytochrome P450 11B2,IC50,88,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4096817,COC(=O)c1cncc(-n2ncc3cc(F)ccc32)c1,Cytochrome P450 11B2,IC50,31,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4063670,COc1cncc(-n2ncc3cc(F)ccc32)c1,Cytochrome P450 11B2,IC50,44,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4091491,CC(C)(O)c1cncc(-n2ncc3cc(F)ccc32)c1,Cytochrome P450 11B2,IC50,10.9,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4101709,CC(O)(c1cncc(-n2ncc3cc(F)ccc32)c1)C(F)(F)F,Cytochrome P450 11B2,IC50,2,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4083708,CC(C)(O)c1cncc(-n2ncc3ccccc32)c1,Cytochrome P450 11B2,IC50,15,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4082750,Cc1nn(-c2cncc(C(C)(C)O)c2)c2ccccc12,Cytochrome P450 11B2,IC50,33.5,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4070125,COc1nn(-c2cncc(C(C)(C)O)c2)c2ccccc12,Cytochrome P450 11B2,IC50,25,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4072268,CC(C)(O)c1cncc(-n2nc(C(F)(F)F)c3ccccc32)c1,Cytochrome P450 11B2,IC50,300,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4099223,CC(C)(O)c1cncc(-n2nc(C3CC3)c3ccccc32)c1,Cytochrome P450 11B2,IC50,760,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4098297,Cc1nn(-c2cncc([C@](C)(O)C(F)(F)F)c2)c2ccccc12,Cytochrome P450 11B2,IC50,14,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4080256,Cc1nn(-c2cncc([C@@](C)(O)C(F)(F)F)c2)c2ccccc12,Cytochrome P450 11B2,IC50,32.9,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4071689,C[C@](O)(c1cncc(-n2nc(C(F)(F)F)c3ccccc32)c1)C(F)(F)F,Cytochrome P450 11B2,IC50,77,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4075377,CC(C)(O)c1cncc(-n2ncc3cccc(F)c32)c1,Cytochrome P450 11B2,IC50,0.9,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4085626,CC(C)(O)c1cncc(-n2ncc3ccc(F)cc32)c1,Cytochrome P450 11B2,IC50,78.5,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4063214,CC(C)(O)c1cncc(-n2ncc3ccc(Cl)cc32)c1,Cytochrome P450 11B2,IC50,528,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4075484,CC(C)(O)c1cncc(-n2ncc3cc(Cl)ccc32)c1,Cytochrome P450 11B2,IC50,27,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4100299,Cc1ccc2c(cnn2-c2cncc(C(C)(C)O)c2)c1,Cytochrome P450 11B2,IC50,97.9,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4100151,COc1ccc2c(cnn2-c2cncc(C(C)(C)O)c2)c1,Cytochrome P450 11B2,IC50,84.9,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4073305,CC(C)(O)c1cncc(-n2ncc3cc(C(F)(F)F)ccc32)c1,Cytochrome P450 11B2,IC50,507,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4081339,CC(C)(O)c1cncc(-n2ncc3c(F)cccc32)c1,Cytochrome P450 11B2,IC50,7.58,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4061038,Cc1cccc2c1cnn2-c1cncc(C(C)(C)O)c1,Cytochrome P450 11B2,IC50,7.77,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4089210,COC(=O)c1cccc2c1cnn2-c1cncc(C(C)(C)O)c1,Cytochrome P450 11B2,IC50,22,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4069720,CC(C)(O)c1cncc(-n2ncc3c(F)ccc(F)c32)c1,Cytochrome P450 11B2,IC50,0.3,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4096914,CC(C)(O)c1cncc(-n2ncc3c(Cl)ccc(F)c32)c1,Cytochrome P450 11B2,IC50,0.2,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4080420,Cc1nn(-c2cncc(C(C)(C)O)c2)c2cccc(F)c12,Cytochrome P450 11B2,IC50,1.3,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL4067000,CC(C)(O)c1cncc(-n2ncc3c(C(F)(F)F)cccc32)c1,Cytochrome P450 11B2,IC50,2.2,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,active,CHEMBL4029972
CHEMBL1397,CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O,Cytochrome P450 11B2,IC50,21,Inhibition of CYP11B2 in human hepatocyte microsomes using deoxycorticosteroid substrate by HPLC/MS/MS method,active,CHEMBL4056600
CHEMBL4127248,Cn1cc(-c2ccc(C#N)cc2)cn1,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4127095,Cc1c(-c2ccc(C#N)cc2)cnn1C,Cytochrome P450 11B2,IC50,290,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4128486,CCc1c(-c2ccc(C#N)cc2)cnn1C,Cytochrome P450 11B2,IC50,150,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4128329,Cn1ncc(-c2ccc(C#N)cc2)c1C(F)(F)F,Cytochrome P450 11B2,IC50,280,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4129712,Cn1ncc(-c2ccc(C#N)cc2)c1CO,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4129567,CN(C)Cc1c(-c2ccc(C#N)cc2)cnn1C,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4126275,CCn1ncc(-c2ccc(C#N)cc2)c1C,Cytochrome P450 11B2,IC50,72,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4126118,N#Cc1ccc(-c2cnn3c2CCC3)cc1,Cytochrome P450 11B2,IC50,13,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4129549,N#Cc1ccc(-c2cnn3c2CCC3)c(F)c1,Cytochrome P450 11B2,IC50,9.2,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4128167,N#Cc1ccc(-c2cnn3c2CCC3)c(Cl)c1,Cytochrome P450 11B2,IC50,5.4,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4128315,Cc1cc(C#N)ccc1-c1cnn2c1CCC2,Cytochrome P450 11B2,IC50,3.7,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4126932,COc1cc(C#N)ccc1-c1cnn2c1CCC2,Cytochrome P450 11B2,IC50,34,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4127082,Cc1cc(-c2cnn3c2CCC3)ccc1C#N,Cytochrome P450 11B2,IC50,6.7,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4125707,N#Cc1ccc(-c2cnn3c2CCC3)cc1F,Cytochrome P450 11B2,IC50,26,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4125850,Cc1cc(C#N)ccc1-c1cnc2n1CCC2,Cytochrome P450 11B2,IC50,2.5,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4129146,Cc1cc(C#N)ccc1-c1cnn2c1C[C@@H](O)C2,Cytochrome P450 11B2,IC50,12,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4129296,CO[C@@H]1Cc2c(-c3ccc(C#N)cc3C)cnn2C1,Cytochrome P450 11B2,IC50,3.2,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4127904,Cc1cc(C#N)ccc1-c1cnn2c1C[C@@H](OCc1ccccc1)C2,Cytochrome P450 11B2,IC50,2.3,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4128829,Cc1cc(C#N)ccc1-c1cnn2c1C[C@@H](OCC(=O)O)C2,Cytochrome P450 11B2,IC50,1000,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4127939,Cc1cc(C#N)ccc1-c1cnn2c1C[C@@H](OCC(N)=O)C2,Cytochrome P450 11B2,IC50,14,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4126893,Cc1cc(C#N)ccc1-c1cnn2c1C[C@@H](Oc1cnccn1)C2,Cytochrome P450 11B2,IC50,2.2,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4129177,Cc1cc(C#N)ccc1-c1cnn2c1C[C@@H](Oc1ncccn1)C2,Cytochrome P450 11B2,IC50,4,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4129619,Cc1cc(C#N)ccc1-c1cnn2c1C[C@@H](Oc1ncc(F)cn1)C2,Cytochrome P450 11B2,IC50,4.7,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4125736,Cc1cnc(O[C@@H]2Cc3c(-c4ccc(C#N)cc4C)cnn3C2)nc1,Cytochrome P450 11B2,IC50,4.2,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4127675,Cc1cc(C#N)ccc1-c1cnn2c1C[C@@H](Oc1ncc(C#N)cn1)C2,Cytochrome P450 11B2,IC50,2.2,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4128736,Cc1cc(C#N)ccc1-c1cnn2c1C[C@H](O)C2,Cytochrome P450 11B2,IC50,29,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4129577,Cc1cc(C#N)ccc1-c1cnn2c1C[C@H](Oc1ncc(F)cn1)C2,Cytochrome P450 11B2,IC50,71,Inhibition of human CYP11B2 expressed in Chinese hamster V79 cell mitochondria assessed as reduction in aldosterone production using deoxycorticosterone as substrate after 1.5 hrs in presence of NADPH by HTRF assay,active,CHEMBL4124785
CHEMBL4206710,O=c1c2ccc(Cn3ccnc3)cc2oc2cc(Oc3ccccc3)ccc12,Cytochrome P450 11B2,IC50,26.2,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate after 30 mins by HPTLC analysis",active,CHEMBL4193320
CHEMBL4203608,O=c1c2ccc(Cn3ccnc3)cc2oc2cc(OCC3CC3)ccc12,Cytochrome P450 11B2,IC50,22.3,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate after 30 mins by HPTLC analysis",active,CHEMBL4193320
CHEMBL4216471,O=c1c2ccc(Cn3ccnc3)cc2oc2cc(OC3CCCC3)ccc12,Cytochrome P450 11B2,IC50,20.3,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate after 30 mins by HPTLC analysis",active,CHEMBL4193320
CHEMBL4207323,CC(C)Oc1ccc2c(=O)c3ccc(Cn4ccnc4)cc3oc2c1,Cytochrome P450 11B2,IC50,16.6,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate after 30 mins by HPTLC analysis",active,CHEMBL4193320
CHEMBL4205228,COc1ccc2c(=O)c3ccc(Cn4ccnc4)cc3oc2c1,Cytochrome P450 11B2,IC50,45.4,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate after 30 mins by HPTLC analysis",active,CHEMBL4193320
CHEMBL4214521,O=c1c2ccc(Br)cc2oc2cc(Cn3ccnc3)ccc12,Cytochrome P450 11B2,IC50,44.4,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate after 30 mins by HPTLC analysis",active,CHEMBL4193320
CHEMBL4209612,O=c1c2ccc(Cl)cc2oc2cc(Cn3ccnc3)ccc12,Cytochrome P450 11B2,IC50,95.3,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate after 30 mins by HPTLC analysis",active,CHEMBL4193320
CHEMBL350922,O=c1c2ccccc2oc2cc(Cn3ccnc3)ccc12,Cytochrome P450 11B2,IC50,344.1,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate after 30 mins by HPTLC analysis",active,CHEMBL4193320
CHEMBL4218934,O=c1c2ccc(F)cc2oc2cc(Cn3ccnc3)ccc12,Cytochrome P450 11B2,IC50,82,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate after 30 mins by HPTLC analysis",active,CHEMBL4193320
CHEMBL4214016,O=c1c2ccc(Cn3ccnc3)cc2oc2cc([N+](=O)[O-])ccc12,Cytochrome P450 11B2,IC50,135.1,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate after 30 mins by HPTLC analysis",active,CHEMBL4193320
CHEMBL1083971,O=c1c2ccccc2oc2c(Cn3ccnc3)cccc12,Cytochrome P450 11B2,IC50,43.7,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate after 30 mins by HPTLC analysis",active,CHEMBL4193320
CHEMBL4464109,Fc1ccc2nc(-c3cn[nH]c3)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,782,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4460334,Fc1ccc2nc(-c3cncs3)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,62,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4560501,Fc1ccc2nc(-c3cncnc3)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,40,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4577872,Fc1ccc2nc(-c3cnccn3)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,541,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4563972,Fc1ccc2nc(-c3cccnn3)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,412,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4457964,Fc1ccc2nc(-c3ccnnc3)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,330,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4576370,Fc1cc2nc(-c3cncnc3)n(C3CC3)c2cc1F,Cytochrome P450 11B2,IC50,22,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4582349,Cc1ncncc1-c1nc2cc(F)c(F)cc2n1C1CC1,Cytochrome P450 11B2,IC50,17,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4470436,CCc1ncncc1-c1nc2cc(F)c(F)cc2n1C1CC1,Cytochrome P450 11B2,IC50,8,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4460841,CC(C)c1ncncc1-c1nc2cc(F)c(F)cc2n1C1CC1,Cytochrome P450 11B2,IC50,5,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4444394,Fc1cc2nc(-c3cncnc3C3CC3)n(C3CC3)c2cc1F,Cytochrome P450 11B2,IC50,172,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4458025,N#Cc1ncncc1-c1nc2cc(F)c(F)cc2n1C1CC1,Cytochrome P450 11B2,IC50,13,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4475659,CNc1ncncc1-c1nc2cc(F)c(F)cc2n1C1CC1,Cytochrome P450 11B2,IC50,2,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4462113,CN(C)c1ncncc1-c1nc2cc(F)c(F)cc2n1C1CC1,Cytochrome P450 11B2,IC50,29,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4528905,Fc1cc2nc(-c3cncnc3NCCC(F)(F)F)n(C3CC3)c2cc1F,Cytochrome P450 11B2,IC50,3,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4476620,Fc1cc2nc(-c3cncnc3C(F)F)n(C3CC3)c2cc1F,Cytochrome P450 11B2,IC50,18,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4439573,Fc1cc2nc(-c3cncnc3C(F)(F)F)n(C3CC3)c2cc1F,Cytochrome P450 11B2,IC50,25,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4456916,CC(F)(F)c1ncncc1-c1nc2cc(F)c(F)cc2n1C1CC1,Cytochrome P450 11B2,IC50,50,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4548610,N#Cc1ccc2nc(-c3cncnc3C(F)F)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,9,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4474610,N#Cc1ccc2nc(-c3cncnc3C(F)(F)F)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,16,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4467192,N#Cc1ccc2nc(-c3cncnc3C(F)F)n(C3CC3)c2n1,Cytochrome P450 11B2,IC50,29,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4476351,N#Cc1ccc2nc(-c3cncnc3C(F)(F)F)n(C3CC3)c2n1,Cytochrome P450 11B2,IC50,24,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,active,CHEMBL4307089
CHEMBL4644373,CC1CN(c2cccnc2)C(=O)c2ccc(Cl)cc21,Cytochrome P450 11B2,IC50,164,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4641568,CC1Cc2cc(Cl)ccc2C(=O)N1c1cccnc1,Cytochrome P450 11B2,IC50,761,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4644873,O=C1c2ccc(Cl)cc2C(C2CC2)N1c1cccnc1,Cytochrome P450 11B2,IC50,161,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4638026,O=C1c2ccc(Cl)cc2C2(CC2)N1c1cccnc1,Cytochrome P450 11B2,IC50,120,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4640325,CC1(C)c2cc(Cl)ccc2C(=O)N1c1cccnc1,Cytochrome P450 11B2,IC50,108,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4636069,CCC1c2cc(Cl)ccc2C(=O)N1c1cccnc1,Cytochrome P450 11B2,IC50,121,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4634229,CC1c2cc(Cl)ccc2C(=O)N1c1cccnc1,Cytochrome P450 11B2,IC50,123,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4634126,N#Cc1ccc2c(c1)CN(c1cccnc1)C2=O,Cytochrome P450 11B2,IC50,232,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4633083,O=C1c2ccc(Cl)cc2CN1c1cccnc1,Cytochrome P450 11B2,IC50,179,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4639620,O=C1c2cc(F)c(Cl)cc2CCN1c1cccnc1,Cytochrome P450 11B2,IC50,104,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4635349,O=C1c2ccc(Cl)cc2CCN1c1cccnc1,Cytochrome P450 11B2,IC50,61,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4648602,Cc1cc(Cl)ccc1C(=O)Nc1cccnc1,Cytochrome P450 11B2,IC50,277,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4648453,O=C(Nc1cccnc1)c1ccc(Cl)cc1F,Cytochrome P450 11B2,IC50,297,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL1596525,O=C(Nc1cccnc1)c1ccccc1Cl,Cytochrome P450 11B2,IC50,967,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4642814,CC(=O)N[C@@H]1CCCc2c1cncc2N1Cc2cc(Cl)ccc2C1=O,Cytochrome P450 11B2,IC50,44,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4642777,CCC(=O)N[C@@H]1CCCc2c1cncc2N1Cc2cc(Cl)ccc2C1=O,Cytochrome P450 11B2,IC50,28,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4637643,CS(=O)(=O)N[C@@H]1CCCc2c1cncc2N1Cc2cc(Cl)ccc2C1=O,Cytochrome P450 11B2,IC50,998,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4645224,CCS(=O)(=O)N[C@@H]1CCCc2c1cncc2N1Cc2cc(Cl)ccc2C1=O,Cytochrome P450 11B2,IC50,40,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4637033,CC(=O)N[C@@H]1CCCc2c1cncc2N1C(=O)c2ccc(Cl)cc2[C@H]1C,Cytochrome P450 11B2,IC50,130,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4645158,CC(=O)N[C@@H]1CCCc2c1cncc2N1C(=O)c2ccc(Cl)cc2[C@@H]1C,Cytochrome P450 11B2,IC50,4,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4639314,CC[C@@H]1c2cc(Cl)ccc2C(=O)N1c1cncc2c1CCC[C@H]2NC(C)=O,Cytochrome P450 11B2,IC50,7,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4633711,CC[C@H]1c2cc(Cl)ccc2C(=O)N1c1cncc2c1CCC[C@H]2NC(C)=O,Cytochrome P450 11B2,IC50,97,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4644978,CCC(=O)N[C@@H]1CCCc2c1cncc2N1C(=O)c2ccc(Cl)cc2[C@H]1C,Cytochrome P450 11B2,IC50,66,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4647877,CCC(=O)N[C@@H]1CCCc2c1cncc2N1C(=O)c2ccc(Cl)cc2[C@@H]1C,Cytochrome P450 11B2,IC50,6,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4646307,CCC(=O)N[C@@H]1CCCc2c1cncc2N1C(=O)c2ccc(Cl)cc2[C@H]1CC,Cytochrome P450 11B2,IC50,90,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4640951,CCC(=O)N[C@@H]1CCCc2c1cncc2N1C(=O)c2ccc(Cl)cc2[C@@H]1CC,Cytochrome P450 11B2,IC50,12,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4638099,CC(=O)N[C@@H]1CCCc2c1cncc2N1C(=O)c2ccc(Cl)cc2[C@H]1C1CC1,Cytochrome P450 11B2,IC50,100,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4636409,CC(=O)N[C@@H]1CCCc2c1cncc2N1C(=O)c2ccc(Cl)cc2[C@@H]1C1CC1,Cytochrome P450 11B2,IC50,354,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4636239,CC(=O)N[C@@H]1CCCc2c1cncc2N1CCc2cc(Cl)ccc2C1=O,Cytochrome P450 11B2,IC50,54,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4634553,CCC(=O)N[C@@H]1CCCc2c1cncc2N1CCc2cc(Cl)ccc2C1=O,Cytochrome P450 11B2,IC50,119,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4649630,CS(=O)(=O)N[C@@H]1CCCc2c1cncc2N1CCc2cc(Cl)ccc2C1=O,Cytochrome P450 11B2,IC50,76,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4639262,CC(=O)NCc1cncc(N2C(=O)c3ccc(Cl)cc3C2(C)C)c1,Cytochrome P450 11B2,IC50,59,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4636718,CCC(=O)NCc1cncc(N2C(=O)c3ccc(Cl)cc3C2(C)C)c1,Cytochrome P450 11B2,IC50,282,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4645918,CC1(C)c2cc(Cl)ccc2C(=O)N1c1cncc(CNS(C)(=O)=O)c1,Cytochrome P450 11B2,IC50,33,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4632486,C[C@@H](NS(C)(=O)=O)c1cncc(N2C(=O)c3ccc(Cl)cc3C2(C)C)c1,Cytochrome P450 11B2,IC50,8,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4638300,CCS(=O)(=O)NCc1cncc(N2C(=O)c3ccc(Cl)cc3C2(C)C)c1,Cytochrome P450 11B2,IC50,92,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4643528,Cc1cccnc1C(=O)NCc1cncc(N2C(=O)c3ccc(Cl)cc3C2(C)C)c1,Cytochrome P450 11B2,IC50,9,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4644311,CC(=O)N1CCC(c2cncc(N3C(=O)c4ccc(Cl)cc4C3(C)C)c2)CC1,Cytochrome P450 11B2,IC50,5,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4642895,CCS(=O)(=O)N1CCC(c2cncc(N3C(=O)c4ccc(Cl)cc4C3(C)C)c2)CC1,Cytochrome P450 11B2,IC50,3,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4634550,CC(=O)N1CCN(c2cncc(N3C(=O)c4ccc(Cl)cc4C3(C)C)c2)CC1,Cytochrome P450 11B2,IC50,9,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4635517,CC1(C)c2cc(Cl)ccc2C(=O)N1c1cncc(N2CCN(S(C)(=O)=O)CC2)c1,Cytochrome P450 11B2,IC50,2,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4647543,CCS(=O)(=O)N1CC(Oc2cncc(N3C(=O)c4ccc(Cl)cc4C3(C)C)c2)C1,Cytochrome P450 11B2,IC50,4,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4634463,CC(=O)N1CC[C@@H](Oc2cncc(N3C(=O)c4ccc(Cl)cc4C3(C)C)c2)C1,Cytochrome P450 11B2,IC50,11,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4638889,CC(=O)N1CC[C@H](Oc2cncc(N3C(=O)c4ccc(Cl)cc4C3(C)C)c2)C1,Cytochrome P450 11B2,IC50,7,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4646980,CC(=O)N1CCC(Oc2cncc(N3C(=O)c4ccc(Cl)cc4C3(C)C)c2)CC1,Cytochrome P450 11B2,IC50,4,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4632945,CC1(C)c2cc(Cl)ccc2C(=O)N1c1cncc(OC2CN(C(=O)c3ncccc3Cl)C2)c1,Cytochrome P450 11B2,IC50,5,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4642138,Cc1ccncc1C(=O)N1CC(Oc2cncc(N3C(=O)c4ccc(Cl)cc4C3(C)C)c2)C1,Cytochrome P450 11B2,IC50,4,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4635011,Cn1cc(C(=O)N2CC(Oc3cncc(N4C(=O)c5ccc(Cl)cc5C4(C)C)c3)C2)cn1,Cytochrome P450 11B2,IC50,0.5,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4638415,CC(=O)N1CC2(C1)CN(c1cncc(N3C(=O)c4ccc(Cl)cc4C3(C)C)c1)C2,Cytochrome P450 11B2,IC50,23,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4640361,CCS(=O)(=O)N1CC2(CN(c3cncc(N4C(=O)c5ccc(Cl)cc5C4(C)C)c3)C2)C1,Cytochrome P450 11B2,IC50,16,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4632981,Cc1ccncc1C(=O)N1CC2(C1)CN(c1cncc(N3C(=O)c4ccc(Cl)cc4C3(C)C)c1)C2,Cytochrome P450 11B2,IC50,14,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL4641359,Cn1cc(C(=O)N2CC3(C2)CN(c2cncc(N4C(=O)c5ccc(Cl)cc5C4(C)C)c2)C3)cn1,Cytochrome P450 11B2,IC50,2,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,active,CHEMBL4618742
CHEMBL169251,O=C1/C(=C\c2c[nH]cn2)CCc2ccccc21,Cytochrome P450 11B2,IC50,73000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,inactive,CHEMBL666526
CHEMBL304903,c1ccc2c(c1)CCC1C(c3ccncc3)C21,Cytochrome P450 11B2,IC50,55000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,inactive,CHEMBL666526
CHEMBL352645,c1ccc2c(c1)CCC1C(c3c[nH]cn3)C21,Cytochrome P450 11B2,IC50,90000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,inactive,CHEMBL666526
CHEMBL4077246,N#Cc1ccc(COc2ccc(C#Cc3ccc(C(F)(F)C(O)(Cn4cnnn4)c4ccc(F)cc4F)nc3)cc2)cc1,Cytochrome P450 11B2,IC50,100000,Inhibition of CYP11B2 in human hepatocyte microsomes using deoxycorticosteroid substrate by HPLC/MS/MS method,inactive,CHEMBL4056600
CHEMBL488,CCC1(c2ccc(N)cc2)CCC(=O)NC1=O,Cytochrome P450 11B2,IC50,110000,In vitro inhibition of aldosterone production in rat adrenal tissue,inactive,CHEMBL847044
CHEMBL27467,Nc1ccc(C23CC(C2)C(=O)N(C2CCCCC2)C3=O)cc1,Cytochrome P450 11B2,IC50,140000,In vitro inhibition of aldosterone production in rat adrenal tissue,inactive,CHEMBL794467
CHEMBL353068,c1ccc2c(c1)CCC1C(c3cc[nH]n3)C21,Cytochrome P450 11B2,IC50,19000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL166709,O=C1/C(=C/c2cccnn2)CCc2ccccc21,Cytochrome P450 11B2,IC50,21000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL424556,O=C1/C(=C/c2ccnnc2)CCc2ccccc21,Cytochrome P450 11B2,IC50,10000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL168636,O=C1/C(=C/c2cccnc2)CCc2ccccc21,Cytochrome P450 11B2,IC50,10000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL90585,O=C1/C(=C/c2ccncc2)CCc2ccccc21,Cytochrome P450 11B2,IC50,12000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL433728,c1ccc2c(c1)CCC1C(c3ccsc3)C21,Cytochrome P450 11B2,IC50,10000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria,intermediate,CHEMBL663826
CHEMBL169449,O=C1c2ccccc2CCC1C(O)c1cnccn1,Cytochrome P450 11B2,IC50,10000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL168434,O=C1/C(=C/c2c[nH]cn2)CCc2ccccc21,Cytochrome P450 11B2,IC50,43000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL440930,c1cncc(C2C3CCc4ccccc4C32)c1,Cytochrome P450 11B2,IC50,24000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL166789,c1ccc(C2C3CCc4ccccc4C32)nc1,Cytochrome P450 11B2,IC50,10000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL415753,O=C1/C(=C/c2cc[nH]n2)CCc2ccccc21,Cytochrome P450 11B2,IC50,20000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL169664,O=C1c2ccccc2CCC1C(O)c1cccnn1,Cytochrome P450 11B2,IC50,10000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL168762,O=C1c2ccccc2CCC1C(O)c1ccnnc1,Cytochrome P450 11B2,IC50,10000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL413344,O=C1/C(=C/c2cnccn2)CCc2ccccc21,Cytochrome P450 11B2,IC50,10000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL168444,O=C1c2ccccc2CCC1C(O)c1ccncn1,Cytochrome P450 11B2,IC50,10000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL169086,O=C1/C(=C/c2cncs2)CCc2ccccc21,Cytochrome P450 11B2,IC50,10000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL168700,c1ccc(C2C3CCc4ccccc4C32)cc1,Cytochrome P450 11B2,IC50,14000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL355681,Nc1ncc(/C=C2\CCc3ccccc3C2=O)s1,Cytochrome P450 11B2,IC50,10000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL424203,O=C1/C(=C/c2ccccn2)CCc2ccccc21,Cytochrome P450 11B2,IC50,10000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL28689,O=C1/C(=C/c2ccccc2)CCc2ccccc21,Cytochrome P450 11B2,IC50,10000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL166974,O=C1/C(=C/c2ccsc2)CCc2ccccc21,Cytochrome P450 11B2,IC50,10000,Inhibitory activity against Steroidgenic Cytochrome P450 C18 using Bovine adrenal mitochondria.,intermediate,CHEMBL666526
CHEMBL425054,COc1ccc2c(c1)CCC(c1ccncc1)=C2,Cytochrome P450 11B2,IC50,2834,Inhibition of human CYP11B2 expressed in V79 11B2 cells,intermediate,CHEMBL860940
CHEMBL501740,COc1ccc2cc(-c3cncc(CC(=O)O)c3)ccc2c1,Cytochrome P450 11B2,IC50,1216,Inhibition of human CYP11B2 expressed in hamster V79 MZh cells,intermediate,CHEMBL1002226
CHEMBL254328,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1,Cytochrome P450 11B2,IC50,1751,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,intermediate,CHEMBL1004811
CHEMBL526081,Br.Oc1ccc(-c2ccc3c(c2)CCC=C3c2ccncc2)cc1O,Cytochrome P450 11B2,IC50,1492,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,intermediate,CHEMBL1004811
CHEMBL496262,OC1(c2ccncc2)CCCc2cc(-c3ccc(F)c(F)c3)ccc21,Cytochrome P450 11B2,IC50,1676,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,intermediate,CHEMBL1004811
CHEMBL14192,c1ccc(Cn2ccnc2)cc1,Cytochrome P450 11B2,IC50,1799,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,intermediate,CHEMBL1072072
CHEMBL597368,OCc1cccc(Cn2ccnc2)c1,Cytochrome P450 11B2,IC50,1174,Inhibition of human CYP11B2 expressed in chinese hamster V79 cells,intermediate,CHEMBL1072072
CHEMBL1173259,CC(C)=C(c1ccncc1)c1ccc(-c2cccc(O)c2)cc1,Cytochrome P450 11B2,IC50,3450,Inhibition of human CYP11B2 expressed in hamster V79MZh cells,intermediate,CHEMBL1177586
CHEMBL1173335,CC(C)=C(c1ccncc1)c1ccc(-c2ccc(O)c(F)c2)cc1,Cytochrome P450 11B2,IC50,1870,Inhibition of human CYP11B2 expressed in hamster V79MZh cells,intermediate,CHEMBL1177586
CHEMBL1173326,CC(C)=C(c1ccncc1)c1ccc(-c2cccc(N)c2)cc1,Cytochrome P450 11B2,IC50,3830,Inhibition of human CYP11B2 expressed in hamster V79MZh cells,intermediate,CHEMBL1177586
CHEMBL1171991,CC(C)=C(c1ccncc1)c1ccc(-c2ccc(N)c(N)c2)cc1,Cytochrome P450 11B2,IC50,1130,Inhibition of human CYP11B2 expressed in hamster V79MZh cells,intermediate,CHEMBL1177586
CHEMBL1172842,CC(C)=C(c1ccncc1)c1ccc(-c2ccc3cc(O)ccc3c2)cc1,Cytochrome P450 11B2,IC50,49500,Inhibition of human CYP11B2 expressed in hamster V79MZh cells,intermediate,CHEMBL1177586
CHEMBL1214739,Oc1ccc2cc(-c3ccc(Cc4ccncc4)cc3)ccc2c1,Cytochrome P450 11B2,IC50,1130,Inhibition of human CYP11B2 expressed in hamster fibroblast,intermediate,CHEMBL1219273
CHEMBL1651503,c1ccc(-c2ccc(Cn3cnc4ccccc43)cc2)cc1,Cytochrome P450 11B2,IC50,1903,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,intermediate,CHEMBL1656353
CHEMBL1651502,c1ccc(-c2cccc(Cn3cnc4ccccc43)c2)cc1,Cytochrome P450 11B2,IC50,2226,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,intermediate,CHEMBL1656353
CHEMBL428780,c1ccc(-c2ccc(Cn3ccnc3)cn2)cc1,Cytochrome P450 11B2,IC50,2768,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,intermediate,CHEMBL1656353
CHEMBL1688911,O=c1cc(Cn2ccnc2)c2ccc(Oc3ccc(F)c(F)c3)cc2o1,Cytochrome P450 11B2,IC50,2190,"Inhibition of human CYP11B2 expressed in Chinese hamster V79MZ cells using [1,2-3H]11-deoxycorticosterone/11-deoxycorticosterone",intermediate,CHEMBL1694078
CHEMBL2011244,Fc1ccccc1-c1ccc(Cn2ccnc2)cn1,Cytochrome P450 11B2,IC50,1736,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,intermediate,CHEMBL2015356
CHEMBL272749,Fc1ccc(-c2ccc(Cn3ccnc3)cn2)cc1,Cytochrome P450 11B2,IC50,2153,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,intermediate,CHEMBL2015356
CHEMBL402522,Fc1ccc(-c2ccc(Cn3ccnc3)cn2)cc1F,Cytochrome P450 11B2,IC50,1665,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,intermediate,CHEMBL2015356
CHEMBL402298,COc1ccccc1-c1ccc(Cn2ccnc2)cn1,Cytochrome P450 11B2,IC50,4391,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,intermediate,CHEMBL2015356
CHEMBL2011247,Nc1ccccc1-c1ccc(Cn2ccnc2)cn1,Cytochrome P450 11B2,IC50,2114,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,intermediate,CHEMBL2015356
CHEMBL273205,Nc1cccc(-c2ccc(Cn3ccnc3)cn2)c1,Cytochrome P450 11B2,IC50,3407,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,intermediate,CHEMBL2015356
CHEMBL2011253,c1ccc2c(-c3ccc(Cn4ccnc4)cn3)cccc2c1,Cytochrome P450 11B2,IC50,2075,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,intermediate,CHEMBL2015356
CHEMBL2011256,c1cncc(-c2ccc(Cn3ccnc3)cn2)c1,Cytochrome P450 11B2,IC50,3955,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,intermediate,CHEMBL2015356
CHEMBL2011261,c1csc(-c2ccc(Cn3ccnc3)cn2)c1,Cytochrome P450 11B2,IC50,1243,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,intermediate,CHEMBL2015356
CHEMBL2011262,c1cn(Cc2ccc(-c3ccsc3)nc2)cn1,Cytochrome P450 11B2,IC50,3265,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,intermediate,CHEMBL2015356
CHEMBL2011433,c1ccc2c(-c3ccc(Cn4ccnc4)cn3)csc2c1,Cytochrome P450 11B2,IC50,1157,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,intermediate,CHEMBL2015356
CHEMBL2011434,c1coc(-c2ccc(Cn3ccnc3)cn2)c1,Cytochrome P450 11B2,IC50,5159,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,intermediate,CHEMBL2015356
CHEMBL2011435,c1cn(Cc2ccc(-c3ccoc3)nc2)cn1,Cytochrome P450 11B2,IC50,2832,Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector,intermediate,CHEMBL2015356
CHEMBL2165324,O=C1CCc2cc(-c3cccnc3)cc(-c3cccnc3)c2N1,Cytochrome P450 11B2,IC50,1097,Inhibition of human CYP11B2 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,intermediate,CHEMBL2166347
CHEMBL2165323,O=C1CCc2cc(-c3cccnc3)cc(-c3ccccc3)c2N1,Cytochrome P450 11B2,IC50,1167,Inhibition of human CYP11B2 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,intermediate,CHEMBL2166347
CHEMBL2165318,O=C1CCc2cc(-c3cccnc3)c(OC3CCCC3)cc2N1,Cytochrome P450 11B2,IC50,1703,Inhibition of human CYP11B2 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,intermediate,CHEMBL2166347
CHEMBL2312963,O=C1CCc2cc(C(c3ccncc3)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,1580,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",intermediate,CHEMBL2321523
CHEMBL2312952,O=C1CCc2cc(C(c3ccncc3)C3CCCCC3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,1290,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",intermediate,CHEMBL2321523
CHEMBL1444,N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,Cytochrome P450 11B2,IC50,1420,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",intermediate,CHEMBL2321523
CHEMBL2312971,O=C1CCc2cc(C(c3cccnc3)c3cccc(Cl)c3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,5000,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",intermediate,CHEMBL2321523
CHEMBL2312970,Cc1cccc(C(c2cccnc2)c2cc3c4c(c2)CCN4C(=O)CC3)c1,Cytochrome P450 11B2,IC50,5000,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",intermediate,CHEMBL2321523
CHEMBL2312969,COc1ccccc1C(c1cccnc1)c1cc2c3c(c1)CCN3C(=O)CC2,Cytochrome P450 11B2,IC50,5000,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",intermediate,CHEMBL2321523
CHEMBL2312964,O=C1CCc2cc(C(O)c3cccnc3)cc3c2N1CC3,Cytochrome P450 11B2,IC50,5000,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",intermediate,CHEMBL2321523
CHEMBL2323959,CC1(C)CC(c2ccc(C#N)cc2F)c2cn[nH]c21,Cytochrome P450 11B2,IC50,7000,Inhibition of human aldosterone synthase transfected in chinese hamster V79 cells after 24 hrs by LC-MS method,intermediate,CHEMBL2327242
CHEMBL2323958,CC1(C)C[C@H](c2ccc(C#N)cc2)c2cn[nH]c21,Cytochrome P450 11B2,IC50,5000,Inhibition of human aldosterone synthase transfected in chinese hamster V79 cells after 24 hrs by LC-MS method,intermediate,CHEMBL2327242
CHEMBL2331707,Fc1ccc(Cn2ccnc2)cn1,Cytochrome P450 11B2,IC50,1736,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]11-deoxycorticosterone as substrate preincubated for 60 mins prior to substrate addition measured after 50 mins by HPLC analysis",intermediate,CHEMBL2345045
CHEMBL2417618,c1ccc(-c2ccc(Nc3cccnc3)cn2)cc1,Cytochrome P450 11B2,IC50,5000,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",intermediate,CHEMBL2423498
CHEMBL2417617,c1ccc(-c2ccc(Oc3cccnc3)cn2)cc1,Cytochrome P450 11B2,IC50,1880,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",intermediate,CHEMBL2423498
CHEMBL2417613,FC(F)(F)c1cncc(Cc2ccc(-c3ccccc3)nc2)c1,Cytochrome P450 11B2,IC50,1115,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",intermediate,CHEMBL2423498
CHEMBL2417638,NC(=O)c1cncc(Cc2ccc(-c3ccccc3)nc2)c1,Cytochrome P450 11B2,IC50,2924,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",intermediate,CHEMBL2423498
CHEMBL2417636,c1ccc(-c2ccc(Cc3cncnc3)cn2)cc1,Cytochrome P450 11B2,IC50,3111,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",intermediate,CHEMBL2423498
CHEMBL2417631,c1ccc(-c2ncc(Cn3ccnc3)cn2)cc1,Cytochrome P450 11B2,IC50,5000,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",intermediate,CHEMBL2423498
CHEMBL2417630,c1ccc(-c2cnc(Cn3ccnc3)cn2)cc1,Cytochrome P450 11B2,IC50,1025,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",intermediate,CHEMBL2423498
CHEMBL2417629,c1ccc(-c2ccc(Cn3ccnc3)nn2)cc1,Cytochrome P450 11B2,IC50,4539,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",intermediate,CHEMBL2423498
CHEMBL3287171,O=C(C1CC1)N1CCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,1285,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,intermediate,CHEMBL3293049
CHEMBL3287172,CC(C)C(=O)N1CCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,5000,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,intermediate,CHEMBL3293049
CHEMBL3287173,O=C(CCCl)N1CCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,5000,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,intermediate,CHEMBL3293049
CHEMBL3287174,O=C(c1ccc(F)cc1)N1CCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,2833,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,intermediate,CHEMBL3293049
CHEMBL3287175,COc1ccc(C(=O)N2CCc3cc(-c4cccnc4)ccc32)cc1,Cytochrome P450 11B2,IC50,1433,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,intermediate,CHEMBL3293049
CHEMBL3287176,O=C(c1cccs1)N1CCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,3070,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,intermediate,CHEMBL3293049
CHEMBL3287177,O=C(Cc1ccccc1)N1CCc2cc(-c3cccnc3)ccc21,Cytochrome P450 11B2,IC50,5000,Inhibition of human CYP11B2 expressed in hamster V79MZh cells using deoxycorticosterone as substrate,intermediate,CHEMBL3293049
CHEMBL437731,O=c1cc(Cn2ccnc2)c2ccc(Oc3ccccc3)cc2o1,Cytochrome P450 11B2,IC50,2190,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",intermediate,CHEMBL3385624
CHEMBL3359965,O=C(Cn1ccnc1)c1ccc(OCc2cccnc2)cc1,Cytochrome P450 11B2,IC50,1397,"Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells using [1,2-3H]-11-deoxycorticosterone substrate incubated for 25 mins by HPLC method",intermediate,CHEMBL3385624
CHEMBL3415170,Cc1nnc2n1-c1c(F)cc(-c3cncc(C#N)c3)cc1CC2,Cytochrome P450 11B2,IC50,1177.9,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,intermediate,CHEMBL3418338
CHEMBL3415165,Fc1cc(-c2cccnc2)cc2c1-n1c(nnc1-c1ccncc1)CC2,Cytochrome P450 11B2,IC50,10000,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,intermediate,CHEMBL3418338
CHEMBL3415164,Fc1cc2c(cc1-c1cccnc1)CCc1nnc(-c3ccncc3)n1-2,Cytochrome P450 11B2,IC50,10000,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,intermediate,CHEMBL3418338
CHEMBL3415162,Fc1cc2c(cc1-c1cccnc1)CCc1nnc(Cc3ccccc3)n1-2,Cytochrome P450 11B2,IC50,4354.4,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,intermediate,CHEMBL3418338
CHEMBL3415161,Fc1cc(-c2cccnc2)cc2c1-n1c(nnc1-c1ccccc1)CC2,Cytochrome P450 11B2,IC50,10000,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,intermediate,CHEMBL3418338
CHEMBL3415160,Fc1cc2c(cc1-c1cccnc1)CCc1nnc(-c3ccccc3)n1-2,Cytochrome P450 11B2,IC50,10000,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,intermediate,CHEMBL3418338
CHEMBL3415159,CC(C)c1nnc2n1-c1c(F)cc(-c3cccnc3)cc1CC2,Cytochrome P450 11B2,IC50,10000,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,intermediate,CHEMBL3418338
CHEMBL3415158,CC(C)c1nnc2n1-c1cc(F)c(-c3cccnc3)cc1CC2,Cytochrome P450 11B2,IC50,10000,Inhibition of human CYP11B2 expressed in V79 MZh cells using [14C]-deoxycorticosterone substrate incubated for 6 hrs by HPTLC method,intermediate,CHEMBL3418338
CHEMBL3421783,c1ccc(CCOc2cccnc2-c2cccnc2)cc1,Cytochrome P450 11B2,IC50,1453,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,intermediate,CHEMBL3424480
CHEMBL3421784,c1ccc(CCOc2cccnc2-c2ccncc2)cc1,Cytochrome P450 11B2,IC50,2441,Inhibition of human CYP11B2 expressed in hamster fibroblast using 100 nM [3H]-11-deoxycorticosterone as substrate after 45 mins by HPLC analysis,intermediate,CHEMBL3424480
CHEMBL3582463,N#Cc1ccc2c(c1)nc(-c1cccnc1)n2C1CC1,Cytochrome P450 11B2,IC50,1768,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,intermediate,CHEMBL3583831
CHEMBL3582461,FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1,Cytochrome P450 11B2,IC50,10000,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,intermediate,CHEMBL3583831
CHEMBL3582454,Fc1ccc2nc(-c3cccnc3)n(C3CCC3)c2c1,Cytochrome P450 11B2,IC50,5000,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,intermediate,CHEMBL3583831
CHEMBL3582453,CC(C)(C)n1c(-c2cccnc2)nc2ccc(F)cc21,Cytochrome P450 11B2,IC50,5000,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,intermediate,CHEMBL3583831
CHEMBL3582448,Fc1ccc2nc(-c3cccnc3)[nH]c2c1,Cytochrome P450 11B2,IC50,10000,Inhibition of human CYP11B2 expressed in V79 cells incubated for 1 hr before 11-deoxycorticosterone substrate addition by HTRF-based assay,intermediate,CHEMBL3583831
CHEMBL3622433,c1cncc(-c2ccc3c(c2)CCc2nnc(C4CCCCC4)n2-3)c1,Cytochrome P450 11B2,IC50,2400,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,intermediate,CHEMBL3624350
CHEMBL3622438,CNC(=O)c1cncc(-c2ccc3c(c2)CCc2nnc(C)n2-3)c1,Cytochrome P450 11B2,IC50,8333,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,intermediate,CHEMBL3624350
CHEMBL3622439,Cc1nnc2n1-c1ccc(-c3cncc(C(=O)N(C)C)c3)cc1CC2,Cytochrome P450 11B2,IC50,8333,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,intermediate,CHEMBL3624350
CHEMBL3622440,Cc1nnc2n1-c1ccc(-c3cncc(S(C)(=O)=O)c3)cc1CC2,Cytochrome P450 11B2,IC50,8333,Inhibition of human CYP11B2 expressed in V79 cells assessed as aldosterone level after 3 hrs by HTRF assay in presence of 125 nM 11-deoxycorticosterone,intermediate,CHEMBL3624350
CHEMBL3794177,COc1ccc2c(=O)cc(Cc3ccncc3)oc2c1,Cytochrome P450 11B2,IC50,5000,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",intermediate,CHEMBL3795161
CHEMBL3792996,O=c1cc(Cc2ccncc2)oc2ccccc12,Cytochrome P450 11B2,IC50,1235.3,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",intermediate,CHEMBL3795161
CHEMBL3794391,COc1ccc2c(=O)c(Cc3ccncc3)coc2c1,Cytochrome P450 11B2,IC50,3270.6,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",intermediate,CHEMBL3795161
CHEMBL3794457,COc1ccc2c(=O)cc(Cn3ccnc3)oc2c1,Cytochrome P450 11B2,IC50,2268.4,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",intermediate,CHEMBL3795161
CHEMBL3793530,COc1ccc2c(=O)c(Cc3c[nH]cn3)coc2c1,Cytochrome P450 11B2,IC50,1066.1,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",intermediate,CHEMBL3795161
CHEMBL3792868,O=c1c(Cc2cccnc2)coc2ccccc12,Cytochrome P450 11B2,IC50,10000,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",intermediate,CHEMBL3795161
CHEMBL3793057,COc1ccc2c(=O)c(Cc3cccnc3)coc2c1,Cytochrome P450 11B2,IC50,10000,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",intermediate,CHEMBL3795161
CHEMBL3794567,O=c1c(Cc2cccnc2)coc2cc(F)ccc12,Cytochrome P450 11B2,IC50,10000,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",intermediate,CHEMBL3795161
CHEMBL3792398,O=c1cc(Cc2cccnc2)oc2ccccc12,Cytochrome P450 11B2,IC50,10000,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",intermediate,CHEMBL3795161
CHEMBL3792680,COc1ccc2c(=O)cc(Cc3cccnc3)oc2c1,Cytochrome P450 11B2,IC50,10000,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",intermediate,CHEMBL3795161
CHEMBL3794438,O=c1cc(Cc2cccnc2)oc2cc(F)ccc12,Cytochrome P450 11B2,IC50,10000,"Inhibition of human CYP11B2 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 30 mins by HPTLC analysis",intermediate,CHEMBL3795161
CHEMBL3971021,CN1CCC2(CCN(c3cncc4ccccc34)CC2)C1=O,Cytochrome P450 11B2,IC50,8000,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,intermediate,CHEMBL3871210
CHEMBL3899850,c1ccc2c(N3CCC4(CCNC4)CC3)cncc2c1,Cytochrome P450 11B2,IC50,10000,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,intermediate,CHEMBL3871210
CHEMBL3974912,CC(=O)N1CCC2(CCN(c3cncc4ccccc34)CC2)C1,Cytochrome P450 11B2,IC50,1031,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,intermediate,CHEMBL3871210
CHEMBL3945534,CC(C)(C)OC(=O)N1CCC2(CCN(c3cncc4ccccc34)CC2)C1,Cytochrome P450 11B2,IC50,1134,Inhibition of human CYP11B2-CLE9 expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,intermediate,CHEMBL3871210
CHEMBL4096290,c1ccc(-c2cc(Cn3ccnc3)on2)cc1,Cytochrome P450 11B2,IC50,1304,"Inhibition of human CYP11B2 expressed in hamster V79MZ cells using [1,2-3H]-11-deoxycorticosterone as substrate after 6 hrs by HPLC analysis",intermediate,CHEMBL4016909
CHEMBL4076806,CC(C)(O)c1cncc(-n2ncc3ccc(C(F)(F)F)cc32)c1,Cytochrome P450 11B2,IC50,2300,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,intermediate,CHEMBL4029972
CHEMBL4099361,CC(C)(O)c1cncc(-n2ncc3cc(C#N)ccc32)c1,Cytochrome P450 11B2,IC50,1156,Inhibition of human CYP11B2-CLE9 expressed in Chinese hamster V79 cells using 11-deoxycorticosterone as substrate preincubated for 1 hr followed by substrate addition measured for 3 hrs by HTRF assay,intermediate,CHEMBL4029972
CHEMBL106,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,Cytochrome P450 11B2,IC50,13000,Inhibition of CYP11B2 in human hepatocyte microsomes using deoxycorticosteroid substrate by HPLC/MS/MS method,intermediate,CHEMBL4056600
CHEMBL1083354,O=c1c2ccccc2oc2ccc(Cn3ccnc3)cc12,Cytochrome P450 11B2,IC50,1140.4,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate after 30 mins by HPTLC analysis",intermediate,CHEMBL4193320
CHEMBL4586863,Fc1ccc2nc(-n3ccnn3)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,1064,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,intermediate,CHEMBL4307089
CHEMBL4464454,Fc1ccc2nc(-c3cnco3)n(C3CC3)c2c1,Cytochrome P450 11B2,IC50,10000,Inhibition of human recombinant CYP11B2 using deoxycorticosterone as substrate incubated for 90 mins by cell-based HPLC analysis,intermediate,CHEMBL4307089
CHEMBL4634791,O=C1c2ccc(Cl)cc2C(Cc2ccccc2)N1c1cccnc1,Cytochrome P450 11B2,IC50,1070,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,intermediate,CHEMBL4618742
CHEMBL4635713,O=C1c2ccccc2CN1c1cccnc1,Cytochrome P450 11B2,IC50,1120,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,intermediate,CHEMBL4618742
CHEMBL4635931,CN(C(=O)c1ccc(C#N)cc1)c1cccnc1,Cytochrome P450 11B2,IC50,3000,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,intermediate,CHEMBL4618742
CHEMBL4642430,Cc1cc(Cl)ccc1C(=O)N(C)c1cccnc1,Cytochrome P450 11B2,IC50,3000,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,intermediate,CHEMBL4618742
CHEMBL4635356,CN(C(=O)c1ccc(Cl)cc1F)c1cccnc1,Cytochrome P450 11B2,IC50,3000,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,intermediate,CHEMBL4618742
CHEMBL259398,Cc1ccc(C(=O)Nc2cccnc2)cc1,Cytochrome P450 11B2,IC50,3000,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,intermediate,CHEMBL4618742
CHEMBL4638042,CC1(C)CN(c2cccnc2)C(=O)c2ccc(Cl)cc21,Cytochrome P450 11B2,IC50,1538,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,intermediate,CHEMBL4618742
CHEMBL4635336,CC(=O)N[C@H]1CCCc2c1cncc2N1Cc2cc(Cl)ccc2C1=O,Cytochrome P450 11B2,IC50,5141,Inhibition of human CYP11B2 expressed in human renal leiomyoblastoma cells harboring FDXR/FDX using 1-deoxycorticosterone as substrate by HTRF assay,intermediate,CHEMBL4618742
CHEMBL281947,Nc1ccc(C23CC2C(=O)N(CC2CCCCC2)C3=O)cc1,Cytochrome P450 11B2,IC50,34000,In vitro inhibition of aldosterone production in rat adrenal tissue,intermediate,CHEMBL795454
CHEMBL294361,COc1ccc2c(c1)C1C(CC2)C1c1ccncc1,Cytochrome P450 11B2,IC50,6000,In vitro inhibition of ACTH-stimulated aldosterone biosynthesis in rat adrenal slices,intermediate,CHEMBL779290
CHEMBL224060,Cn1nnc2ccc([C@H](c3ccc(Cl)cc3)n3cncn3)cc21,Cytochrome P450 11B2,IC50,12000,In vitro inhibition of ACTH-stimulated aldosterone biosynthesis in rat adrenal slices,intermediate,CHEMBL779291
CHEMBL304583,Oc1ccc2c(c1)C1C(CC2)C1c1ccncc1,Cytochrome P450 11B2,IC50,7000,In vitro inhibition of ACTH-stimulated aldosterone biosynthesis in rat adrenal slices,intermediate,CHEMBL779290
